Craig Mayer, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

_See the full regCOVID repository with detailed results at https://github.com/lhncbc/r-snippets-bmi/tree/master/regCOVID

Study Status

overall_status Study_Count
Active, not recruiting 287
Approved for marketing 2
Available 21
Completed 505
Enrolling by invitation 127
No longer available 5
Not yet recruiting 865
Recruiting 2002
Suspended 26
Terminated 34
Withdrawn 67

Study Types

Type Study_count
Total_Studies 2955
interventional 1568
Observational 1181
Registry 206

Studies over Time

Total studies by type over time

Total studies by type over time

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 370
Drug|placebo 294
Other 149
Biological 139
Behavioral 92
Biological|placebo 92
Device 79
Drug|Other 68
Diagnostic Test 57
Procedure 29
Biological|Other 24
Biological|Drug 23
Dietary Supplement 15
Device|Other 12
Dietary Supplement|placebo 12
Radiation 10
Behavioral|Other 9
Dietary Supplement|Drug 9
Combination Product 8
Drug|Other|placebo 8
Biological|Drug|placebo 5
Other|placebo 5
Combination Product|Drug 4
Behavioral|placebo 3
Device|Drug|Procedure 3
Device|placebo 3
Dietary Supplement|Drug|placebo 3
Dietary Supplement|Other 3
Other|Procedure 3
Behavioral|Biological 2
Biological|Device|Other 2
Biological|Diagnostic Test 2
Biological|Other|placebo 2
Combination Product|placebo 2
Device|Drug 2
Device|Drug|Radiation 2
Device|Procedure 2
Diagnostic Test|Other 2
Drug|placebo|Procedure 2
Drug|Procedure 2
Behavioral|Combination Product 1
Behavioral|Device 1
Behavioral|Diagnostic Test 1
Behavioral|Drug 1
Biological|Combination Product|Drug|placebo 1
Biological|Device|Diagnostic Test 1
Biological|Drug|Procedure 1
Biological|Genetic|Other 1
Combination Product|Dietary Supplement 1
Diagnostic Test|Dietary Supplement 1
Diagnostic Test|Drug|Other|placebo 1
Dietary Supplement|Drug|Other 1
Drug|placebo|Radiation 1
Other|Radiation 1
placebo|Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Weekly studies for each intervention

Studies by Country

Country Study_Count
United States 449
France 136
China 76
Spain 64
Brazil 60
Canada 53
United Kingdom 51
Mexico 44
Italy 41
Egypt 37
Turkey 29
Russian Federation 28
Pakistan 26
Belgium 25
Germany 24
Argentina 19
Denmark 18
India 18
Iran, Islamic Republic of 18
Australia 16
Israel 15
Sweden 15
Netherlands 12
Switzerland 12
Bangladesh 11
Korea, Republic of 10
Saudi Arabia 10
Colombia 9
Greece 9
Indonesia 8
Hong Kong 7
Singapore 7
South Africa 7
United States|Puerto Rico 7
Japan 6
United States|Brazil 6
Poland 5
Qatar 5
United States|Canada 5
Austria 4
Chile 4
Hungary 4
Iraq 4
Norway 4
Taiwan 4
Malaysia 3
Romania 3
Bahrain 2
Belarus 2
Finland 2
France|Monaco 2
French Guiana 2
Guinea 2
Guinea-Bissau 2
Kazakhstan 2
Kuwait 2
North Macedonia 2
Peru 2
Thailand 2
Ukraine 2
United States|Chile|Colombia|Israel|Russian Federation|Spain|United Kingdom 2
Vietnam 2
Argentina|Brazil|Canada|Chile|France|Germany|Israel|Italy|Japan|Russian Federation|Spain 1
Argentina|Brazil|Chile|Mexico|Russian Federation 1
Argentina|Brazil|Denmark|Germany|Hungary|India|Mexico|Netherlands|Peru|Russian Federation|South Africa|Spain 1
Argentina|Chile|Mexico|Pakistan|Russian Federation 1
Argentina|Egypt 1
Australia|Netherlands|Spain|United Kingdom 1
Australia|United States|Philippines|Romania 1
Austria|Belgium|France|Luxembourg 1
Austria|Denmark|Germany|Russian Federation|United Kingdom 1
Austria|Germany 1
Bahrain|Egypt|Jordan|United Arab Emirates 1
Belgium|Brazil|France|Germany|Italy|Mexico|Spain|United Kingdom 1
Belgium|France 1
Belgium|France|Monaco 1
Belgium|Germany 1
Bosnia and Herzegovina 1
Brazil|Canada|Chile|Colombia|Ecuador|Egypt|India|Pakistan|Philippines|Russian Federation|Saudi Arabia|United Arab Emirates 1
Brazil|Italy 1
Brazil|United States 1
Bulgaria|Germany 1
Canada|Israel 1
Canada|Mongolia 1
Canada|Saudi Arabia 1
China|Indonesia 1
China|Italy 1
Costa Rica 1
Czechia 1
Denmark|India|Sweden|Switzerland 1
Dominican Republic 1
Ecuador 1
French Guiana|Guadeloupe|New Caledonia 1
Germany|Israel 1
Germany|Netherlands 1
Germany|Netherlands|Spain 1
Germany|Sweden 1
Gibraltar 1
Honduras 1
Iceland 1
India|Israel 1
India|United Kingdom 1
Indonesia|Italy|Lao People’s Democratic Republic|Pakistan|Thailand|United Kingdom 1
Ireland 1
Israel|Mexico|Russian Federation 1
Italy|Spain 1
Jordan 1
Kenya 1
Kyrgyzstan 1
Moldova, Republic of 1
Moldova, Republic of|Romania|Ukraine|United Kingdom 1
1
New Zealand 1
Nigeria 1
Panama|Peru 1
Philippines 1
Puerto Rico 1
Russian Federation|Spain 1
Rwanda 1
Senegal 1
Slovenia 1
Sweden|United States|China|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|Netherlands|Singapore|Spain|Switzerland|Taiwan|United Kingdom 1
Turkey|Argentina|Brazil|Chile|France|Germany|India|Italy|Mexico|Peru|Russian Federation|South Africa|Spain 1
Uganda 1
Ukraine|South Africa|United States|Belgium|Brazil|Moldova, Republic of|Romania 1
United Arab Emirates 1
United States|Argentina|Belgium|Brazil|Canada|Chile|France|India|Japan|Mexico|Netherlands|Peru|Poland|Russian Federation|South Africa|Spain|United Kingdom 1
United States|Argentina|Brazil|Chile|Colombia|Mexico|Peru|Philippines|South Africa|Ukraine 1
United States|Argentina|Brazil|Colombia|France|Germany|Mexico|Peru|Russian Federation|Spain|Turkey|United Kingdom 1
United States|Argentina|Brazil|Germany|India|Italy|Japan|Korea, Republic of|Mexico|Puerto Rico|Russian Federation|Spain|United Kingdom 1
United States|Argentina|Brazil|Germany|South Africa|Turkey 1
United States|Argentina|Chile|Colombia|Peru 1
United States|Australia 1
United States|Australia|Brazil|Spain 1
United States|Austria|Belgium 1
United States|Austria|France|Israel|Spain|United Kingdom 1
United States|Belgium 1
United States|Belgium|Brazil|France 1
United States|Belgium|Canada|France|Japan|Spain 1
United States|Belgium|Colombia|France|Germany|Philippines|South Africa|Spain|United Kingdom 1
United States|Belgium|France|Netherlands 1
United States|Brazil|Canada|Chile|Peru|Spain|United Kingdom 1
United States|Brazil|Canada|Mexico 1
United States|Brazil|Canada|South Africa|Spain 1
United States|Brazil|Chile|Moldova, Republic of|Romania 1
United States|Brazil|Chile|Peru|South Africa 1
United States|Brazil|France|Russian Federation|Spain 1
United States|Brazil|Kenya|Mexico|Peru|South Africa 1
United States|Brazil|Mexico 1
United States|Brazil|Mexico|Spain 1
United States|Brazil|Russian Federation 1
United States|Canada|Denmark|France|Germany|Italy|Netherlands|Spain|United Kingdom 1
United States|Canada|Ghana|Ireland|Netherlands|South Africa|Uganda|United Kingdom|Zambia|Zimbabwe 1
United States|Denmark 1
United States|Denmark|Germany|Greece|Japan|Korea, Republic of|Mexico|Singapore|Spain|United Kingdom 1
United States|Denmark|Greece|Japan|Nigeria|United Kingdom 1
United States|Denmark|Japan|Korea, Republic of|Mexico|Singapore|Spain|United Kingdom 1
United States|Denmark|Singapore|Spain 1
United States|France|Italy|Russian Federation|Spain|United Kingdom 1
United States|France|Japan|Spain|United Kingdom 1
United States|Israel 1
United States|Italy 1
United States|Italy|Spain|United Kingdom 1
United States|Japan|Korea, Republic of|Mexico|Singapore 1
United States|Moldova, Republic of|Romania 1
United States|New Zealand 1
United States|Romania 1
United States|Russian Federation 1
United States|Spain 1
United States|Spain|China|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|Netherlands|Singapore|Sweden|Switzerland|Taiwan|United Kingdom 1
United States|Switzerland 1
United States|Turkey 1

Sites per Study

Site_count Study_Count
1 1008
2 129
3 61
4 52
5 33
6 28
7 23
8 23
9 19
10 19
11 17
12 14
13 14
14 7
15 8
16 8
17 5
18 4
19 4
20 4
21 3
22 6
23 2
24 2
25 3
26 5
27 2
28 3
29 2
30 4
31 2
32 1
33 2
34 2
35 2
37 1
39 1
40 4
43 1
45 1
47 3
48 1
51 1
53 2
59 2
60 1
61 3
62 1
64 1
65 1
67 1
69 2
71 3
73 2
77 1
96 1
100 2
110 2
115 1
116 1
127 1
128 1
129 1
155 1
183 1
184 1
261 1

Phase

Phase Study_Count
N/A 538
Phase 2 399
Phase 3 230
Phase 2/Phase 3 109
Phase 1 101
Phase 1/Phase 2 93
Phase 4 76
Early Phase 1 22

Number of Arms

Number_of_Arms Count_of_Studies
1 266
2 976
3 155
4 81
5 21
6 25
7 3
8 9
9 4
10 4
11 2
12 3
13 1
14 1
15 1
16 1
17 2
21 1
28 1
11

Number of Updates

Count of Versions Count of Studies
1 325
2 390
3 331
4 191
5 102
6 65
7 36
8 22
9 19
10 16
11 10
12 5
13 9
14 7
15 2
16 4
17 1
18 3
19 2
20 5
22 2
24 1
28 1
33 1
36 1
130 1

Update History Change Type

Change Type Count_of_Changes Count_of_Studies ratio
Study Status 3945 1227 3.215159
Contacts/Locations 2349 994 2.363179
None (earliest Version on record) 1552 1552 1.000000
Recruitment Status 1119 918 1.218954
Outcome Measures 738 541 1.364140
Eligibility 635 433 1.466513
Study Design 614 471 1.303609
Study Description 550 420 1.309524
Study Identification 504 393 1.282443
Oversight 500 463 1.079914
Arms 461 342 1.347953
Interventions 461 342 1.347953
Sponsor/Collaborators 199 165 1.206061
Conditions 157 136 1.154412
IPDSharing 71 67 1.059702
References 68 56 1.214286
Documents 39 29 1.344828
Results 8 8 1.000000
Results Submission Events 6 6 1.000000
2020Recruitment Status 4 3 1.333333
Reported Adverse Events 4 3 1.333333
2020 Outcome Measures 1 1 1.000000
Baseline Characteristics 1 1 1.000000
More Information 1 1 1.000000
Quality Control Review has not concludedReturned: August 18 1 1 1.000000
Quality Control Review has not concludedReturned: November 17 1 1 1.000000
Quality Control Review has not concludedReturned: November 24 1 1 1.000000
Quality Control Review has not concludedReturned: September 10 1 1 1.000000
Quality Control Review has not concludedReturned: September 3 1 1 1.000000

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 9.00000 2.000 5.00000 1.0000 1.0000 5.000 1.000 10.000
1st Qu. 12.50000 46.500 24.00000 30.0000 50.0000 120.000 189.500 60.000
Median 55.00000 120.000 45.00000 60.0000 100.0000 310.000 456.500 178.000
Mean 69.86364 4569.764 76.31683 251.2151 221.9925 1157.394 2608.704 1576.579
3rd Qu. 98.50000 343.000 90.00000 210.0000 200.0000 500.000 1289.250 616.500
Max. 250.00000 506517.000 940.00000 2970.0000 10000.0000 43998.000 60000.000 80000.000

Trial Group Type

group_type Group_Count
Experimental 1966
Placebo Comparator 566
Active Comparator 556
No Intervention 326
Other 194
Sham Comparator 22
11

Intervention Model

intervention_model Study_Count
Parallel Assignment 1132
Single Group Assignment 308
Sequential Assignment 72
Crossover Assignment 29
Factorial Assignment 27

Primary Purpose

primary_purpose Study_Count
Treatment 1054
Prevention 225
Diagnostic 77
Supportive Care 76
Other 74
Health Services Research 26
Basic Science 16
Screening 16
Device Feasibility 4

Has Results

nct_id brief_title link
NCT04280705 Adaptive COVID-19 Treatment Trial (ACTT) https://ClinicalTrials.gov/show/NCT04280705
NCT04343092 Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management https://ClinicalTrials.gov/show/NCT04343092
NCT04343261 Convalescent Plasma in the Treatment of COVID 19 https://ClinicalTrials.gov/show/NCT04343261
NCT04410159 Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients https://ClinicalTrials.gov/show/NCT04410159
NCT04435808 Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19 https://ClinicalTrials.gov/show/NCT04435808
NCT04422561 Prophylactic Ivermectin in COVID-19 Contacts https://ClinicalTrials.gov/show/NCT04422561
NCT04491240 Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Pneumonia. https://ClinicalTrials.gov/show/NCT04491240
NCT04491994 Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression https://ClinicalTrials.gov/show/NCT04491994
NCT04523831 Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 Infection https://ClinicalTrials.gov/show/NCT04523831
NCT04542694 Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04542694

Vaccines

nct_id brief_title link
NCT04276896 Immunity and Safety of Covid-19 Synthetic Minigene Vaccine https://ClinicalTrials.gov/show/NCT04276896
NCT04283461 Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04283461
NCT04299724 Safety and Immunity of Covid-19 aAPC Vaccine https://ClinicalTrials.gov/show/NCT04299724
NCT04313127 Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults https://ClinicalTrials.gov/show/NCT04313127
NCT04324606 A Study of a Candidate COVID-19 Vaccine (COV001) https://ClinicalTrials.gov/show/NCT04324606
NCT04327206 BCG Vaccination to Protect Healthcare Workers Against COVID-19 https://ClinicalTrials.gov/show/NCT04327206
NCT04328441 Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine https://ClinicalTrials.gov/show/NCT04328441
NCT04348370 BCG Vaccine for Health Care Workers as Defense Against COVID 19 https://ClinicalTrials.gov/show/NCT04348370
NCT04334980 Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT04334980
NCT04336410 Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers https://ClinicalTrials.gov/show/NCT04336410
NCT04341389 A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector) https://ClinicalTrials.gov/show/NCT04341389
NCT04352608 Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04352608
NCT04357028 Measles Vaccine in HCW https://ClinicalTrials.gov/show/NCT04357028
NCT04368988 Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant https://ClinicalTrials.gov/show/NCT04368988
NCT04368728 Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals https://ClinicalTrials.gov/show/NCT04368728
NCT04369794 COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement https://ClinicalTrials.gov/show/NCT04369794
NCT04380532 Tableted COVID-19 Therapeutic Vaccine https://ClinicalTrials.gov/show/NCT04380532
NCT04373291 Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04373291
NCT04379336 BCG Vaccination for Healthcare Workers in COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04379336
NCT04384549 Efficacy of BCG Vaccination in the Prevention of COVID19 Via the Strengthening of Innate Immunity in Health Care Workers https://ClinicalTrials.gov/show/NCT04384549
NCT04380701 A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults https://ClinicalTrials.gov/show/NCT04380701
NCT04383574 Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19) https://ClinicalTrials.gov/show/NCT04383574
NCT04400838 Investigating a Vaccine Against COVID-19 https://ClinicalTrials.gov/show/NCT04400838
NCT04405076 Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older https://ClinicalTrials.gov/show/NCT04405076
NCT04412538 Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 https://ClinicalTrials.gov/show/NCT04412538
NCT04417335 Reducing COVID-19 Related Hospital Admission in Elderly by BCG Vaccination https://ClinicalTrials.gov/show/NCT04417335
NCT04405908 SCB-2019 as COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04405908
NCT04414267 Bacillus Calmette-guérin Vaccination to Prevent COVID-19 https://ClinicalTrials.gov/show/NCT04414267
NCT04453852 Monovalent Recombinant COVID19 Vaccine https://ClinicalTrials.gov/show/NCT04453852
NCT04444674 COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection https://ClinicalTrials.gov/show/NCT04444674
NCT04447781 Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19 https://ClinicalTrials.gov/show/NCT04447781
NCT04445194 Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine https://ClinicalTrials.gov/show/NCT04445194
NCT04437875 An Open Study of the Safety, Tolerability and Immunogenicity of “Gam-COVID-Vac Lyo” Vaccine Against COVID-19 https://ClinicalTrials.gov/show/NCT04437875
NCT04436471 An Open Study of the Safety, Tolerability and Immunogenicity of the Drug “Gam-COVID-Vac” Vaccine Against COVID-19 https://ClinicalTrials.gov/show/NCT04436471
NCT04450004 Safety, Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years. https://ClinicalTrials.gov/show/NCT04450004
NCT04449276 A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults https://ClinicalTrials.gov/show/NCT04449276
NCT04445389 Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults https://ClinicalTrials.gov/show/NCT04445389
NCT04445428 OPV as Potential Protection Against COVID-19 https://ClinicalTrials.gov/show/NCT04445428
NCT04456595 Clinical Trial of Efficacy and Safety of Sinovac’s Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals https://ClinicalTrials.gov/show/NCT04456595
NCT04460703 COVID-19 Vaccine Messaging, Part 1 https://ClinicalTrials.gov/show/NCT04460703
NCT04461379 Prevention, Efficacy and Safety of BCG Vaccine in COVID-19 Among Healthcare Workers https://ClinicalTrials.gov/show/NCT04461379
NCT04466085 Clinical Study of Recombinant Novel Coronavirus Vaccine https://ClinicalTrials.gov/show/NCT04466085
NCT04463472 Study of COVID-19 DNA Vaccine (AG0301-COVID19) https://ClinicalTrials.gov/show/NCT04463472
NCT04471519 Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers https://ClinicalTrials.gov/show/NCT04471519
NCT04470427 A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19 https://ClinicalTrials.gov/show/NCT04470427
NCT04495933 A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults https://ClinicalTrials.gov/show/NCT04495933
NCT04470609 Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 in People Aged ⩾60 Years https://ClinicalTrials.gov/show/NCT04470609
NCT04475302 BCG Vaccine in Reducing Morbidity and Mortality in Elderly Individuals in COVID-19 Hotspots https://ClinicalTrials.gov/show/NCT04475302
NCT04480957 Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects https://ClinicalTrials.gov/show/NCT04480957
NCT04497298 Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04497298
NCT04498247 A Study to Assess Safety, Tolerability, and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Participants (V591-001) https://ClinicalTrials.gov/show/NCT04498247
NCT04510207 A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above https://ClinicalTrials.gov/show/NCT04510207
NCT04508075 Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine https://ClinicalTrials.gov/show/NCT04508075
NCT04527575 Study of the Safety, Reactogenicity and Immunogenicity of “EpiVacCorona” Vaccine for the Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT04527575
NCT04522089 A Study to Evaluate the Safety and Immunogenicity of COVID-19 (AdimrSC-2f) Vaccine https://ClinicalTrials.gov/show/NCT04522089
NCT04515147 A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19 https://ClinicalTrials.gov/show/NCT04515147
NCT04550351 Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2 Phase I Clinical Trial (≥60 Years Old) https://ClinicalTrials.gov/show/NCT04550351
NCT04540419 Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Against COVID-19 https://ClinicalTrials.gov/show/NCT04540419
NCT04516746 Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults https://ClinicalTrials.gov/show/NCT04516746
NCT04612972 Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Adult Population In Peru https://ClinicalTrials.gov/show/NCT04612972
NCT04523571 Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b1) in Chinese Healthy Subjects https://ClinicalTrials.gov/show/NCT04523571
NCT04528641 GRAd-COV2 Vaccine Against COVID-19 https://ClinicalTrials.gov/show/NCT04528641
NCT04523246 Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents https://ClinicalTrials.gov/show/NCT04523246
NCT04568031 Study of AZD1222 for the Prevention of COVID-19 in Japan https://ClinicalTrials.gov/show/NCT04568031
NCT04526990 Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above https://ClinicalTrials.gov/show/NCT04526990
NCT04527081 Study of COVID-19 DNA Vaccine (AG0302-COVID19) https://ClinicalTrials.gov/show/NCT04527081
NCT04530396 Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 https://ClinicalTrials.gov/show/NCT04530396
NCT04530357 Reactogenicity, Safety and Immunogenicity of QazCovid-in® COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04530357
NCT04535453 A Study to Evaluate a Range of Dose Levels and Vaccination Intervals of Ad26.COV2.S in Healthy Adults https://ClinicalTrials.gov/show/NCT04535453
NCT04537663 Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults https://ClinicalTrials.gov/show/NCT04537663
NCT04533399 A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults https://ClinicalTrials.gov/show/NCT04533399
NCT04536051 A Study of a Candidate COVID-19 Vaccine (COV003) https://ClinicalTrials.gov/show/NCT04536051
NCT04545749 A Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04545749
NCT04537949 A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults https://ClinicalTrials.gov/show/NCT04537949
NCT04537208 Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older https://ClinicalTrials.gov/show/NCT04537208
NCT04540185 A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 https://ClinicalTrials.gov/show/NCT04540185
NCT04542330 Using BCG to Protect Senior Citizens During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04542330
NCT04552366 A Clinical Trial of a Recombinant Adenovirus 5 Vectored COVID-19 Vaccine (Ad5-nCoV) With Two Doses in Healthy Adults https://ClinicalTrials.gov/show/NCT04552366
NCT04551547 Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT04551547
NCT04560881 Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19) https://ClinicalTrials.gov/show/NCT04560881
NCT04563702 Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults https://ClinicalTrials.gov/show/NCT04563702
NCT04566770 A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) https://ClinicalTrials.gov/show/NCT04566770
NCT04564716 Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus https://ClinicalTrials.gov/show/NCT04564716
NCT04569786 Dose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001) https://ClinicalTrials.gov/show/NCT04569786
NCT04568811 The Phase I Clinical Trial of Booster Vaccination of Adenovirus Type-5 Vectored COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04568811
NCT04582344 Clinical Trial For SARS-CoV-2 Vaccine (COVID-19) https://ClinicalTrials.gov/show/NCT04582344
NCT04583995 A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom https://ClinicalTrials.gov/show/NCT04583995
NCT04587219 The Study of “Gam-COVID-Vac” Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and Older https://ClinicalTrials.gov/show/NCT04587219
NCT04591717 Study of the Safety of Prophylactic Vaccination With 2nd Generation E1/E2B/E3-Deleted Adenoviral-COVID-19 in Normal Healthy Volunteers https://ClinicalTrials.gov/show/NCT04591717
NCT04588480 Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Japanese Adults https://ClinicalTrials.gov/show/NCT04588480
NCT04608305 Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine https://ClinicalTrials.gov/show/NCT04608305
NCT04639466 A Synthetic MVA-based SARS-CoV-2 Vaccine, COH04S1, for the Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT04639466
NCT04617483 Study of the Commercial Scale SARS-CoV-2 Vaccine Against the Pilot Scale Among Adults, and Bridging Study of the Immunogenicity in Elderly Against That in Adults https://ClinicalTrials.gov/show/NCT04617483
NCT04641481 An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers https://ClinicalTrials.gov/show/NCT04641481
NCT04639375 Polio Vaccine (IPV) for SARS-CoV-2 and Prevention of Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04639375
NCT04634760 Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Japanese Adults https://ClinicalTrials.gov/show/NCT04634760
NCT04636333 Phase I Trial of a Recombinant SARS-CoV-2 Vaccine (CHO Cell) https://ClinicalTrials.gov/show/NCT04636333
NCT04640402 A Phase â…¡ Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells) https://ClinicalTrials.gov/show/NCT04640402

Phase

phase Study_Count
Early Phase 1 1
N/A 1
Phase 1 24
Phase 1/Phase 2 28
Phase 2 9
Phase 2/Phase 3 2
Phase 3 26
Phase 4 7

Country

country Study_Count
Argentina 4
Australia 6
Austria 1
Bahrain 1
Belarus 1
Belgium 3
Brazil 4
Canada 2
Chile 2
China 19
Colombia 1
Denmark 2
Egypt 2
France 2
Germany 5
Greece 1
Guinea-Bissau 1
India 3
Indonesia 1
Israel 1
Italy 1
Japan 5
Jordan 1
Kazakhstan 1
Korea, Republic of 2
Mexico 2
Mongolia 1
Netherlands 5
New Zealand 1
Pakistan 1
Panama 1
Peru 3
Russian Federation 7
Singapore 1
South Africa 4
Spain 2
Taiwan 2
Turkey 2
United Arab Emirates 1
United Kingdom 4
United States 18

Site Count

Site_count Study_Count
1 51
2 12
3 3
4 2
5 1
6 4
7 3
8 1
9 3
10 2
11 1
12 1
14 1
15 1
16 1
18 1
20 2
23 1
24 1
28 1
33 1
69 1
100 1
116 1
155 1

Arms

number_of_arms Study_Count
1 7
2 34
3 18
4 11
6 9
7 1
8 3
9 3
10 2
11 1
12 3
13 1
14 1
15 1
16 1
21 1
28 1

Enrollment

Measure Vaccine
Min 12.000
1st Qu 120.000
Median 476.000
Mean 4156.745
3rd Qu 1755.000
Max 45000.000

Model

intervention_model Study_Count
Crossover Assignment 1
Parallel Assignment 63
Sequential Assignment 26
Single Group Assignment 8

Group Types

group_type Group_Count
Experimental 326
Placebo Comparator 91
Active Comparator 39
No Intervention 1
Other 1
Sham Comparator 1

Update Count

Count of Versions Count of Studies
1 11
2 19
3 29
4 13
5 8
6 2
7 5
8 1
9 2
10 1
11 1
13 1
14 1
20 1

Change Type

Change Type Count_of_Changes Count_of_Studies ratio
Study Status 274 84 3.261905
Contacts/Locations 169 72 2.347222
None (earliest Version on record) 95 95 1.000000
Recruitment Status 80 62 1.290323
Study Design 60 41 1.463415
Outcome Measures 55 35 1.571429
Eligibility 54 29 1.862069
Study Identification 51 36 1.416667
Arms 49 31 1.580645
Interventions 49 31 1.580645
Study Description 47 31 1.516129
Oversight 22 18 1.222222
Sponsor/Collaborators 13 11 1.181818
Conditions 12 9 1.333333
References 8 5 1.600000
IPDSharing 5 5 1.000000
Documents 1 1 1.000000

Observational Studies

Studies by Country

Country Study_Count
France 264
United States 173
Italy 84
United Kingdom 76
Egypt 75
Turkey 67
China 44
Spain 40
Germany 30
Switzerland 28
Canada 25
Belgium 19
Denmark 16
India 13
Norway 13
Russian Federation 13
Sweden 13
Argentina 10
Austria 10
Brazil 10
Hong Kong 10
Mexico 10
Pakistan 9
Israel 8
Netherlands 7
Saudi Arabia 7
Poland 6
Singapore 6
Chile 5
Greece 5
Hungary 4
Malaysia 4
Australia 3
Czechia 3
Monaco 3
Portugal 3
Qatar 3
France|French Guiana 2
Korea, Republic of 2
Luxembourg 2
Peru 2
Taiwan 2
United Arab Emirates 2
Albania|Brazil|Bulgaria|Chile|Cyprus|France|Greece|Israel|Malta|Portugal|Spain|Turkey|United Kingdom 1
Algeria 1
Argentina|Bosnia and Herzegovina|Ghana|India|Iran, Islamic Republic of|Sudan 1
Argentina|Chile|Colombia|Ecuador|Spain 1
Austria|Belgium|Czechia|Denmark|France|Germany|Greece|Hungary|Israel|Italy|Lithuania|Netherlands|Poland|Portugal|Russian Federation|Spain|Sweden|Switzerland|United Kingdom 1
Austria|Belgium|Czechia|Germany|Greece|Italy|Netherlands|United Kingdom 1
Belgium|Italy|United Kingdom 1
Bolivia 1
Brazil|Chile|Uruguay 1
Burkina Faso 1
Chile|Colombia|Ecuador|Spain 1
Colombia 1
Croatia 1
Denmark|France|Germany|Norway 1
Ecuador 1
Ethiopia 1
Finland|France|Germany|Italy|Sweden|United Kingdom 1
France|Germany|Spain 1
France|Guadeloupe|Martinique 1
France|Martinique 1
France|Martinique|Mayotte|Réunion 1
Germany|Romania 1
Iran, Islamic Republic of 1
Ireland 1
Israel|Italy|Malaysia|Australia|Canada|China|France|Gambia|Germany|Poland|Portugal|Romania|Singapore|Switzerland 1
Italy|Romania|United Kingdom 1
Italy|San Marino 1
Japan 1
Jordan 1
Kazakhstan 1
1
Nepal 1
Nigeria 1
Philippines 1
Romania 1
Slovenia 1
Tunisia 1
United States|Albania|Australia|Czechia|France|Germany|Hong Kong|Israel|Italy|Lebanon|Norway|Poland|Spain|Sweden|Taiwan 1
United States|Argentina|Armenia|Australia|Bolivia|Chile|Costa Rica|Czechia|Germany|Guatemala|Italy|Lebanon|Mexico|Netherlands|Nigeria|Puerto Rico|Saudi Arabia|Spain|Tunisia|Turkey|Venezuela 1
United States|Argentina|Botswana|Brazil|Kenya|Malawi|Mexico|Mozambique|Peru|South Africa|Tanzania|Zambia|Zimbabwe 1
United States|Argentina|Denmark|United Kingdom 1
United States|Bolivia|Canada|Chile|India|United Kingdom 1
United States|Canada|Puerto Rico 1
United States|Egypt|Germany|Peru|Singapore 1
United States|Egypt|Iran, Islamic Republic of 1
United States|France|Germany|Italy|Poland|Spain|United Kingdom 1
United States|India 1
United States|Malawi|Mozambique|Peru|South Africa|Tanzania|Zambia|Zimbabwe 1
United States|Spain 1
United States|United Kingdom 1

Sites per Study

Site_count Study_Count
1 973
2 64
3 35
4 16
5 15
6 9
7 7
8 7
9 6
10 1
11 4
12 4
13 2
14 5
15 3
17 4
18 1
19 1
20 2
21 1
22 3
23 3
31 1
32 1
33 1
34 1
40 1
44 1
58 2
68 2
81 2
97 1
128 1
842 1

Number of Updates

Count of Versions Count of Studies
1 450
2 395
3 184
4 74
5 32
6 8
7 4
8 4
9 4
10 2
11 1
12 1
13 1
14 3
19 1
20 1
28 1
33 2
36 1
39 1
40 1
44 3
88 1
97 1
111 1
120 1
123 1
133 1
140 1

Update History Change Type

Change Type Count_of_Changes Count_of_Studies ratio
Study Status 2495 731 3.413133
None (earliest Version on record) 1181 1181 1.000000
Contacts/Locations 696 441 1.578231
Recruitment Status 460 395 1.164557
Study Description 272 222 1.225225
Outcome Measures 263 230 1.143478
Study Design 239 210 1.138095
Study Identification 232 206 1.126214
Eligibility 175 144 1.215278
Oversight 141 137 1.029197
Groups 101 85 1.188235
Interventions 101 85 1.188235
Sponsor/Collaborators 91 83 1.096386
Conditions 61 57 1.070175
References 34 32 1.062500
IPDSharing 10 10 1.000000
Documents 8 7 1.142857
Results Submission Events 6 6 1.000000
Results 2 2 1.000000

Enrollment Metrics

Measure Observational
Min 3.0
1st Qu 100.0
Median 300.0
Mean 26921.4
3rd Qu 1000.0
Max 10000000.0

Observation Model

observational_model Study_Count
Cohort 748
Case-Only 134
Other 122
Case-Control 112
Ecologic or Community 44
Case-Crossover 14
Family-Based 6
1

Time Perspective

time_perspective Study_Count
Prospective 686
Retrospective 269
Cross-Sectional 152
Other 73
1

Has Results

nct_id brief_title link
NCT04425863 Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of Covid 19 https://ClinicalTrials.gov/show/NCT04425863
NCT04425850 USEFULNESS of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid 19 https://ClinicalTrials.gov/show/NCT04425850

Registries

Studies by Country

Country Study_Count
France 31
United States 31
Spain 22
Italy 15
Turkey 13
Egypt 8
Germany 8
Belgium 6
Sweden 6
Brazil 4
China 4
Denmark 4
Mexico 4
Switzerland 4
United Kingdom 4
Argentina 3
Canada 3
Netherlands 3
Norway 3
Austria 2
Bangladesh 2
Chile 2
Poland 2
Russian Federation 2
Australia 1
Belgium|France 1
China|Hong Kong|Spain 1
China|India|Indonesia|Japan|Malaysia|Pakistan|Singapore 1
France|Martinique 1
Hungary 1
Iceland 1
India 1
Israel 1
Kuwait 1
Pakistan 1
Qatar 1
Singapore 1
South Africa 1
Tunisia 1
Ukraine 1
United States|Brazil|Colombia|Egypt|France|Mexico|Spain 1
United States|Canada|Israel|Japan|Serbia|Spain|United Kingdom 1
United States|Poland 1
United States|United Kingdom 1

Sites per Study

Site_count Study_Count
1 161
2 16
3 2
4 2
5 3
7 1
9 2
10 1
11 3
14 2
15 1
17 2
18 1
22 1
27 1
31 1
36 1
39 1
47 1
75 1
76 1
148 1

Number of Updates

Count of Versions Count of Studies
1 75
2 68
3 40
4 11
5 5
6 2
7 3
9 1
14 1

Update History Change Type

Change Type Count_of_Changes Count_of_Studies ratio
Study Status 249 131 1.900763
None (earliest Version on record) 206 206 1.000000
Contacts/Locations 126 78 1.615385
Recruitment Status 77 69 1.115942
Study Design 45 41 1.097561
Study Description 43 38 1.131579
Study Identification 38 35 1.085714
Outcome Measures 37 34 1.088235
Oversight 24 24 1.000000
Eligibility 22 22 1.000000
Sponsor/Collaborators 14 14 1.000000
Groups 12 12 1.000000
Interventions 12 12 1.000000
References 10 9 1.111111
Conditions 8 8 1.000000
Documents 5 3 1.666667
IPDSharing 3 3 1.000000
Results 1 1 1.000000
Results Submission Events 1 1 1.000000

Enrollment Metrics

Measure Registries
Min 1.00
1st Qu 100.00
Median 362.50
Mean 62888.68
3rd Qu 1500.00
Max 12000000.00

Registry Model

observational_model Study_Count
Cohort 145
Case-Control 22
Case-Only 19
Other 17
Ecologic or Community 3

Time Perspective

time_perspective Study_Count
Prospective 154
Other 29
Cross-Sectional 23

Follow-up

target_duration Study_Count
1 Year 27
12 Months 23
6 Months 21
1 Month 17
3 Months 15
1 Day 11
2 Months 10
30 Days 10
2 Years 9
28 Days 5
4 Weeks 5
14 Days 4
18 Months 4
10 Days 3
2 Weeks 3
20 Years 3
60 Days 3
21 Days 2
3 Weeks 2
3 Years 2
5 Months 2
5 Years 2
6 Weeks 2
9 Months 2
1 Week 1
10 Months 1
100 Years 1
12 Weeks 1
12 Years 1
14 Weeks 1
16 Months 1
2 Days 1
20 Days 1
20 Months 1
24 Months 1
3 Days 1
36 Months 1
5 Days 1
7 Days 1
7 Months 1
8 Weeks 1
9 Weeks 1
90 Days 1

Has Results

nct_id brief_title link
NCT04323592 Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome https://ClinicalTrials.gov/show/NCT04323592

Overview of trials

Interventional Trials

nct_id brief_title link
NCT04244591 Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure https://ClinicalTrials.gov/show/NCT04244591
NCT04252118 Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19 https://ClinicalTrials.gov/show/NCT04252118
NCT04251871 Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection https://ClinicalTrials.gov/show/NCT04251871
NCT04252274 Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04252274
NCT04252885 The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection https://ClinicalTrials.gov/show/NCT04252885
NCT04257656 A Trial of Remdesivir in Adults With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04257656
NCT04263402 The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia https://ClinicalTrials.gov/show/NCT04263402
NCT04255017 A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia https://ClinicalTrials.gov/show/NCT04255017
NCT04254874 A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia https://ClinicalTrials.gov/show/NCT04254874
NCT04264533 Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia https://ClinicalTrials.gov/show/NCT04264533
NCT04261270 A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia https://ClinicalTrials.gov/show/NCT04261270
NCT04331613 Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS https://ClinicalTrials.gov/show/NCT04331613
NCT04275245 Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia https://ClinicalTrials.gov/show/NCT04275245
NCT04261517 Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04261517
NCT04269525 Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia https://ClinicalTrials.gov/show/NCT04269525
NCT04282902 A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection https://ClinicalTrials.gov/show/NCT04282902
NCT04276688 Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment https://ClinicalTrials.gov/show/NCT04276688
NCT04280224 NK Cells Treatment for COVID-19 https://ClinicalTrials.gov/show/NCT04280224
NCT04304313 A Pilot Study of Sildenafil in COVID-19 https://ClinicalTrials.gov/show/NCT04304313
NCT04275414 Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04275414
NCT04273763 Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19) https://ClinicalTrials.gov/show/NCT04273763
NCT04279197 Treatment of Pulmonary Fibrosis Due to COVID-19 With Fuzheng Huayu https://ClinicalTrials.gov/show/NCT04279197
NCT04273321 Efficacy and Safety of Corticosteroids in COVID-19 https://ClinicalTrials.gov/show/NCT04273321
NCT04645407 Effects of Fuzheng Huayu Tablets on COVID-19 https://ClinicalTrials.gov/show/NCT04645407
NCT04276987 A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia https://ClinicalTrials.gov/show/NCT04276987
NCT04276896 Immunity and Safety of Covid-19 Synthetic Minigene Vaccine https://ClinicalTrials.gov/show/NCT04276896
NCT04343794 Using Biovitals® Sentinel to Monitor Disease Progression in Subjects Quarantined for Suspected COVID-19 https://ClinicalTrials.gov/show/NCT04343794
NCT04280705 Adaptive COVID-19 Treatment Trial (ACTT) https://ClinicalTrials.gov/show/NCT04280705
NCT04283461 Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04283461
NCT04303299 Favipiravir, Protease Inhibitors, Oseltamivir -Gpo, Hydroxychloroquine for Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04303299
NCT04288102 Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04288102
NCT04291729 Evaluation of Ganovo (Danoprevir ) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04291729
NCT04292899 Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734â„¢) in Participants With Severe Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04292899
NCT04292730 Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734â„¢) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment https://ClinicalTrials.gov/show/NCT04292730
NCT04296643 Medical Masks vs N95 Respirators for COVID-19 https://ClinicalTrials.gov/show/NCT04296643
NCT04308317 Tetrandrine Tablets Used in the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04308317
NCT04304053 Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention https://ClinicalTrials.gov/show/NCT04304053
NCT04299724 Safety and Immunity of Covid-19 aAPC Vaccine https://ClinicalTrials.gov/show/NCT04299724
NCT04303507 Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting https://ClinicalTrials.gov/show/NCT04303507
NCT04306055 Blood Donor Recruitment During Epidemic of COVID-19 https://ClinicalTrials.gov/show/NCT04306055
NCT04310228 Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019 https://ClinicalTrials.gov/show/NCT04310228
NCT04305106 Bevacizumab in Severe or Critically Severe Patients With COVID-19 Pneumonia-RCT https://ClinicalTrials.gov/show/NCT04305106
NCT04304690 COVID-19 Seroconversion Among Front Line Medical and Paramedical Staff in Emergency, Intensive Care Units and Infectious Disease Departments During the 2020 Epidemic https://ClinicalTrials.gov/show/NCT04304690
NCT04305457 Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04305457
NCT04307693 Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04307693
NCT04306393 Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19 https://ClinicalTrials.gov/show/NCT04306393
NCT04308668 Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2 https://ClinicalTrials.gov/show/NCT04308668
NCT04316377 Norwegian Coronavirus Disease 2019 Study https://ClinicalTrials.gov/show/NCT04316377
NCT04315948 Trial of Treatments for COVID-19 in Hospitalized Adults https://ClinicalTrials.gov/show/NCT04315948
NCT04312009 Losartan for Patients With COVID-19 Requiring Hospitalization https://ClinicalTrials.gov/show/NCT04312009
NCT04311177 Losartan for Patients With COVID-19 Not Requiring Hospitalization https://ClinicalTrials.gov/show/NCT04311177
NCT04315480 Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis https://ClinicalTrials.gov/show/NCT04315480
NCT04311697 Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure https://ClinicalTrials.gov/show/NCT04311697
NCT04315298 Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04315298
NCT04313322 Treatment of COVID-19 Patients Using Wharton’s Jelly-Mesenchymal Stem Cells https://ClinicalTrials.gov/show/NCT04313322
NCT04313127 Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults https://ClinicalTrials.gov/show/NCT04313127
NCT04312243 NO Prevention of COVID-19 for Healthcare Providers https://ClinicalTrials.gov/show/NCT04312243
NCT04313023 The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04313023
NCT04312997 The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04312997
NCT04323514 Use of Ascorbic Acid in Patients With COVID 19 https://ClinicalTrials.gov/show/NCT04323514
NCT04321174 COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir https://ClinicalTrials.gov/show/NCT04321174
NCT04315896 Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial) https://ClinicalTrials.gov/show/NCT04315896
NCT04317040 CD24Fc as a Non-antiviral Immunomodulator in COVID-19 Treatment https://ClinicalTrials.gov/show/NCT04317040
NCT04323527 Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2 https://ClinicalTrials.gov/show/NCT04323527
NCT04320056 Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During SARS-CoV-2 Pneumonia (COVID-19) https://ClinicalTrials.gov/show/NCT04320056
NCT04318015 Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial) https://ClinicalTrials.gov/show/NCT04318015
NCT04317092 Tocilizumab in COVID-19 Pneumonia (TOCIVID-19) https://ClinicalTrials.gov/show/NCT04317092
NCT04321928 Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary https://ClinicalTrials.gov/show/NCT04321928
NCT04319900 Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia https://ClinicalTrials.gov/show/NCT04319900
NCT04319445 Mindfulness During COVID-19 https://ClinicalTrials.gov/show/NCT04319445
NCT04318444 Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04318444
NCT04318431 Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children https://ClinicalTrials.gov/show/NCT04318431
NCT04324606 A Study of a Candidate COVID-19 Vaccine (COV001) https://ClinicalTrials.gov/show/NCT04324606
NCT04325867 Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19 https://ClinicalTrials.gov/show/NCT04325867
NCT04320953 Non-contact Endoscopy at Covid-19 Outbreak https://ClinicalTrials.gov/show/NCT04320953
NCT04320238 Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff https://ClinicalTrials.gov/show/NCT04320238
NCT04319731 A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure https://ClinicalTrials.gov/show/NCT04319731
NCT04328129 Household Transmission Investigation Study for COVID-19 in Tropical Regions https://ClinicalTrials.gov/show/NCT04328129
NCT04323345 Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus https://ClinicalTrials.gov/show/NCT04323345
NCT04323228 Anti-inflammatory/Antioxidant Oral Nutrition Supplementation in COVID-19 https://ClinicalTrials.gov/show/NCT04323228
NCT04322396 Proactive Prophylaxis With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04322396
NCT04322344 Escin in Patients With Covid-19 Infection https://ClinicalTrials.gov/show/NCT04322344
NCT04321616 The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients https://ClinicalTrials.gov/show/NCT04321616
NCT04321421 Hyperimmune Plasma for Critical Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04321421
NCT04321278 Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II) https://ClinicalTrials.gov/show/NCT04321278
NCT04321096 The Impact of Camostat Mesilate on COVID-19 Infection https://ClinicalTrials.gov/show/NCT04321096
NCT04320615 A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04320615
NCT04328961 Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP) https://ClinicalTrials.gov/show/NCT04328961
NCT04330690 Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial https://ClinicalTrials.gov/show/NCT04330690
NCT04322682 Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA) https://ClinicalTrials.gov/show/NCT04322682
NCT04327349 Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial https://ClinicalTrials.gov/show/NCT04327349
NCT04326920 Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC) https://ClinicalTrials.gov/show/NCT04326920
NCT04322773 Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure https://ClinicalTrials.gov/show/NCT04322773
NCT04322565 Colchicine Counteracting Inflammation in COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04322565
NCT04322123 Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19) https://ClinicalTrials.gov/show/NCT04322123
NCT04321993 Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients https://ClinicalTrials.gov/show/NCT04321993
NCT04323800 Convalescent Plasma to Stem Coronavirus (CSSC-001) https://ClinicalTrials.gov/show/NCT04323800
NCT04371601 Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019 https://ClinicalTrials.gov/show/NCT04371601
NCT04353271 Trial of Hydroxychloroquine In Covid-19 Kinetics https://ClinicalTrials.gov/show/NCT04353271
NCT04336462 Hydrogen-Oxygen Generator With Nebulizer in the Improvement of Symptoms in Patients Infected With COVID-19 https://ClinicalTrials.gov/show/NCT04336462
NCT04328285 Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers https://ClinicalTrials.gov/show/NCT04328285
NCT04327206 BCG Vaccination to Protect Healthcare Workers Against COVID-19 https://ClinicalTrials.gov/show/NCT04327206
NCT04326452 Treating COVID-19 With a Bidirectional Oxygenation Valve https://ClinicalTrials.gov/show/NCT04326452
NCT04325893 Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease https://ClinicalTrials.gov/show/NCT04325893
NCT04324528 Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation https://ClinicalTrials.gov/show/NCT04324528
NCT04324489 DAS181 for Severe COVID-19: Compassionate Use https://ClinicalTrials.gov/show/NCT04324489
NCT04324463 Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial https://ClinicalTrials.gov/show/NCT04324463
NCT04324073 Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI https://ClinicalTrials.gov/show/NCT04324073
NCT04324021 Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection. https://ClinicalTrials.gov/show/NCT04324021
NCT04327505 Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04327505
NCT04324996 A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19 https://ClinicalTrials.gov/show/NCT04324996
NCT04355962 Sevoflurane in COVID-19 ARDS (SevCov) https://ClinicalTrials.gov/show/NCT04355962
NCT04327401 COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III https://ClinicalTrials.gov/show/NCT04327401
NCT04327388 Sarilumab COVID-19 https://ClinicalTrials.gov/show/NCT04327388
NCT04326790 The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention https://ClinicalTrials.gov/show/NCT04326790
NCT04326426 ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection https://ClinicalTrials.gov/show/NCT04326426
NCT04326036 Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection https://ClinicalTrials.gov/show/NCT04326036
NCT04325906 Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS https://ClinicalTrials.gov/show/NCT04325906
NCT04324190 DIgital Online SuPport for COVID-19 StrEss https://ClinicalTrials.gov/show/NCT04324190
NCT04329533 Effects of Using Mobile App on Perceived Stress During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04329533
NCT04331899 Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19 https://ClinicalTrials.gov/show/NCT04331899
NCT04328493 The Vietnam Chloroquine Treatment on COVID-19 https://ClinicalTrials.gov/show/NCT04328493
NCT04328467 Pre-exposure Prophylaxis for SARS-Coronavirus-2 https://ClinicalTrials.gov/show/NCT04328467
NCT04328441 Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine https://ClinicalTrials.gov/show/NCT04328441
NCT04328012 COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04328012
NCT04336254 Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients https://ClinicalTrials.gov/show/NCT04336254
NCT04329195 ACE Inhibitors or ARBs Discontinuation in Context of SARS-CoV-2 Pandemic https://ClinicalTrials.gov/show/NCT04329195
NCT04333368 Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS https://ClinicalTrials.gov/show/NCT04333368
NCT04331054 Protective Role of Inhaled Steroids for Covid-19 Infection https://ClinicalTrials.gov/show/NCT04331054
NCT04329611 ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 Disease https://ClinicalTrials.gov/show/NCT04329611
NCT04328480 The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients. https://ClinicalTrials.gov/show/NCT04328480
NCT04348370 BCG Vaccine for Health Care Workers as Defense Against COVID 19 https://ClinicalTrials.gov/show/NCT04348370
NCT04332380 Convalescent Plasma for Patients With COVID-19: A Pilot Study https://ClinicalTrials.gov/show/NCT04332380
NCT04332081 Hyperbaric Oxygen for COVID-19 Patients https://ClinicalTrials.gov/show/NCT04332081
NCT04331600 Chloroquine as Antiviral Treatment in Coronavirus Infection 2020 https://ClinicalTrials.gov/show/NCT04331600
NCT04331470 Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04331470
NCT04329923 The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine) https://ClinicalTrials.gov/show/NCT04329923
NCT04329832 Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19 https://ClinicalTrials.gov/show/NCT04329832
NCT04332107 Azithromycin for COVID-19 Treatment in Outpatients Nationwide https://ClinicalTrials.gov/show/NCT04332107
NCT04333732 CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION https://ClinicalTrials.gov/show/NCT04333732
NCT04352348 Cohort of Patients Infected With SARS-CoV2 (COVID-19) or Suspected of Being https://ClinicalTrials.gov/show/NCT04352348
NCT04347174 A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients https://ClinicalTrials.gov/show/NCT04347174
NCT04343651 Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04343651
NCT04336332 Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19 https://ClinicalTrials.gov/show/NCT04336332
NCT04334980 Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT04334980
NCT04333355 Safety in Convalescent Plasma Transfusion to COVID-19 https://ClinicalTrials.gov/show/NCT04333355
NCT04332991 Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease https://ClinicalTrials.gov/show/NCT04332991
NCT04332094 Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04332094
NCT04331808 CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI) https://ClinicalTrials.gov/show/NCT04331808
NCT04331366 Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19 https://ClinicalTrials.gov/show/NCT04331366
NCT04330586 A Trial of Ciclesonide in Adults With Mild-to-moderate COVID-19 https://ClinicalTrials.gov/show/NCT04330586
NCT04329650 Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04329650
NCT04335305 Checkpoint Blockade in COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04335305
NCT04332835 Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study https://ClinicalTrials.gov/show/NCT04332835
NCT04376515 Harnessing Online Peer Education Online Support Intervention for COVID-19 (HOPE COVID-19) https://ClinicalTrials.gov/show/NCT04376515
NCT04335123 Study of Open Label Losartan in COVID-19 https://ClinicalTrials.gov/show/NCT04335123
NCT04330638 Treatment of COVID-19 Patients With Anti-interleukin Drugs https://ClinicalTrials.gov/show/NCT04330638
NCT04342182 Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study) https://ClinicalTrials.gov/show/NCT04342182
NCT04339712 Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction https://ClinicalTrials.gov/show/NCT04339712
NCT04338009 Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019 https://ClinicalTrials.gov/show/NCT04338009
NCT04337996 Dynamic Evaluation of COVID-19 Diagnostic Tests https://ClinicalTrials.gov/show/NCT04337996
NCT04335279 Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program https://ClinicalTrials.gov/show/NCT04335279
NCT04335136 Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04335136
NCT04335097 Sensor Based Vital Signs Monitoring of Covid 19 Patients During Home Isolation https://ClinicalTrials.gov/show/NCT04335097
NCT04334265 Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019 https://ClinicalTrials.gov/show/NCT04334265
NCT04334044 Treatment of SARS Caused by COVID-19 With Ruxolitinib https://ClinicalTrials.gov/show/NCT04334044
NCT04333654 Hydroxychloroquine in Outpatient Adults With COVID-19 https://ClinicalTrials.gov/show/NCT04333654
NCT04333628 Chloroquine for Mild Symptomatic and Asymptomatic COVID-19 https://ClinicalTrials.gov/show/NCT04333628
NCT04333589 Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive https://ClinicalTrials.gov/show/NCT04333589
NCT04333550 Application of Desferal to Treat COVID-19 https://ClinicalTrials.gov/show/NCT04333550
NCT04333407 Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial. https://ClinicalTrials.gov/show/NCT04333407
NCT04333225 Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers https://ClinicalTrials.gov/show/NCT04333225
NCT04331795 Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis https://ClinicalTrials.gov/show/NCT04331795
NCT04333420 Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04333420
NCT04347226 Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04347226
NCT04345523 Convalescent Plasma Therapy vs. SOC for the Treatment of COVID19 in Hospitalized Patients https://ClinicalTrials.gov/show/NCT04345523
NCT04340349 Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals https://ClinicalTrials.gov/show/NCT04340349
NCT04339660 Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04339660
NCT04337541 Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System https://ClinicalTrials.gov/show/NCT04337541
NCT04335851 Video-Based Exercises and Well-Being During Social Isolation https://ClinicalTrials.gov/show/NCT04335851
NCT04335786 Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease https://ClinicalTrials.gov/show/NCT04335786
NCT04335084 A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04335084
NCT04335071 Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04335071
NCT04334928 Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel https://ClinicalTrials.gov/show/NCT04334928
NCT04334850 Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04334850
NCT04334629 LIBERATE Trial in COVID-19 https://ClinicalTrials.gov/show/NCT04334629
NCT04334512 A Study of Quintuple Therapy to Treat COVID-19 Infection https://ClinicalTrials.gov/show/NCT04334512
NCT04334382 Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19 https://ClinicalTrials.gov/show/NCT04334382
NCT04334460 Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects https://ClinicalTrials.gov/show/NCT04334460
NCT04348409 Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04348409
NCT04343053 Pro-thrombotic Status in Patients With SARS-Cov-2 Infection https://ClinicalTrials.gov/show/NCT04343053
NCT04337008 Renin Angiotensin System - CoronaVirus https://ClinicalTrials.gov/show/NCT04337008
NCT04336904 Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19 https://ClinicalTrials.gov/show/NCT04336904
NCT04336410 Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers https://ClinicalTrials.gov/show/NCT04336410
NCT04335552 Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04335552
NCT04340544 Hydroxychloroquine for the Treatment of Mild COVID-19 Disease https://ClinicalTrials.gov/show/NCT04340544
NCT04341116 Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04341116
NCT04342650 Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection https://ClinicalTrials.gov/show/NCT04342650
NCT04338698 Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT https://ClinicalTrials.gov/show/NCT04338698
NCT04338568 Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study https://ClinicalTrials.gov/show/NCT04338568
NCT04345861 Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial) https://ClinicalTrials.gov/show/NCT04345861
NCT04341675 Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04341675
NCT04338841 HOME-CoV: Hospitalization or Outpatient ManagEment of Patients With a SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04338841
NCT04338828 Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED https://ClinicalTrials.gov/show/NCT04338828
NCT04343092 Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management https://ClinicalTrials.gov/show/NCT04343092
NCT04349631 A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19 https://ClinicalTrials.gov/show/NCT04349631
NCT04346797 CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients With COVID-19 Infection, Nested in the CORIMUNO-19 Cohort https://ClinicalTrials.gov/show/NCT04346797
NCT04344951 Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial https://ClinicalTrials.gov/show/NCT04344951
NCT04340557 Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04340557
NCT04338074 TXA and Corona Virus 2019 (COVID19) in Outpatients https://ClinicalTrials.gov/show/NCT04338074
NCT04337918 Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection https://ClinicalTrials.gov/show/NCT04337918
NCT04339816 Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial https://ClinicalTrials.gov/show/NCT04339816
NCT04345614 A Study of Auxora in Patients With Severe COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04345614
NCT04384380 Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04384380
NCT04364893 Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19 https://ClinicalTrials.gov/show/NCT04364893
NCT04353674 Modulation of Hyperinflammation in COVID-19 https://ClinicalTrials.gov/show/NCT04353674
NCT04352933 PROLIFIC ChemoprophylaxisTrial (COVID-19) https://ClinicalTrials.gov/show/NCT04352933
NCT04347031 A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19 https://ClinicalTrials.gov/show/NCT04347031
NCT04345848 Preventing COVID-19 Complications With Low- and High-dose Anticoagulation https://ClinicalTrials.gov/show/NCT04345848
NCT04344210 Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus https://ClinicalTrials.gov/show/NCT04344210
NCT04341922 A Online-delivered Cognitive-behavioral Intervention for Dysfunctional Worry Related to the Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04341922
NCT04341493 Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04341493
NCT04341441 Will Hydroxychloroquine Impede or Prevent COVID-19 https://ClinicalTrials.gov/show/NCT04341441
NCT04341415 Impact of Auricular Vagus Nerve Neuromodulation on COVID-19 Positive Inpatients Outcome https://ClinicalTrials.gov/show/NCT04341415
NCT04341389 A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector) https://ClinicalTrials.gov/show/NCT04341389
NCT04341038 Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury https://ClinicalTrials.gov/show/NCT04341038
NCT04339426 Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection https://ClinicalTrials.gov/show/NCT04339426
NCT04338958 Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation https://ClinicalTrials.gov/show/NCT04338958
NCT04346147 Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19 https://ClinicalTrials.gov/show/NCT04346147
NCT04342169 University of Utah COVID-19 Hydrochloroquine Trial https://ClinicalTrials.gov/show/NCT04342169
NCT04340050 COVID-19 Convalescent Plasma https://ClinicalTrials.gov/show/NCT04340050
NCT04358081 Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease https://ClinicalTrials.gov/show/NCT04358081
NCT04350580 Polyvalent Immunoglobulin in COVID-19 Related ARds https://ClinicalTrials.gov/show/NCT04350580
NCT04348383 Defibrotide as Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome of Covid 19. https://ClinicalTrials.gov/show/NCT04348383
NCT04347941 Awake Prone Positioning to Reduce Invasive VEntilation in COVID-19 Induced Acute Respiratory failurE https://ClinicalTrials.gov/show/NCT04347941
NCT04347681 Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19 https://ClinicalTrials.gov/show/NCT04347681
NCT04346693 An Open Randomized Study of Dalargin Effectiveness in Patients With Severe and Critical Manifestations of SARS-COVID-19 https://ClinicalTrials.gov/show/NCT04346693
NCT04346420 Impact of the Double-Trunk Mask on Oxygenation Titration in COVID-19 https://ClinicalTrials.gov/show/NCT04346420
NCT04345653 Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers https://ClinicalTrials.gov/show/NCT04345653
NCT04344457 Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19 https://ClinicalTrials.gov/show/NCT04344457
NCT04344236 Gargling and Nasal Rinses to Reduce Oro- and Nasopharyngeal Viral Load in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04344236
NCT04344106 Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study https://ClinicalTrials.gov/show/NCT04344106
NCT04343768 An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial https://ClinicalTrials.gov/show/NCT04343768
NCT04343755 Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04343755
NCT04343261 Convalescent Plasma in the Treatment of COVID 19 https://ClinicalTrials.gov/show/NCT04343261
NCT04343248 Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF) https://ClinicalTrials.gov/show/NCT04343248
NCT04342728 Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation https://ClinicalTrials.gov/show/NCT04342728
NCT04342689 The Role of Resistant Starch in COVID-19 Infection https://ClinicalTrials.gov/show/NCT04342689
NCT04342663 A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04342663
NCT04341207 Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients https://ClinicalTrials.gov/show/NCT04341207
NCT04341142 Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER https://ClinicalTrials.gov/show/NCT04341142
NCT04342221 Hydroxychloroquine for COVID-19 https://ClinicalTrials.gov/show/NCT04342221
NCT04344587 Awake Prone Position for Early Hypoxemia in COVID-19 https://ClinicalTrials.gov/show/NCT04344587
NCT04353037 PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine https://ClinicalTrials.gov/show/NCT04353037
NCT04351906 Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04351906
NCT04348513 Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04348513
NCT04347980 Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19 https://ClinicalTrials.gov/show/NCT04347980
NCT04346615 Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen https://ClinicalTrials.gov/show/NCT04346615
NCT04346589 Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients https://ClinicalTrials.gov/show/NCT04346589
NCT04346199 Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. https://ClinicalTrials.gov/show/NCT04346199
NCT04344730 Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia https://ClinicalTrials.gov/show/NCT04344730
NCT04344431 Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04344431
NCT04344080 Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04344080
NCT04344041 COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial) https://ClinicalTrials.gov/show/NCT04344041
NCT04344015 COVID-19 Plasma Collection https://ClinicalTrials.gov/show/NCT04344015
NCT04343989 A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection https://ClinicalTrials.gov/show/NCT04343989
NCT04343976 Pegylated Interferon Lambda Treatment for COVID-19 https://ClinicalTrials.gov/show/NCT04343976
NCT04343963 Pyridostigmine in Severe SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04343963
NCT04343729 Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19 https://ClinicalTrials.gov/show/NCT04343729
NCT04345692 A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients https://ClinicalTrials.gov/show/NCT04345692
NCT04438850 COVidIVERmectin: Ivermectin for Treatment of Covid-19 https://ClinicalTrials.gov/show/NCT04438850
NCT04390178 Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04390178
NCT04351724 Austrian CoronaVirus Adaptive Clinical Trial (COVID-19) https://ClinicalTrials.gov/show/NCT04351724
NCT04348929 Birth Experience During COVID-19 Confinement https://ClinicalTrials.gov/show/NCT04348929
NCT04346628 Oral Favipiravir Compared to Placebo in Subjects With Mild COVID-19 https://ClinicalTrials.gov/show/NCT04346628
NCT04345991 Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the CORIMUNO-19 Cohort https://ClinicalTrials.gov/show/NCT04345991
NCT04345549 Ayurveda Self-Management for Flu Like Symptoms During the Covid-19 Outbreak https://ClinicalTrials.gov/show/NCT04345549
NCT04345289 Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04345289
NCT04345276 Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04345276
NCT04344600 Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection https://ClinicalTrials.gov/show/NCT04344600
NCT04344561 Incline Positioning in COVID-19 Patients for Improvement in Oxygen Saturation https://ClinicalTrials.gov/show/NCT04344561
NCT04344535 Convalescent Plasma vs. Standard Plasma for COVID-19 https://ClinicalTrials.gov/show/NCT04344535
NCT04344444 Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease https://ClinicalTrials.gov/show/NCT04344444
NCT04344288 Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection https://ClinicalTrials.gov/show/NCT04344288
NCT04342897 A Study of LY3127804 in Participants With COVID-19 https://ClinicalTrials.gov/show/NCT04342897
NCT04357444 Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19 https://ClinicalTrials.gov/show/NCT04357444
NCT04356495 Treatments to Decrease the Risk of Hospitalization or Death in Elderly Outpatients With Symptomatic SARS-CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04356495
NCT04351789 Impact of a Minimal Psychoeducational Intervention on Anxiety Among Hospitalized COVID-19 Patients in Denmark https://ClinicalTrials.gov/show/NCT04351789
NCT04348305 Hydrocortisone for COVID-19 and Severe Hypoxia https://ClinicalTrials.gov/show/NCT04348305
NCT04345419 Remdesivir vs Chloroquine in Covid 19 https://ClinicalTrials.gov/show/NCT04345419
NCT04349410 The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol https://ClinicalTrials.gov/show/NCT04349410
NCT04347382 Honey & Nigella Sativa Trial Against COVID-19 https://ClinicalTrials.gov/show/NCT04347382
NCT04347538 Impact of Nasal Saline Irrigations on Viral Load in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04347538
NCT04463433 Psychological Intervention for Parent-child Relationship and Couple Relationship Under COVID-19 in China https://ClinicalTrials.gov/show/NCT04463433
NCT04349592 Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19 https://ClinicalTrials.gov/show/NCT04349592
NCT04349371 Saved From COVID-19 https://ClinicalTrials.gov/show/NCT04349371
NCT04346355 Efficacy of Early Administration of Tocilizumab in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04346355
NCT04360824 Covid-19 Associated Coagulopathy https://ClinicalTrials.gov/show/NCT04360824
NCT04359251 Different PEEP Settings of COVID-19 Induced ARDS https://ClinicalTrials.gov/show/NCT04359251
NCT04357340 The Effects of Pulmonary Physiotherapy Treatments on Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04357340
NCT04354155 COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial https://ClinicalTrials.gov/show/NCT04354155
NCT04350281 Double Therapy With IFN-beta 1b and Hydroxychloroquine https://ClinicalTrials.gov/show/NCT04350281
NCT04349241 Efficacy and Safety of Favipiravir in Management of COVID-19 https://ClinicalTrials.gov/show/NCT04349241
NCT04348695 Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19. https://ClinicalTrials.gov/show/NCT04348695
NCT04348500 Clazakizumab (Anti-IL- 6 Monoclonal) Compared to Placebo for COVID19 Disease https://ClinicalTrials.gov/show/NCT04348500
NCT04347954 PVP-I Nasal Sprays and SARS-CoV-2 Nasopharyngeal Titers (for COVID-19) https://ClinicalTrials.gov/show/NCT04347954
NCT04346667 Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds https://ClinicalTrials.gov/show/NCT04346667
NCT04346017 Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in COVID-19 Patients With a Systemic Inflammatory Response Syndrome https://ClinicalTrials.gov/show/NCT04346017
NCT04348864 COVID-19 Diagnostic Self-testing Using Virtual Point-of-care https://ClinicalTrials.gov/show/NCT04348864
NCT04348656 CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1) https://ClinicalTrials.gov/show/NCT04348656
NCT04355728 Use of UC-MSCs for COVID-19 Patients https://ClinicalTrials.gov/show/NCT04355728
NCT04347239 Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04347239
NCT04354610 Cardiovascular and Renal Biomarkers to Predict Acute Heart or Kidney Injury in Severe Covid-19 Infection https://ClinicalTrials.gov/show/NCT04354610
NCT04382391 Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms https://ClinicalTrials.gov/show/NCT04382391
NCT04361916 Home Care for Patients With COVID-19: Active Monitoring in Two Italian Health Units (Casale Monferrato and Torino) https://ClinicalTrials.gov/show/NCT04361916
NCT04357106 COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma https://ClinicalTrials.gov/show/NCT04357106
NCT04356833 Nebulised Rt-PA for ARDS Due to COVID-19 https://ClinicalTrials.gov/show/NCT04356833
NCT04355143 Colchicine to Reduce Cardiac Injury in COVID-19 (COLHEART-19) https://ClinicalTrials.gov/show/NCT04355143
NCT04354831 A Study Evaluating the Efficacy and Safety of High-Titer Anti-SARS-CoV-2 Plasma in Hospitalized Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04354831
NCT04353596 Stopping ACE-inhibitors in COVID-19 https://ClinicalTrials.gov/show/NCT04353596
NCT04352608 Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04352608
NCT04351542 Ayurveda for Flu Like Illness During Covid-19 Outbreak https://ClinicalTrials.gov/show/NCT04351542
NCT04351763 Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms https://ClinicalTrials.gov/show/NCT04351763
NCT04351620 High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19 https://ClinicalTrials.gov/show/NCT04351620
NCT04351581 Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04351581
NCT04351191 PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds https://ClinicalTrials.gov/show/NCT04351191
NCT04350736 First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19 https://ClinicalTrials.gov/show/NCT04350736
NCT04350723 Awake Prone Position in Hypoxemic Patients With Coronavirus Disease 19 (COVI-PRONE): A Randomized Clinical Trial https://ClinicalTrials.gov/show/NCT04350723
NCT04350684 Umifenovir in Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04350684
NCT04350671 Interferon Beta 1a in Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04350671
NCT04350593 Dapagliflozin in Respiratory Failure in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04350593
NCT04350320 Trial to Study the Benefit of Colchicine in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04350320
NCT04349098 Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection https://ClinicalTrials.gov/show/NCT04349098
NCT04348435 A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Allogeneic Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19 https://ClinicalTrials.gov/show/NCT04348435
NCT04347915 The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04347915
NCT04346446 Efficacy of Convalescent Plasma Therapy in Severely Sick COVID-19 Patients https://ClinicalTrials.gov/show/NCT04346446
NCT04357808 Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID) https://ClinicalTrials.gov/show/NCT04357808
NCT04498936 Sofosbuvir/Ledipasvir and Nitazoxanide for Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04498936
NCT04359095 Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia https://ClinicalTrials.gov/show/NCT04359095
NCT04356534 Convalescent Plasma Trial in COVID -19 Patients https://ClinicalTrials.gov/show/NCT04356534
NCT04355897 CoVID-19 Plasma in Treatment of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04355897
NCT04355637 Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia https://ClinicalTrials.gov/show/NCT04355637
NCT04355364 Efficacy and Safety of Aerosolized Intra-tracheal Dornase Alfa Administration in Patients With COVID19-induced ARDS (COVIDORNASE) https://ClinicalTrials.gov/show/NCT04355364
NCT04355026 Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04355026
NCT04353336 Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment https://ClinicalTrials.gov/show/NCT04353336
NCT04352959 COVID-19: Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses https://ClinicalTrials.gov/show/NCT04352959
NCT04351347 The Efficacy of Ivermectin and Nitazoxanide in COVID-19 Treatment https://ClinicalTrials.gov/show/NCT04351347
NCT04351295 Efficacy of Faviprevir in COVID-19 Treatment https://ClinicalTrials.gov/show/NCT04351295
NCT04351152 Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04351152
NCT04359290 Ruxolitinib for Treatment of Covid-19 Induced Lung Injury ARDS https://ClinicalTrials.gov/show/NCT04359290
NCT04351243 A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE) https://ClinicalTrials.gov/show/NCT04351243
NCT04357327 Rapid Salivary Test to Detect SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04357327
NCT04351516 Test and Treat COVID 65plus+ https://ClinicalTrials.gov/show/NCT04351516
NCT04353284 Camostat Mesylate in COVID-19 Outpatients https://ClinicalTrials.gov/show/NCT04353284
NCT04419610 RAS and Coagulopathy in COVID19 https://ClinicalTrials.gov/show/NCT04419610
NCT04367662 Study of the Vascular Compartment and Hypercoagulability During Coronavirus Infection COVID-19 https://ClinicalTrials.gov/show/NCT04367662
NCT04361838 The COVID-19 ICU PRAYER Study https://ClinicalTrials.gov/show/NCT04361838
NCT04361344 Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection https://ClinicalTrials.gov/show/NCT04361344
NCT04359264 Direct Income SupporT and Advice Negating Spread of Epidemic COVID-19: a Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT04359264
NCT04358406 Rhu-pGSN for Severe Covid-19 Pneumonia https://ClinicalTrials.gov/show/NCT04358406
NCT04354870 COVID-19 PrEP HCW HCQ Study https://ClinicalTrials.gov/show/NCT04354870
NCT04354259 Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19 https://ClinicalTrials.gov/show/NCT04354259
NCT04353206 Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure https://ClinicalTrials.gov/show/NCT04353206
NCT04353128 Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers. https://ClinicalTrials.gov/show/NCT04353128
NCT04352751 Experimental Use of Convalescent Plasma for Passive Immunization in Current COVID-19 Pandemic in Pakistan in 2020 https://ClinicalTrials.gov/show/NCT04352751
NCT04358549 Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19 https://ClinicalTrials.gov/show/NCT04358549
NCT04354428 Treatment for COVID-19 in High-Risk Adult Outpatients https://ClinicalTrials.gov/show/NCT04354428
NCT04358939 Prone Position in Patients on High-flow Nasal Oxygen Therapy for COVID-19 (HIGH-PRONE-COVID-19) https://ClinicalTrials.gov/show/NCT04358939
NCT04375774 Verification of Alternative Do-it-yourself Equipment Respirators for the COVID-19 Personal Protective Equipment (PPE) https://ClinicalTrials.gov/show/NCT04375774
NCT04373044 Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19 https://ClinicalTrials.gov/show/NCT04373044
NCT04361942 Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV) https://ClinicalTrials.gov/show/NCT04361942
NCT04359953 Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04359953
NCT04357782 Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation https://ClinicalTrials.gov/show/NCT04357782
NCT04356690 Etoposide in Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04356690
NCT04356482 CONVALESCENT PLASMA FOR ILL PATIENTS BY COVID-19 https://ClinicalTrials.gov/show/NCT04356482
NCT04355936 Telmisartan for Treatment of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04355936
NCT04355533 Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19 https://ClinicalTrials.gov/show/NCT04355533
NCT04355351 Study of Immune Response During SARS-CoV-2 Infection - (COVID-19) https://ClinicalTrials.gov/show/NCT04355351
NCT04355247 Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm https://ClinicalTrials.gov/show/NCT04355247
NCT04355234 Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns https://ClinicalTrials.gov/show/NCT04355234
NCT04355767 Convalescent Plasma in Outpatients With COVID-19 https://ClinicalTrials.gov/show/NCT04355767
NCT04377308 Fluoxetine to Reduce Intubation and Death After COVID19 Infection https://ClinicalTrials.gov/show/NCT04377308
NCT04357730 Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04357730
NCT04376034 Convalescent Plasma Collection and Treatment in Pediatrics and Adults https://ClinicalTrials.gov/show/NCT04376034
NCT04363814 Clinical Impact of BACTEK-R in Subject With Mild Pneumonia Due to COVID-19 Infection https://ClinicalTrials.gov/show/NCT04363814
NCT04358614 Baricitinib Therapy in COVID-19 https://ClinicalTrials.gov/show/NCT04358614
NCT04357028 Measles Vaccine in HCW https://ClinicalTrials.gov/show/NCT04357028
NCT04356937 Efficacy of Tocilizumab on Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04356937
NCT04385771 Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation https://ClinicalTrials.gov/show/NCT04385771
NCT04534673 Pegylated Interferon Lambda for Treatment of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04534673
NCT04358003 Plasma Adsorption in Patients With Confirmed COVID-19 https://ClinicalTrials.gov/show/NCT04358003
NCT04374149 Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS https://ClinicalTrials.gov/show/NCT04374149
NCT04374084 Moxibustion Plus Cupping in Convalescent Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04374084
NCT04368845 Telerehabilitation in Patients With COVID-19 After Hospitalization. The ATHLOS Study https://ClinicalTrials.gov/show/NCT04368845
NCT04368156 Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms https://ClinicalTrials.gov/show/NCT04368156
NCT04366063 Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04366063
NCT04364763 A Study to Evaluate the Effect of RBT-9 on Progression of COVID-19 in High-Risk Individuals (The PREVENT Study) https://ClinicalTrials.gov/show/NCT04364763
NCT04362332 Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19 https://ClinicalTrials.gov/show/NCT04362332
NCT04362085 Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care https://ClinicalTrials.gov/show/NCT04362085
NCT04362059 A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19 https://ClinicalTrials.gov/show/NCT04362059
NCT04359901 Sarilumab for Patients With Moderate COVID-19 Disease https://ClinicalTrials.gov/show/NCT04359901
NCT04359537 Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19 https://ClinicalTrials.gov/show/NCT04359537
NCT04359277 A Randomized Trial of Anticoagulation Strategies in COVID-19 https://ClinicalTrials.gov/show/NCT04359277
NCT04358068 Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19 https://ClinicalTrials.gov/show/NCT04358068
NCT04357990 Viruxal Oral and Nasal Spray for Treating the Symptoms of COVID-19 https://ClinicalTrials.gov/show/NCT04357990
NCT04357457 Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia https://ClinicalTrials.gov/show/NCT04357457
NCT04359680 Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04359680
NCT04357366 suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE) https://ClinicalTrials.gov/show/NCT04357366
NCT04359797 COVID-19 Patient Positioning Pragmatic Trial https://ClinicalTrials.gov/show/NCT04359797
NCT04413864 Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19 https://ClinicalTrials.gov/show/NCT04413864
NCT04363736 A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04363736
NCT04363385 Collection of Biological Samples With Clinical Characterization of Covid-19 Patients https://ClinicalTrials.gov/show/NCT04363385
NCT04362189 Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04362189
NCT04362111 Early Treatment of Cytokine Storm Syndrome in Covid-19 https://ClinicalTrials.gov/show/NCT04362111
NCT04361526 Pilot Study on Cytokine Filtration in COVID-19 ARDS https://ClinicalTrials.gov/show/NCT04361526
NCT04360551 Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04360551
NCT04359862 Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection https://ClinicalTrials.gov/show/NCT04359862
NCT04359654 Nebulised Dornase Alfa for Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04359654
NCT04359329 Estrogen Patch for COVID-19 Symptoms https://ClinicalTrials.gov/show/NCT04359329
NCT04358783 Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia https://ClinicalTrials.gov/show/NCT04358783
NCT04358926 Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19) https://ClinicalTrials.gov/show/NCT04358926
NCT04359810 Plasma Therapy of COVID-19 in Severely Ill Patients https://ClinicalTrials.gov/show/NCT04359810
NCT04362176 Passive Immunity Trial for Our Nation to Treat COVID-19 in Hospitalized Adults https://ClinicalTrials.gov/show/NCT04362176
NCT04365101 Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 https://ClinicalTrials.gov/show/NCT04365101
NCT04361474 Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity https://ClinicalTrials.gov/show/NCT04361474
NCT04373200 Human Ab Response & immunoMONItoring of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04373200
NCT04366882 Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients https://ClinicalTrials.gov/show/NCT04366882
NCT04366323 Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19 https://ClinicalTrials.gov/show/NCT04366323
NCT04366245 Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04366245
NCT04366089 Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora https://ClinicalTrials.gov/show/NCT04366089
NCT04364737 CONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients https://ClinicalTrials.gov/show/NCT04364737
NCT04364594 COVID-19 Search in Conjunctival Cells https://ClinicalTrials.gov/show/NCT04364594
NCT04361396 Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04361396
NCT04360980 The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection https://ClinicalTrials.gov/show/NCT04360980
NCT04360837 PEEP Incremental and Decremental Alveolar Recruitment of Critically Ill Corona Virus Disease-19 (COVID-19) Patients https://ClinicalTrials.gov/show/NCT04360837
NCT04360811 Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04360811
NCT04361214 Leflunomide in Mild COVID-19 Patients https://ClinicalTrials.gov/show/NCT04361214
NCT04363463 Impact of Prone Position in Patients Under Spontaneous Breathing on Intubation or Non-invasive Ventilation or Death Incidence During COVID-19 Acute Respiratory Distress https://ClinicalTrials.gov/show/NCT04363463
NCT04362137 Phase 3 Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID) https://ClinicalTrials.gov/show/NCT04362137
NCT04377750 The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation https://ClinicalTrials.gov/show/NCT04377750
NCT04368377 Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04368377
NCT04366947 Intravascular Access in Suspected/Confirmed COVID-19 Patient https://ClinicalTrials.gov/show/NCT04366947
NCT04366297 Intravascular Access of COVID-19 Patient Under Personal Protective Equipment https://ClinicalTrials.gov/show/NCT04366297
NCT04366271 Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04366271
NCT04364022 Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland https://ClinicalTrials.gov/show/NCT04364022
NCT04363528 Incidence of Deep Vein Thrombosis at Doppler Echo in Covid-19 Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU https://ClinicalTrials.gov/show/NCT04363528
NCT04363502 Use of the Interleukin-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection https://ClinicalTrials.gov/show/NCT04363502
NCT04363450 Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP) https://ClinicalTrials.gov/show/NCT04363450
NCT04363437 COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19 https://ClinicalTrials.gov/show/NCT04363437
NCT04363346 Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia https://ClinicalTrials.gov/show/NCT04363346
NCT04361253 Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy https://ClinicalTrials.gov/show/NCT04361253
NCT04363541 Local Thermotherapy for Patients With Mild-to-moderate COVID-19 https://ClinicalTrials.gov/show/NCT04363541
NCT04393961 At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study https://ClinicalTrials.gov/show/NCT04393961
NCT04385095 Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection https://ClinicalTrials.gov/show/NCT04385095
NCT04372979 Efficacy of Convalescent Plasma Therapy in the Early Care of COVID-19 Patients. https://ClinicalTrials.gov/show/NCT04372979
NCT04372589 Antithrombotic Therapy to Ameliorate Complications of COVID-19 ( ATTACC ) https://ClinicalTrials.gov/show/NCT04372589
NCT04368988 Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant https://ClinicalTrials.gov/show/NCT04368988
NCT04368923 Management of Covid-19 Patients During Home Isolation https://ClinicalTrials.gov/show/NCT04368923
NCT04368260 Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04368260
NCT04368000 Prone Positioning in Awake Patients With COVID-19 Requiring Hospitalization https://ClinicalTrials.gov/show/NCT04368000
NCT04367168 Colchicine Twice Daily During 10 Days as an Option for the Treatment of Symptoms Induced by Inflammation in Patients With Mild and Severe Coronavirus Disease https://ClinicalTrials.gov/show/NCT04367168
NCT04366960 Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04366960
NCT04366791 Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19 https://ClinicalTrials.gov/show/NCT04366791
NCT04366141 COVID-19 (Coronavirus Disease 2019) Intubation Barrier Box https://ClinicalTrials.gov/show/NCT04366141
NCT04366050 Ramipril for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04366050
NCT04365972 Attention Bias Modification for Reducing Health Anxiety During the Coronavirus Pandemic https://ClinicalTrials.gov/show/NCT04365972
NCT04365608 Prehospital Intubation of COVID-19 Patient With Personal Protective Equipment https://ClinicalTrials.gov/show/NCT04365608
NCT04365309 Protective Effect of Aspirin on COVID-19 Patients https://ClinicalTrials.gov/show/NCT04365309
NCT04365257 Prazosin to Prevent COVID-19 (PREVENT-COVID Trial) https://ClinicalTrials.gov/show/NCT04365257
NCT04365153 Canakinumab in Covid-19 Cardiac Injury (The Three C Study) https://ClinicalTrials.gov/show/NCT04365153
NCT04365127 Progesterone for the Treatment of COVID-19 in Hospitalized Men https://ClinicalTrials.gov/show/NCT04365127
NCT04363827 Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04363827
NCT04363606 Chronic Fatigue Etiology and Recovery in Covid-19 Patients: the Role of Fatigability https://ClinicalTrials.gov/show/NCT04363606
NCT04363593 Serology COVID-19 From the Cornwall Hospital Union https://ClinicalTrials.gov/show/NCT04363593
NCT04363372 A Study for Efficacy and Safety of Live Biotherapeutic MRx4DP0004 to Treat COVID-19 https://ClinicalTrials.gov/show/NCT04363372
NCT04362813 Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia https://ClinicalTrials.gov/show/NCT04362813
NCT04369378 Effectiveness of Using a Meditation App in Reducing Anxiety and Improving Well-being During the Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04369378
NCT04518969 Determination of the Hemoadsorption Impact as Adjunctive Treatment Upon the Support Therapy of COVID-19 https://ClinicalTrials.gov/show/NCT04518969
NCT04364802 COVID-19: Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and Inpatients https://ClinicalTrials.gov/show/NCT04364802
NCT04392778 Clinical Use of Stem Cells for the Treatment of Covid-19 https://ClinicalTrials.gov/show/NCT04392778
NCT04372017 Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection https://ClinicalTrials.gov/show/NCT04372017
NCT04368299 Telemedicine for Follow-up of Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT04368299
NCT04365699 Cardiovascular Effects of COVID-19 https://ClinicalTrials.gov/show/NCT04365699
NCT04428268 Chloroquine + Losartan Compared to Chloroquine Alone for the Treatment of COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04428268
NCT04373824 Max Ivermectin- COVID 19 Study Versus Standard of Care Treatment for COVID 19 Cases. A Pilot Study https://ClinicalTrials.gov/show/NCT04373824
NCT04370782 Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting https://ClinicalTrials.gov/show/NCT04370782
NCT04368676 Breath Regulation and Yogic Exercise An Online Therapy for Calm and Happiness https://ClinicalTrials.gov/show/NCT04368676
NCT04366856 PROne Positioning in coVID-19 Oxygeno-dependent Patients in Spontaneous Ventilation (PROVID Study) https://ClinicalTrials.gov/show/NCT04366856
NCT04365985 Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19 https://ClinicalTrials.gov/show/NCT04365985
NCT04365738 Pulmonary Rehabilitation in Post-Acute Period of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04365738
NCT04368728 Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals https://ClinicalTrials.gov/show/NCT04368728
NCT04400032 Cellular Immuno-Therapy for COVID-19 Acute Respiratory Distress Syndrome - Vanguard https://ClinicalTrials.gov/show/NCT04400032
NCT04389710 Convalescent Plasma for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04389710
NCT04379453 Robot Assisted Percutaneous Cardiovascular Intervention as a Strategy to Reduce or Risk of Intra-Procedure Contamination by COVID-19 and Other Respiratory Viruses https://ClinicalTrials.gov/show/NCT04379453
NCT04374565 Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia https://ClinicalTrials.gov/show/NCT04374565
NCT04370262 Multi-site Adaptive Trials for COVID-19 https://ClinicalTrials.gov/show/NCT04370262
NCT04369794 COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement https://ClinicalTrials.gov/show/NCT04369794
NCT04369456 Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients https://ClinicalTrials.gov/show/NCT04369456
NCT04369365 A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic https://ClinicalTrials.gov/show/NCT04369365
NCT04369066 COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie and Institute Pasteur https://ClinicalTrials.gov/show/NCT04369066
NCT04367831 Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19 https://ClinicalTrials.gov/show/NCT04367831
NCT04367077 MultiStem Administration for COVID-19 Induced ARDS (MACoVIA) https://ClinicalTrials.gov/show/NCT04367077
NCT04366180 Evaluation of the Probiotic Lactobacillus Coryniformis K8 on COVID-19 Prevention in Healthcare Workers https://ClinicalTrials.gov/show/NCT04366180
NCT04372693 Unplanned Shifting to Online Distance Learning: Nursing Students’ Perception and Achievement https://ClinicalTrials.gov/show/NCT04372693
NCT04367545 Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04367545
NCT04366232 Efficacy of Intravenous Anakinra and Ruxolitinib During COVID-19 Inflammation (JAKINCOV) https://ClinicalTrials.gov/show/NCT04366232
NCT04406181 Psychological Well-being of Patients Awaiting for Cardiac Surgery During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04406181
NCT04379154 Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by SARS-COV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04379154
NCT04376476 Host-pathogen Interactions During SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04376476
NCT04371510 Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Chronic Haemodialysis Patients https://ClinicalTrials.gov/show/NCT04371510
NCT04371419 COVID-19 Health Messaging to Underserved Communities https://ClinicalTrials.gov/show/NCT04371419
NCT04370886 Recruit Blood Donors Via SMS During Epidemic of COVID-19 https://ClinicalTrials.gov/show/NCT04370886
NCT04371029 Impact of Neck Inspiratory Muscle Activation During Sleep in ICU Patients After a COVID 19 ARDS https://ClinicalTrials.gov/show/NCT04371029
NCT04369599 Trans Thoracic Manipulation of Ventilation/Perfusion: the V/Q Vest for COVID-19 https://ClinicalTrials.gov/show/NCT04369599
NCT04410354 Study of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19 https://ClinicalTrials.gov/show/NCT04410354
NCT04371393 MSCs in COVID-19 ARDS https://ClinicalTrials.gov/show/NCT04371393
NCT04369469 Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia https://ClinicalTrials.gov/show/NCT04369469
NCT04392219 COVID-19 First In Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of EIDD-2801 in Healthy Volunteers https://ClinicalTrials.gov/show/NCT04392219
NCT04384588 COVID19-Convalescent Plasma for Treating Patients With Active Symptomatic COVID 19 Infection (FALP-COVID) https://ClinicalTrials.gov/show/NCT04384588
NCT04380532 Tableted COVID-19 Therapeutic Vaccine https://ClinicalTrials.gov/show/NCT04380532
NCT04378712 Hydrogen/Oxygen Mixed Gas Inhalation for Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04378712
NCT04374487 Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications https://ClinicalTrials.gov/show/NCT04374487
NCT04372004 Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19) https://ClinicalTrials.gov/show/NCT04372004
NCT04371965 Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Naso- Pharyngeal Viral Load in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04371965
NCT04371367 Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE ) https://ClinicalTrials.gov/show/NCT04371367
NCT04370938 Provider Burnout During COVID-19 https://ClinicalTrials.gov/show/NCT04370938
NCT04370288 Clinical Application of Methylene Blue for Treatment of Covid-19 Patients https://ClinicalTrials.gov/show/NCT04370288
NCT04370236 INB03 for the Treatment of Pulmonary Complications From COVID-19 https://ClinicalTrials.gov/show/NCT04370236
NCT04369820 C5a Receptor Expression - COVID-19 (C5-COV) https://ClinicalTrials.gov/show/NCT04369820
NCT04372186 A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04372186
NCT04375202 Colchicine in COVID-19: a Pilot Study https://ClinicalTrials.gov/show/NCT04375202
NCT04387955 Analysis of Chilblains pROfile During coVID-19 Epidemic (ACROVID) https://ClinicalTrials.gov/show/NCT04387955
NCT04385810 Description of Ophthalmologic Injuries in Intensive Care During the SARS-CoV2 Epidemic - COVID19 https://ClinicalTrials.gov/show/NCT04385810
NCT04408066 COVID-19: A POC Test Under Research & Evaluation https://ClinicalTrials.gov/show/NCT04408066
NCT04379531 LDCT in COVID-19 Pneumonia: a Prospective Moscow Study https://ClinicalTrials.gov/show/NCT04379531
NCT04374942 Does Hydroxychloroquine Before & During Patient Exposure Protect Healthcare Workers From Coronavirus? https://ClinicalTrials.gov/show/NCT04374942
NCT04374032 Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection https://ClinicalTrials.gov/show/NCT04374032
NCT04373161 Home Pulse Oximeter Use in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04373161
NCT04373135 Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19 https://ClinicalTrials.gov/show/NCT04373135
NCT04372680 WeanINg From Mechanical Ventilation for ARDS CovId-19 Patients Guided by Combined Thoracic UltraSound https://ClinicalTrials.gov/show/NCT04372680
NCT04372628 Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19 https://ClinicalTrials.gov/show/NCT04372628
NCT04371978 Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19 https://ClinicalTrials.gov/show/NCT04371978
NCT04373382 Peer Champion Support for Hospital Staff During and After the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04373382
NCT04373460 Convalescent Plasma to Limit SARS-CoV-2 Associated Complications https://ClinicalTrials.gov/show/NCT04373460
NCT04372602 Duvelisib to Combat COVID-19 https://ClinicalTrials.gov/show/NCT04372602
NCT04377568 Efficacy of Human Coronavirus-immune Convalescent Plasma for the Treatment of COVID-19 Disease in Hospitalized Children https://ClinicalTrials.gov/show/NCT04377568
NCT04373707 Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19 https://ClinicalTrials.gov/show/NCT04373707
NCT04373291 Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04373291
NCT04383002 High Dose Inhaled Nitric Oxide for COVID-19 (ICU Patients) https://ClinicalTrials.gov/show/NCT04383002
NCT04379271 A Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator’s Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19 (COVID-19) https://ClinicalTrials.gov/show/NCT04379271
NCT04378738 Social Media and Covid19 Pandemic https://ClinicalTrials.gov/show/NCT04378738
NCT04377789 Effect of Quercetin on Prophylaxis and Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04377789
NCT04376788 Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04376788
NCT04375124 Treatment of Angiotensin Peptide (1-7) for COVID-19 https://ClinicalTrials.gov/show/NCT04375124
NCT04374786 Effects of Mobile App in House Staff Health and Well-being During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04374786
NCT04373733 Early Intervention in COVID-19: Favipiravir Verses Standard Care https://ClinicalTrials.gov/show/NCT04373733
NCT04374461 A Study of N-acetylcysteine in Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04374461
NCT04374019 Novel Agents for Treatment of High-risk COVID-19 Positive Patients https://ClinicalTrials.gov/show/NCT04374019
NCT04374591 The Role of Sodium Bicarbonate as Adjuvant Treatment of Computed Tomography Identified COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04374591
NCT04374539 Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT04374539
NCT04374526 Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression. https://ClinicalTrials.gov/show/NCT04374526
NCT04394455 Brief Cognitive Behavioral Therapy Versus Crisis Intervention Therapy Through Telepsychiatry on Psychiatric Symptoms https://ClinicalTrials.gov/show/NCT04394455
NCT04392531 Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19 https://ClinicalTrials.gov/show/NCT04392531
NCT04376814 Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19 https://ClinicalTrials.gov/show/NCT04376814
NCT04376593 PET/CT Imaging in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04376593
NCT04375098 Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection https://ClinicalTrials.gov/show/NCT04375098
NCT04581031 COntinuous Signs Monitoring In Covid-19 Patients https://ClinicalTrials.gov/show/NCT04581031
NCT04391712 Photobiomodulation Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease https://ClinicalTrials.gov/show/NCT04391712
NCT04388527 COVID-19 Convalescent Plasma for Mechanically Ventilated Population https://ClinicalTrials.gov/show/NCT04388527
NCT04385043 Hyperimmune Plasma in Patients With COVID-19 Severe Infection https://ClinicalTrials.gov/show/NCT04385043
NCT04380935 Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04380935
NCT04380818 Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19 https://ClinicalTrials.gov/show/NCT04380818
NCT04379375 Nudges to Improve Health Behaviors That Limit COVID-19 Spread https://ClinicalTrials.gov/show/NCT04379375
NCT04379336 BCG Vaccination for Healthcare Workers in COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04379336
NCT04378803 Mindfulness Training for Seniors https://ClinicalTrials.gov/show/NCT04378803
NCT04377672 Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04377672
NCT04377620 Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT) https://ClinicalTrials.gov/show/NCT04377620
NCT04377477 COVID-19 Pneumonitis Low Dose Lung Radiotherapy (COLOR-19) https://ClinicalTrials.gov/show/NCT04377477
NCT04377659 Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection https://ClinicalTrials.gov/show/NCT04377659
NCT04377165 Innovative Tool to Limit Spread of SARS-CoV-2 (COVID 19) in Residential Aged Care Facilities https://ClinicalTrials.gov/show/NCT04377165
NCT04375397 Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury https://ClinicalTrials.gov/show/NCT04375397
NCT04376684 Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease https://ClinicalTrials.gov/show/NCT04376684
NCT04392713 Efficacy of Ivermectin in COVID-19 https://ClinicalTrials.gov/show/NCT04392713
NCT04389372 Effectiveness and Acceptability of MINDFULNESS by Smartphone, for Patients With Chronic Migraine and Medication Overuse https://ClinicalTrials.gov/show/NCT04389372
NCT04385108 Predictive Immune Biomarkers for COVID-19 Pathogenesis https://ClinicalTrials.gov/show/NCT04385108
NCT04383613 Prone Positioning for Patients on General Medical Wards With COVID19 https://ClinicalTrials.gov/show/NCT04383613
NCT04382560 Coping Strategies and Responsiveness to a Brief Online Intervention During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04382560
NCT04381884 Ivermectin Effect on SARS-CoV-2 Replication in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04381884
NCT04379661 SUNLIGHT Study: Online Support Groups for MS to Address COVID-19 https://ClinicalTrials.gov/show/NCT04379661
NCT04379076 InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort https://ClinicalTrials.gov/show/NCT04379076
NCT04379037 Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients https://ClinicalTrials.gov/show/NCT04379037
NCT04377711 A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04377711
NCT04377100 Impact on Anxiety and Motivation of COVID-19 and Predictors of Individual Responses https://ClinicalTrials.gov/show/NCT04377100
NCT04378920 A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes https://ClinicalTrials.gov/show/NCT04378920
NCT04379518 Rintatolimod and IFN Alpha-2b for the Treatment of Mild or Moderate COVID-19 Infection in Cancer Patients https://ClinicalTrials.gov/show/NCT04379518
NCT04385901 Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealth https://ClinicalTrials.gov/show/NCT04385901
NCT04384549 Efficacy of BCG Vaccination in the Prevention of COVID19 Via the Strengthening of Innate Immunity in Health Care Workers https://ClinicalTrials.gov/show/NCT04384549
NCT04383535 Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia https://ClinicalTrials.gov/show/NCT04383535
NCT04382768 Inhaled Ibuprofen to Treat COVID-19 https://ClinicalTrials.gov/show/NCT04382768
NCT04382092 Co-infection Management in COVID-19 Critically Ill https://ClinicalTrials.gov/show/NCT04382092
NCT04381858 Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04381858
NCT04380701 A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults https://ClinicalTrials.gov/show/NCT04380701
NCT04380519 Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04380519
NCT04380376 Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia https://ClinicalTrials.gov/show/NCT04380376
NCT04433910 A Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04433910
NCT04380961 A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19 https://ClinicalTrials.gov/show/NCT04380961
NCT04390477 Study to Evaluate the Effect of a Probiotic in COVID-19 https://ClinicalTrials.gov/show/NCT04390477
NCT04390139 Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19 https://ClinicalTrials.gov/show/NCT04390139
NCT04390022 Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial https://ClinicalTrials.gov/show/NCT04390022
NCT04384731 Curosurf® in Adult Acute Respiratory Distress Syndrome Due to COVID-19 https://ClinicalTrials.gov/show/NCT04384731
NCT04384497 Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study https://ClinicalTrials.gov/show/NCT04384497
NCT04382755 Zilucoplan® in Improving Oxygenation and Short- and Long-term Outcome of COVID-19 Patients With Acute Hypoxic Respiratory Failure https://ClinicalTrials.gov/show/NCT04382755
NCT04382586 Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants https://ClinicalTrials.gov/show/NCT04382586
NCT04382040 A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19 https://ClinicalTrials.gov/show/NCT04382040
NCT04381962 A Multicentre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID19 (ATOMIC2) https://ClinicalTrials.gov/show/NCT04381962
NCT04381377 Efficacy and Safety of Polyoxidonium® in Hospitalized Patients With Coronavirus Disease COVID-19 https://ClinicalTrials.gov/show/NCT04381377
NCT04381364 Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19) https://ClinicalTrials.gov/show/NCT04381364
NCT04381000 Quarantine and Telerehabilitation in Chronic Pain Patients During COVID-19 Pandemic. https://ClinicalTrials.gov/show/NCT04381000
NCT04380909 ROCO - Self-help for People With Psychological Distress Due to the Covid-19 Situation https://ClinicalTrials.gov/show/NCT04380909
NCT04380688 Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. https://ClinicalTrials.gov/show/NCT04380688
NCT04521309 SARS-CoV-2 Antibodies Based IVIG Therapy for COVID-19 Patients https://ClinicalTrials.gov/show/NCT04521309
NCT04382066 Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04382066
NCT04381936 Randomised Evaluation of COVID-19 Therapy https://ClinicalTrials.gov/show/NCT04381936
NCT04405986 Exploring Brain Damages After COVID-19 Infection https://ClinicalTrials.gov/show/NCT04405986
NCT04400929 Using GM-CSF as a Host Directed Therapeutic Against COVID-19 https://ClinicalTrials.gov/show/NCT04400929
NCT04394416 Trial of Imatinib for Hospitalized Adults With COVID-19 https://ClinicalTrials.gov/show/NCT04394416
NCT04394377 Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial https://ClinicalTrials.gov/show/NCT04394377
NCT04390464 mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Repurposed Drugs (TACTIC-R) https://ClinicalTrials.gov/show/NCT04390464
NCT04389294 HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists https://ClinicalTrials.gov/show/NCT04389294
NCT04384965 Accelerated iTBS for Depressed Patients During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04384965
NCT04384458 Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis https://ClinicalTrials.gov/show/NCT04384458
NCT04382729 Neuromuscular Electrical Stimulation in Patients With COVID19 Associated Pneumonia https://ClinicalTrials.gov/show/NCT04382729
NCT04382924 Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Hospitalized Patient With Confirmed COVID-19 Disease https://ClinicalTrials.gov/show/NCT04382924
NCT04382547 Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells https://ClinicalTrials.gov/show/NCT04382547
NCT04382131 Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19 (ELVIS COVID-19) https://ClinicalTrials.gov/show/NCT04382131
NCT04381988 A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy https://ClinicalTrials.gov/show/NCT04381988
NCT04382053 Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04382053
NCT04386694 Photobiomodulation Therapy Combined With Static Magnetic Field in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04386694
NCT04382651 Study of Efficacy and Safety of MAS825 in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04382651
NCT04389333 Feasibility of Non-contact Magnetically-controlled Capsule Endoscopy During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04389333
NCT04387760 Favipiravir vs Hydroxychloroquine in COVID -19 https://ClinicalTrials.gov/show/NCT04387760
NCT04385199 Convalescent Plasma for Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04385199
NCT04384445 Zofin (Organicell Flow) for Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04384445
NCT04383574 Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19) https://ClinicalTrials.gov/show/NCT04383574
NCT04392973 FAvipiravir and HydroxyChloroquine Combination Therapy https://ClinicalTrials.gov/show/NCT04392973
NCT04391140 Prone Positioning and High-flow Nasal Cannula in COVID-19 Induced ARDS https://ClinicalTrials.gov/show/NCT04391140
NCT04385836 Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) https://ClinicalTrials.gov/show/NCT04385836
NCT04385017 Role of Inflammasomes in COVID-19 Disease https://ClinicalTrials.gov/show/NCT04385017
NCT04446104 A Preventive Treatment for Migrant Workers at High-risk of COVID-19 https://ClinicalTrials.gov/show/NCT04446104
NCT04442191 Convalescent Plasma as a Possible Treatment for COVID-19 https://ClinicalTrials.gov/show/NCT04442191
NCT04393077 Emotional Freedom Technique (EFT) Effect on Nurses https://ClinicalTrials.gov/show/NCT04393077
NCT04393636 Digital Cardiac Counseling Trial: DCC Trial https://ClinicalTrials.gov/show/NCT04393636
NCT04388514 Blood Ozonization in Patients With SARS-CoV-2 Respiratory Failure https://ClinicalTrials.gov/show/NCT04388514
NCT04387409 Study to Assess VPM1002 in Reducing Healthcare Professionals’ Absenteeism in COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04387409
NCT04386850 Oral 25-hydroxyvitamin D3 and COVID-19 https://ClinicalTrials.gov/show/NCT04386850
NCT04386291 Meditation and Kundalini Yoga for Heightened Anxiety Related to COVID-19 https://ClinicalTrials.gov/show/NCT04386291
NCT04384900 Accelerated Prone Position Ventilation of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04384900
NCT04386616 A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04386616
NCT04522128 Does Quality of Life Decline During the COVID-19 Pandemic and Can we Change Behaviour to Improve Poor Quality of Life? https://ClinicalTrials.gov/show/NCT04522128
NCT04412330 Optimizing Outcomes With Physical Therapy Treatment for IndividuALs Surviving an ICU Admission for Covid-19 https://ClinicalTrials.gov/show/NCT04412330
NCT04402944 Pulmozyme to Improve COVID-19 ARDS Outcomes https://ClinicalTrials.gov/show/NCT04402944
NCT04390191 Early CPAP in COVID-19 Confirmed or Suspected Patients https://ClinicalTrials.gov/show/NCT04390191
NCT04389944 Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19 https://ClinicalTrials.gov/show/NCT04389944
NCT04389385 COVID-19 Specific T Cell Derived Exosomes (CSTC-Exo) https://ClinicalTrials.gov/show/NCT04389385
NCT04387253 Study of Late Fetal Loss in Poitou-Charentes. GYNE-COVID https://ClinicalTrials.gov/show/NCT04387253
NCT04388410 Safety and Efficacy of Convalescent Plasma Transfusion for Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04388410
NCT04387292 Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic https://ClinicalTrials.gov/show/NCT04387292
NCT04386668 Let It Out (LIO) and COVID19: Testing an Online Emotional Disclosure-based Intervention During the COVID19 Pandemic https://ClinicalTrials.gov/show/NCT04386668
NCT04402957 LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04402957
NCT04391127 Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04391127
NCT04400838 Investigating a Vaccine Against COVID-19 https://ClinicalTrials.gov/show/NCT04400838
NCT04479202 The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19 https://ClinicalTrials.gov/show/NCT04479202
NCT04416919 Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment https://ClinicalTrials.gov/show/NCT04416919
NCT04405076 Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older https://ClinicalTrials.gov/show/NCT04405076
NCT04394403 Pilot Internet-based Self-Help Program for Managing Corona (COVID-19) Stress https://ClinicalTrials.gov/show/NCT04394403
NCT04394169 Early Care Program for the Management of Post-ICU Syndrome and Chronic Pain After COVID-19 Infection. https://ClinicalTrials.gov/show/NCT04394169
NCT04392414 Hyperimmune Convalescent Plasma in Moderate and Severe COVID-19 Disease https://ClinicalTrials.gov/show/NCT04392414
NCT04391829 Detection of SARS-CoV-2 in Semen of COVID-19 Positive Males https://ClinicalTrials.gov/show/NCT04391829
NCT04389840 Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure https://ClinicalTrials.gov/show/NCT04389840
NCT04388683 Inhaled Nitric Oxide for Preventing Progression in COVID-19 https://ClinicalTrials.gov/show/NCT04388683
NCT04388826 COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111 https://ClinicalTrials.gov/show/NCT04388826
NCT04390412 Low Dose Radiotherapy in COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04390412
NCT04420390 Low Dose Radiotherapy for COVID-19 Pneumonitis https://ClinicalTrials.gov/show/NCT04420390
NCT04397718 Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization https://ClinicalTrials.gov/show/NCT04397718
NCT04390594 Efficacy and Safety Evaluation of Treatment Regimens in Adult COVID-19 Patients in Senegal https://ClinicalTrials.gov/show/NCT04390594
NCT04390516 Respiratory Decompensation and Model for the Triage of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04390516
NCT04390503 Convalescent Plasma for COVID-19 Close Contacts https://ClinicalTrials.gov/show/NCT04390503
NCT04389450 Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04389450
NCT04391179 Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19 https://ClinicalTrials.gov/show/NCT04391179
NCT04408040 Use of Convalescent Plasma for COVID-19 https://ClinicalTrials.gov/show/NCT04408040
NCT04400799 Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04400799
NCT04395144 COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEss https://ClinicalTrials.gov/show/NCT04395144
NCT04394208 Silymarin in COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04394208
NCT04394182 Ultra Low Doses of Therapy With Radiation Applicated to COVID-19 https://ClinicalTrials.gov/show/NCT04394182
NCT04393948 Lung Irradiation for COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04393948
NCT04393415 Using PRP and Cord Blood in Treatment of Covid -19 https://ClinicalTrials.gov/show/NCT04393415
NCT04392232 A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection https://ClinicalTrials.gov/show/NCT04392232
NCT04392323 Incidence of COVID-19 Test Conversion in Post-surgical Patients https://ClinicalTrials.gov/show/NCT04392323
NCT04392141 Colchicine Plus Phenolic Monoterpenes to Treat COVID-19 https://ClinicalTrials.gov/show/NCT04392141
NCT04474483 Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19 https://ClinicalTrials.gov/show/NCT04474483
NCT04407208 Convalescent Plasma Therapy in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04407208
NCT04396106 Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04396106
NCT04395105 Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial https://ClinicalTrials.gov/show/NCT04395105
NCT04393246 mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Experimental Drugs and Mechanisms https://ClinicalTrials.gov/show/NCT04393246
NCT04393727 Transfusion of Convalescent Plasma for the Early Treatment of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04393727
NCT04407130 Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection. https://ClinicalTrials.gov/show/NCT04407130
NCT04398004 Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early https://ClinicalTrials.gov/show/NCT04398004
NCT04395911 Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections https://ClinicalTrials.gov/show/NCT04395911
NCT04394442 Hydroxychloroquine in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04394442
NCT04394793 Low Dose Radiation Therapy for Covid-19 Pneumonia https://ClinicalTrials.gov/show/NCT04394793
NCT04421625 Patients and Health Staff of Cancer Centres During the Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04421625
NCT04405999 Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease https://ClinicalTrials.gov/show/NCT04405999
NCT04403269 NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER, COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE https://ClinicalTrials.gov/show/NCT04403269
NCT04402918 Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 (COVID-19) During Pregnancy https://ClinicalTrials.gov/show/NCT04402918
NCT04399317 Flow Controlled Ventilation in ARDS Associated With COVID-19 https://ClinicalTrials.gov/show/NCT04399317
NCT04397796 Study of the Safety of Therapeutic Tx With Immunomodulatory MSC in Adults With COVID-19 Infection Requiring Mechanical Ventilation https://ClinicalTrials.gov/show/NCT04397796
NCT04395807 Helmet CPAP Versus HFNC in COVID-19 https://ClinicalTrials.gov/show/NCT04395807
NCT04395768 International ALLIANCE Study of Therapies to Prevent Progression of COVID-19 https://ClinicalTrials.gov/show/NCT04395768
NCT04394117 Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease https://ClinicalTrials.gov/show/NCT04394117
NCT04394013 A Web-Based Gentle Body Stretching to Alleviate Loneliness and Improve Mental Fitness During COVID-19 Isolation Period https://ClinicalTrials.gov/show/NCT04394013
NCT04393818 Mobile Phone Based Intervention to Protect Mental Health in Healthcare Workers at Frontline Against COVID19 https://ClinicalTrials.gov/show/NCT04393818
NCT04393792 SINUS WASH Pilot Study in Adults Testing Positive for COVID-19 https://ClinicalTrials.gov/show/NCT04393792
NCT04393038 ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04393038
NCT04418206 Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19 https://ClinicalTrials.gov/show/NCT04418206
NCT04416360 Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak https://ClinicalTrials.gov/show/NCT04416360
NCT04414631 Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04414631
NCT04407286 Vitamin D Testing and Treatment for COVID 19 https://ClinicalTrials.gov/show/NCT04407286
NCT04402203 Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh https://ClinicalTrials.gov/show/NCT04402203
NCT04399967 COVID-19 Brief Advice and Chat-based Support for Smoking Cessation Via “Quit to Win” Contest 2020 https://ClinicalTrials.gov/show/NCT04399967
NCT04399746 Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19 https://ClinicalTrials.gov/show/NCT04399746
NCT04399252 Effect of Lactobacillus on the Microbiome of Household Contacts Exposed to COVID-19 https://ClinicalTrials.gov/show/NCT04399252
NCT04399005 The Efficacy Comparing Daily and After-each-case Room Disinfection. https://ClinicalTrials.gov/show/NCT04399005
NCT04397757 COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2. https://ClinicalTrials.gov/show/NCT04397757
NCT04397692 Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial) https://ClinicalTrials.gov/show/NCT04397692
NCT04397510 Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury https://ClinicalTrials.gov/show/NCT04397510
NCT04399356 Niclosamide for Mild to Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04399356
NCT04397562 A Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04397562
NCT04441684 Seroprevalence of SARS-CoV-2 in Strasbourg University Hospital, Strasbourg, France (COVID-19) https://ClinicalTrials.gov/show/NCT04441684
NCT04403477 Convalescent Plasma Therapy in Severe COVID-19 Infection https://ClinicalTrials.gov/show/NCT04403477
NCT04402970 Dornase Alfa for ARDS in Patients With SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04402970
NCT04401293 Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients https://ClinicalTrials.gov/show/NCT04401293
NCT04398277 A Daily Coping Toolkit for Medical Personnel and First-Responders During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04398277
NCT04397666 RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19 https://ClinicalTrials.gov/show/NCT04397666
NCT04397523 Efficacy and Safety of COVID-19 Convalescent Plasma https://ClinicalTrials.gov/show/NCT04397523
NCT04552951 Effect of Vitamin D on Morbidity and Mortality of the COVID-19 https://ClinicalTrials.gov/show/NCT04552951
NCT04413006 Self-compassion for Chronic Pain Virtual Group Treatment Program https://ClinicalTrials.gov/show/NCT04413006
NCT04412538 Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 https://ClinicalTrials.gov/show/NCT04412538
NCT04410549 Pulmonary Optical Coherence Tomography in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04410549
NCT04401423 TXA127 for the Treatment of Severe COVID-19 https://ClinicalTrials.gov/show/NCT04401423
NCT04401202 Nigella Sativa in COVID-19 https://ClinicalTrials.gov/show/NCT04401202
NCT04401150 Lessening Organ Dysfunction With VITamin C - COVID-19 https://ClinicalTrials.gov/show/NCT04401150
NCT04400279 The COVID-19 Pandemic and Exercise Study https://ClinicalTrials.gov/show/NCT04400279
NCT04399980 Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation https://ClinicalTrials.gov/show/NCT04399980
NCT04399889 hCT-MSCs for COVID19 ARDS https://ClinicalTrials.gov/show/NCT04399889
NCT04399681 The Utility of Bedside Lung Ultrasonography on Diagnosis of COVID-19 https://ClinicalTrials.gov/show/NCT04399681
NCT04399109 Evaluation of a Remote Monitoring Smartphone Application and Care Model of COVID-19 Patients in the Community (ReCOVER) https://ClinicalTrials.gov/show/NCT04399109
NCT04401410 Anti-SARS Cov-2 T Cell Infusions for COVID 19 https://ClinicalTrials.gov/show/NCT04401410
NCT04400305 “Increasing Physical Activity in Canadian Adults Affected by COVID-19 Social Distancing Restrictions: A Feasibility Trial of an Online Intervention” https://ClinicalTrials.gov/show/NCT04400305
NCT04400058 Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression https://ClinicalTrials.gov/show/NCT04400058
NCT04411602 Feasibility Study of Anti-SARS-CoV-2 Plasma Transfusions in COVID-19 Patients With SRD https://ClinicalTrials.gov/show/NCT04411602
NCT04410016 Evaluation of Staff COVID-19 Wellbeing Centres in a Healthcare Workplace: COVID-WELL Study https://ClinicalTrials.gov/show/NCT04410016
NCT04408183 GLS-1200Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19) in Health Care Personnel https://ClinicalTrials.gov/show/NCT04408183
NCT04407390 Effects of Nicotinamide Riboside on the Clinical Outcome of Covid-19 in the Elderly https://ClinicalTrials.gov/show/NCT04407390
NCT04402983 The Effectiveness of Telerehabilitation-Based Physiotherapy in COVID 19 Patients https://ClinicalTrials.gov/show/NCT04402983
NCT04402866 TD-0903 for ALI Associated With COVID-19 https://ClinicalTrials.gov/show/NCT04402866
NCT04402060 A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19 https://ClinicalTrials.gov/show/NCT04402060
NCT04401579 Adaptive COVID-19 Treatment Trial 2 (ACTT-2) https://ClinicalTrials.gov/show/NCT04401579
NCT04401046 COVID-19 and Reorganisation of Cancer Patient Care: Self- Evaluation of Potential Post-traumatic Stress Disorder https://ClinicalTrials.gov/show/NCT04401046
NCT04400890 Randomized Proof-of-Concept Trial to Evaluate the Safety and Explore the Effectiveness of a Plant Polyphenol for COVID-19 https://ClinicalTrials.gov/show/NCT04400890
NCT04402879 CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals https://ClinicalTrials.gov/show/NCT04402879
NCT04402840 Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS) https://ClinicalTrials.gov/show/NCT04402840
NCT04404426 CACOLAC : Citrulline Administration in the Hospital Patient in Intensive Care for COVID-19 Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04404426
NCT04404361 PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer https://ClinicalTrials.gov/show/NCT04404361
NCT04411433 Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04411433
NCT04406493 Monitoring COVID-19 Patients’ Lung Fluid Using Impedance Technique https://ClinicalTrials.gov/show/NCT04406493
NCT04405843 Efficacy of Ivermectin in Adult Patients With Early Stages of COVID-19 https://ClinicalTrials.gov/show/NCT04405843
NCT04403555 Ivermectin and Doxycycine in COVID-19 Treatment https://ClinicalTrials.gov/show/NCT04403555
NCT04403100 Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: “The Hope Coalition - 1” https://ClinicalTrials.gov/show/NCT04403100
NCT04429711 Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04429711
NCT04412356 Timing of Tracheotomy in Covid-19 Patients https://ClinicalTrials.gov/show/NCT04412356
NCT04408456 Efficacy of Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT04408456
NCT04406246 Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide https://ClinicalTrials.gov/show/NCT04406246
NCT04404218 The Açaí Berry COVID-19 Anti-Inflammation Trial https://ClinicalTrials.gov/show/NCT04404218
NCT04403685 Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers https://ClinicalTrials.gov/show/NCT04403685
NCT04417335 Reducing COVID-19 Related Hospital Admission in Elderly by BCG Vaccination https://ClinicalTrials.gov/show/NCT04417335
NCT04410536 Home Detox in Medication Overuse Headache (MOH) During Covid-19 Emergency https://ClinicalTrials.gov/show/NCT04410536
NCT04407182 Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19 https://ClinicalTrials.gov/show/NCT04407182
NCT04405908 SCB-2019 as COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04405908
NCT04408209 Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection https://ClinicalTrials.gov/show/NCT04408209
NCT04430608 Remote Continues Glucose Monitoring During the COVID-19 Pandemic in Quarantined Hospitalized Patients https://ClinicalTrials.gov/show/NCT04430608
NCT04410562 Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy https://ClinicalTrials.gov/show/NCT04410562
NCT04406389 Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial) https://ClinicalTrials.gov/show/NCT04406389
NCT04405739 The Safety of Molnupiravir (EIDD-2801) and Its Effect on Viral Shedding of SARS-CoV-2 (END-COVID) https://ClinicalTrials.gov/show/NCT04405739
NCT04405310 Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial https://ClinicalTrials.gov/show/NCT04405310
NCT04405102 COVID-19 Ozanimod Intervention Study https://ClinicalTrials.gov/show/NCT04405102
NCT04409496 Chat-based Support for Preventing Smoking Relapse https://ClinicalTrials.gov/show/NCT04409496
NCT04405570 A Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19 https://ClinicalTrials.gov/show/NCT04405570
NCT04405544 Determination of Acute Encephalopathy Predictors in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04405544
NCT04411446 Cholecalciferol to Improve the Outcomes of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04411446
NCT04408157 A Research Study to Evaluate the Benefits of a Self-management Booklet to Promote Wellbeing During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04408157
NCT04414618 A Study of Opaganib in Coronavirus Disease 2019 Pneumonia https://ClinicalTrials.gov/show/NCT04414618
NCT04457609 Administration of Allogenic UC-MSCs as Adjuvant Therapy for Critically-Ill COVID-19 Patients https://ClinicalTrials.gov/show/NCT04457609
NCT04444271 Mesenchymal Stem Cell Infusion for COVID-19 Infection https://ClinicalTrials.gov/show/NCT04444271
NCT04425317 Detection of SARS-CoV-2 in Follicular Fluid and Cumulus-oocyte-complexes in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04425317
NCT04416308 COVID 19 : Seroprevalence Study of Anti SRAS-CoV-2 Antibodies in GHT Employees in Haute Bretagne (AntiCoV-HB) https://ClinicalTrials.gov/show/NCT04416308
NCT04410692 Can the Prediction Market Improve Predictions of COVID-19? https://ClinicalTrials.gov/show/NCT04410692
NCT04410510 P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19 https://ClinicalTrials.gov/show/NCT04410510
NCT04410159 Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients https://ClinicalTrials.gov/show/NCT04410159
NCT04407689 InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection FR BL Cohort https://ClinicalTrials.gov/show/NCT04407689
NCT04417257 Study of LAU-7b for the Treatment of COVID-19 Disease in Adults https://ClinicalTrials.gov/show/NCT04417257
NCT04412486 COVID-19 Convalescent Plasma (CCP) Transfusion https://ClinicalTrials.gov/show/NCT04412486
NCT04410328 Aggrenox To Treat Acute Covid-19 https://ClinicalTrials.gov/show/NCT04410328
NCT04409834 Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial https://ClinicalTrials.gov/show/NCT04409834
NCT04409743 Brief Telehealth CBT-I Intervention in the Context of the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04409743
NCT04409522 Evaluation of Therapeutic Effects of Melatonin by Inhibition of NLRP3 Inflammasome in COVID19 Patients https://ClinicalTrials.gov/show/NCT04409522
NCT04409509 Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04409509
NCT04409327 Phase 3 Study to Determine if RTB101 Reduces the Severity of COVID-19 in Older Adults Residing in Nursing Homes https://ClinicalTrials.gov/show/NCT04409327
NCT04408131 Morbi-mortality by COVID-19 Among Homeless People in Marseille: a Cohort Study https://ClinicalTrials.gov/show/NCT04408131
NCT04433546 Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS). https://ClinicalTrials.gov/show/NCT04433546
NCT04409262 A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04409262
NCT04427098 Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients https://ClinicalTrials.gov/show/NCT04427098
NCT04424901 Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04424901
NCT04420182 COVID-19 Virtual Care at Home https://ClinicalTrials.gov/show/NCT04420182
NCT04418947 Project Resurgence Communication Trial https://ClinicalTrials.gov/show/NCT04418947
NCT04412057 Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury https://ClinicalTrials.gov/show/NCT04412057
NCT04412018 An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19 https://ClinicalTrials.gov/show/NCT04412018
NCT04410458 Recruit Blood Donors Via SMS During Epidemic of COVID-19 (Repeat Trial) https://ClinicalTrials.gov/show/NCT04410458
NCT04411628 A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19 https://ClinicalTrials.gov/show/NCT04411628
NCT04412343 The Seniors COvid-19 Pandemic and Exercise Study https://ClinicalTrials.gov/show/NCT04412343
NCT04411667 Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04411667
NCT04411680 Study of Sargramostim in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04411680
NCT04416139 Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19 https://ClinicalTrials.gov/show/NCT04416139
NCT04412239 To Assess the Efficiency and Satisfaction of Pharmacist Giving Patient-centred Advice on Telephone Consultation in TB Patients: Experience of the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04412239
NCT04414371 Tools for Wellbeing COVID-19 National Study of Undergraduate Students https://ClinicalTrials.gov/show/NCT04414371
NCT04424953 To Compare Videolaryngoscope Against Direct Laryngoscope for Intubation When Powered Air Purifying Respirator is Worn https://ClinicalTrials.gov/show/NCT04424953
NCT04414267 Bacillus Calmette-guérin Vaccination to Prevent COVID-19 https://ClinicalTrials.gov/show/NCT04414267
NCT04414124 A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19 https://ClinicalTrials.gov/show/NCT04414124
NCT04412785 Cyclosporine in Patients With Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04412785
NCT04412291 A Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study https://ClinicalTrials.gov/show/NCT04412291
NCT04417270 Reliability of the Freestyle Libre CGM in the Inpatient Setting During the COVID-19 Surge https://ClinicalTrials.gov/show/NCT04417270
NCT04415086 Treatment of Patients With COVID-19 With Convalescent Plasma https://ClinicalTrials.gov/show/NCT04415086
NCT04412772 Trial of Tocilizumab for Treatment of Severe COVID-19: ARCHITECTS https://ClinicalTrials.gov/show/NCT04412772
NCT04412668 Study to Evaluate the Safety and Efficacy of ATYR1923 In Patients With Severe Pneumonia Related to COVID-19 https://ClinicalTrials.gov/show/NCT04412668
NCT04420247 Efficacy of Chloroquine or Hydroxychloroquine in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19 https://ClinicalTrials.gov/show/NCT04420247
NCT04415151 Tofacitinib for Treatment of Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04415151
NCT04415060 SedAting With Volatile Anesthetics Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival https://ClinicalTrials.gov/show/NCT04415060
NCT04413968 COVID-19 Infection and Transmission in Exposed, Confined and Community-based Infants https://ClinicalTrials.gov/show/NCT04413968
NCT04425720 Use of Remote Monitoring for COVID-19 Patient https://ClinicalTrials.gov/show/NCT04425720
NCT04453852 Monovalent Recombinant COVID19 Vaccine https://ClinicalTrials.gov/show/NCT04453852
NCT04426305 Community Health Workers Against COVID19 https://ClinicalTrials.gov/show/NCT04426305
NCT04425616 SafeFit Trial: Virtual Clinics to Deliver Universal Interventions in People With Cancer https://ClinicalTrials.gov/show/NCT04425616
NCT04422509 Lanadelumab for Treatment of COVID-19 Disease https://ClinicalTrials.gov/show/NCT04422509
NCT04421404 Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients https://ClinicalTrials.gov/show/NCT04421404
NCT04420273 Targeted Melanoma Detection With Skin Self-Examination During COVID-19 Restricted Physician Access https://ClinicalTrials.gov/show/NCT04420273
NCT04419623 A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer https://ClinicalTrials.gov/show/NCT04419623
NCT04419025 Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease https://ClinicalTrials.gov/show/NCT04419025
NCT04418518 A Trial of CONvalescent Plasma for Hospitalized Adults With Acute COVID-19 Respiratory Illness https://ClinicalTrials.gov/show/NCT04418518
NCT04418505 Vielight RX Plus for the Treatment of COVID-19 Respiratory Symptoms https://ClinicalTrials.gov/show/NCT04418505
NCT04416399 STerOids in COVID-19 Study https://ClinicalTrials.gov/show/NCT04416399
NCT04439045 Efficacy and Safety of VPM1002 in Reducing SARS-CoV-2 (COVID-19) Infection Rate and Severity https://ClinicalTrials.gov/show/NCT04439045
NCT04416334 PREEMPTIVE THERAPY WITH COLCHICINE IN PATIENTS OLDER THAN 60 YEARS WITH HIGH RISK OF SEVERE PNEUMONIAE DUE TO CORONAVIRUS https://ClinicalTrials.gov/show/NCT04416334
NCT04424212 ICBT for Mental Health Problems Related to the Coronavirus Pandemic https://ClinicalTrials.gov/show/NCT04424212
NCT04421391 QuadraMune(TM) for Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT04421391
NCT04420741 Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory Failure https://ClinicalTrials.gov/show/NCT04420741
NCT04420676 Synbiotic Therapy of Gastrointestinal Symptoms During Covid-19 Infection https://ClinicalTrials.gov/show/NCT04420676
NCT04435808 Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19 https://ClinicalTrials.gov/show/NCT04435808
NCT04541979 Aerosoliserat DNase for Treatment of Respiratory Failure in Severe COVID-19 https://ClinicalTrials.gov/show/NCT04541979
NCT04513990 Novel Point-of-Care Diagnostic Test for SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04513990
NCT04427566 Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise https://ClinicalTrials.gov/show/NCT04427566
NCT04424797 Prone Positioning on Admission for Hospitalized COVID-19 Pneumonia Protocol https://ClinicalTrials.gov/show/NCT04424797
NCT04425031 Handling Oxygenation Targets in COVID-19 https://ClinicalTrials.gov/show/NCT04425031
NCT04421664 Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada) https://ClinicalTrials.gov/show/NCT04421664
NCT04421508 A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04421508
NCT04420338 SeroCOVIDial Study: Assessment of COVID-19 Seroconversion in Patients on Chronic Hemodialysis and in Their Caregivers, a Cohort Study https://ClinicalTrials.gov/show/NCT04420338
NCT04420299 Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19 https://ClinicalTrials.gov/show/NCT04420299
NCT04422613 Characterization of Persistent Pulmonary Abnormalities Following COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04422613
NCT04421027 A Study of Baricitinib (LY3009104) in Participants With COVID-19 https://ClinicalTrials.gov/show/NCT04421027
NCT04420806 Effects of COVID-19 Lockdown in Exercising Early Postmenopausal Women https://ClinicalTrials.gov/show/NCT04420806
NCT04441918 Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects https://ClinicalTrials.gov/show/NCT04441918
NCT04423289 Telematic Monitoring Through a Mobile Application of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04423289
NCT04422561 Prophylactic Ivermectin in COVID-19 Contacts https://ClinicalTrials.gov/show/NCT04422561
NCT04428021 Standard or Convalescent Plasma in Patients With Recent Onset of COVID-19 Respiratory Failure https://ClinicalTrials.gov/show/NCT04428021
NCT04425915 Efficacy of Convalescent Plasma Therapy in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04425915
NCT04422353 Video Dance Class and Unsupervised Physical Activity During Covid-19 Pandemic in People With Parkinson’s Disease https://ClinicalTrials.gov/show/NCT04422353
NCT04424082 External Dead Space in Ventilated COVID-19 Patients https://ClinicalTrials.gov/show/NCT04424082
NCT04475601 Enzalutamide Treatment in COVID-19 https://ClinicalTrials.gov/show/NCT04475601
NCT04442087 Study of Seroprevalence of Anti-SARS-CoV2 Among Children of Hospital Workers in AP-HP https://ClinicalTrials.gov/show/NCT04442087
NCT04426292 SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel During the 2020 COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04426292
NCT04425707 Ivermectin In Treatment of COVID 19 Patients https://ClinicalTrials.gov/show/NCT04425707
NCT04425538 A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19). https://ClinicalTrials.gov/show/NCT04425538
NCT04425005 Home-based Exercise Training During Covid-19 Pandemic in Post-bariatric https://ClinicalTrials.gov/show/NCT04425005
NCT04423991 Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning https://ClinicalTrials.gov/show/NCT04423991
NCT04431453 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734â„¢) in Participants From Birth to < 18 Years of Age With Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04431453
NCT04426695 Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04426695
NCT04425629 Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04425629
NCT04458948 Open Label Non-comparative Trial of the Combination of Hydroxychloroquine and Azithromycin in the Treatment of Hospitalized Patients https://ClinicalTrials.gov/show/NCT04458948
NCT04445246 Inhaled Iloprost for Suspected COVID-19 Respiratory Failure https://ClinicalTrials.gov/show/NCT04445246
NCT04434131 Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19 https://ClinicalTrials.gov/show/NCT04434131
NCT04429854 Donated Antibodies Working Against nCoV https://ClinicalTrials.gov/show/NCT04429854
NCT04429529 Safety of TY027, a Treatment for COVID-19, in Humans https://ClinicalTrials.gov/show/NCT04429529
NCT04428099 Healthy Lifestyle Promotion as Adjunctive Teletherapy for Treatment-resistant Major Depression https://ClinicalTrials.gov/show/NCT04428099
NCT04425252 Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04425252
NCT04426318 COVID-19 and the Healthy Minds Program for Educators https://ClinicalTrials.gov/show/NCT04426318
NCT04497389 Safety and Feasibility of Amniotic Fluid as a Treatment for COVID-19 Patients https://ClinicalTrials.gov/show/NCT04497389
NCT04427501 A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness https://ClinicalTrials.gov/show/NCT04427501
NCT04584541 SarS-Cov-2 Viral Infection (COVID-19) in Patients With Chronic Inflammatory Rheumatism https://ClinicalTrials.gov/show/NCT04584541
NCT04433078 RepurpoSing Old Drugs TO SuppRess a Modern Threat: COVID-19 STORM https://ClinicalTrials.gov/show/NCT04433078
NCT04431466 A Study to Compare the Efficacy and Safety of Different Doses of Ivermectin for COVID-19 https://ClinicalTrials.gov/show/NCT04431466
NCT04429867 Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease https://ClinicalTrials.gov/show/NCT04429867
NCT04429724 Health Professional Exposure Assessment to Covid-19 https://ClinicalTrials.gov/show/NCT04429724
NCT04429594 Study of the Incidence of SARS-CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04429594
NCT04427137 Accelerated LFR for Bipolar Patients During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04427137
NCT04470258 Elmo Respiratory Support Project - COVID-19 https://ClinicalTrials.gov/show/NCT04470258
NCT04555005 Mindfulness-based Crisis Intervention for COVID-19 Frontline Healthcare Workers During COVID-19 https://ClinicalTrials.gov/show/NCT04555005
NCT04435717 Efficacy of Tocilizumab in Modifying the Inflammatory Parameters of Patients With COVID-19 (COVITOZ-01) https://ClinicalTrials.gov/show/NCT04435717
NCT04432051 The Use of Lung Ultrasonography in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04432051
NCT04623255 Randomised Study of Plasma Exchange in Severe COVID-19 https://ClinicalTrials.gov/show/NCT04623255
NCT04441424 Convalescent Plasma Therapy on Critically-ill Novel Coronavirus (COVID-19) Patients https://ClinicalTrials.gov/show/NCT04441424
NCT04433949 Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04433949
NCT04432324 Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04432324
NCT04432298 Study of the Efficacy and Safety of Intravenous Pamrevlumab, in Hospitalized Patients With Acute COVID-19 Disease https://ClinicalTrials.gov/show/NCT04432298
NCT04432272 ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS) https://ClinicalTrials.gov/show/NCT04432272
NCT04431180 Recruit Blood Donors Via SMS During Epidemic of COVID-19 #Second Repeat Trial# https://ClinicalTrials.gov/show/NCT04431180
NCT04431856 CO-PARENT: COVID-19 - Parent Action in Response to Emotions and Needs for Treatment https://ClinicalTrials.gov/show/NCT04431856
NCT04445272 Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04445272
NCT04434248 An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04434248
NCT04435353 Assessment of the Effectiveness of Vibroacoustic Therapy for Respiratory Failure Caused by COVID 19 https://ClinicalTrials.gov/show/NCT04435353
NCT04435522 Maraviroc in Patients With Moderate and Severe COVID-19 https://ClinicalTrials.gov/show/NCT04435522
NCT04432987 Dornase Alpha for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04432987
NCT04432805 Descriptive and Evaluation Study of the Use of Pulmonary Ultrasound in the Initial Management of Pregnant Women in the Context of COVID-19 https://ClinicalTrials.gov/show/NCT04432805
NCT04444674 COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection https://ClinicalTrials.gov/show/NCT04444674
NCT04436276 A Study of Ad26.COV2.S in Adults (COVID-19) https://ClinicalTrials.gov/show/NCT04436276
NCT04447781 Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19 https://ClinicalTrials.gov/show/NCT04447781
NCT04445194 Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine https://ClinicalTrials.gov/show/NCT04445194
NCT04435379 Study to Assess VPM1002 in Reducing Hospital Admissions and/or Severe Respiratory Infectious Diseases in Elderly in COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04435379
NCT04438694 Assessment of the Effect of Convalescent Plasma Therapy in Patients With Life-threatening COVID19 Infection https://ClinicalTrials.gov/show/NCT04438694
NCT04437875 An Open Study of the Safety, Tolerability and Immunogenicity of “Gam-COVID-Vac Lyo” Vaccine Against COVID-19 https://ClinicalTrials.gov/show/NCT04437875
NCT04436471 An Open Study of the Safety, Tolerability and Immunogenicity of the Drug “Gam-COVID-Vac” Vaccine Against COVID-19 https://ClinicalTrials.gov/show/NCT04436471
NCT04435795 Inhaled Ciclesonide for Outpatients With COVID19 https://ClinicalTrials.gov/show/NCT04435795
NCT04435184 Crizanlizumab for Treating COVID-19 Vasculopathy https://ClinicalTrials.gov/show/NCT04435184
NCT04497948 Acalabrutinib Study With Best Supportive Care in Participants Hospitalized With COVID-19 https://ClinicalTrials.gov/show/NCT04497948
NCT04499677 FLARE: Favipiravir +/- Lopinavir: A RCT of Early Antivirals https://ClinicalTrials.gov/show/NCT04499677
NCT04449718 Vitamin D Supplementation in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04449718
NCT04442958 Effectiveness of Convalescent Immune Plasma Therapy https://ClinicalTrials.gov/show/NCT04442958
NCT04442230 NasoVAX in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04442230
NCT04439006 Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization https://ClinicalTrials.gov/show/NCT04439006
NCT04438070 COVID Screening Strategies in Homeless Shelters https://ClinicalTrials.gov/show/NCT04438070
NCT04438057 Evaluating the Efficacy of Convalescent Plasma in Symptomatic Outpatients Infected With COVID-19 https://ClinicalTrials.gov/show/NCT04438057
NCT04437823 Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04437823
NCT04437719 Prospective Cohort Study to Describe the Clinical Characteristics of COVID-19, the Acquired Immune Response and the Biological and Clinical Parameters of Patients Followed in Oncology by the Saint-Joseph Hospital Group for a Period of 6 Months During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04437719
NCT04439071 A Study to Evaluate Efficacy and Safety of PTC299 in Hospitalized Participants With Coronavirus (COVID-19) https://ClinicalTrials.gov/show/NCT04439071
NCT04440007 Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized With COVID-19 https://ClinicalTrials.gov/show/NCT04440007
NCT04450004 Safety, Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years. https://ClinicalTrials.gov/show/NCT04450004
NCT04449276 A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults https://ClinicalTrials.gov/show/NCT04449276
NCT04444596 Conjunctival Swab vs Nasopharyngeal Swab in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04444596
NCT04443881 Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19 (ANA-COVID-GEAS) https://ClinicalTrials.gov/show/NCT04443881
NCT04443673 Glycine Supplement for Severe COVID-19 https://ClinicalTrials.gov/show/NCT04443673
NCT04441632 Effect of Positive Attitudes on Behavior and Wellness https://ClinicalTrials.gov/show/NCT04441632
NCT04441385 Study to Evaluate the Efficacy and Safety of Maraviroc in SARS-CoV-2 Infection (COVID-19). https://ClinicalTrials.gov/show/NCT04441385
NCT04438980 Glucocorticoids in COVID-19 (CORTIVID) https://ClinicalTrials.gov/show/NCT04438980
NCT04445454 Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection https://ClinicalTrials.gov/show/NCT04445454
NCT04445389 Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults https://ClinicalTrials.gov/show/NCT04445389
NCT04445311 Ivermectin in Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04445311
NCT04442178 InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I ) https://ClinicalTrials.gov/show/NCT04442178
NCT04442152 Impact of COVID-19 on Family Dynamics on Bandebereho Study Participants https://ClinicalTrials.gov/show/NCT04442152
NCT04441996 Therapeutic Plasma Exchange for COVID-19-associated Hyperviscosity https://ClinicalTrials.gov/show/NCT04441996
NCT04442048 Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure https://ClinicalTrials.gov/show/NCT04442048
NCT04466683 Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia https://ClinicalTrials.gov/show/NCT04466683
NCT04446429 Anti-Androgen Treatment for COVID-19 https://ClinicalTrials.gov/show/NCT04446429
NCT04473274 GlitazOne Treatment for Coronavirus HypoxiA, a Safety and Tolerability Open Label With Matching Cohort Pilot Study https://ClinicalTrials.gov/show/NCT04473274
NCT04453384 Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia https://ClinicalTrials.gov/show/NCT04453384
NCT04447235 Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04447235
NCT04445597 Unraveling the Mechanisms of Olfactory Dysfunction in COVID-19 https://ClinicalTrials.gov/show/NCT04445597
NCT04445467 An Adaptive Clinical Trial of Antivirals for COVID-19 Infection https://ClinicalTrials.gov/show/NCT04445467
NCT04445428 OPV as Potential Protection Against COVID-19 https://ClinicalTrials.gov/show/NCT04445428
NCT04445376 Effect of Physical Therapy Exercises on Cardiorespiratory Fitness Level in COVID19 Patients After Recovery. https://ClinicalTrials.gov/show/NCT04445376
NCT04445285 Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure https://ClinicalTrials.gov/show/NCT04445285
NCT04445324 Effects of Online and Recovery-oriented Peer Support Groups Facilitated by Peer Support Workers in Times of COVID-19 https://ClinicalTrials.gov/show/NCT04445324
NCT04445220 A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy https://ClinicalTrials.gov/show/NCT04445220
NCT04444700 A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04444700
NCT04456361 Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19 https://ClinicalTrials.gov/show/NCT04456361
NCT04448769 Epidemiological Study of Seroprevalence Against the SARS-CoV-2 Virus (COVID-19) https://ClinicalTrials.gov/show/NCT04448769
NCT04447534 Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04447534
NCT04447404 DUR-928 in Subjects With SARS-CoV-2 With Acute Liver or Kidney Injury https://ClinicalTrials.gov/show/NCT04447404
NCT04445935 Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial https://ClinicalTrials.gov/show/NCT04445935
NCT04446377 A Study of LAM-002A for the Prevention of Progression of COVID-19 https://ClinicalTrials.gov/show/NCT04446377
NCT04449380 Clinical Study for the Treatment With Interferon-ß-1a (IFNß-1a) of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04449380
NCT04447469 Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation https://ClinicalTrials.gov/show/NCT04447469
NCT04448119 Control of COVID-19 Outbreaks in Long Term Care https://ClinicalTrials.gov/show/NCT04448119
NCT04458363 Convalescent Plasma in Pediatric COVID-19 https://ClinicalTrials.gov/show/NCT04458363
NCT04455815 A Trial Looking at the Use of Camostat to Reduce Progression of Symptoms of Coronavirus (COVID-19) in People Who Have Tested Positive But Are Able to Stay at Home https://ClinicalTrials.gov/show/NCT04455815
NCT04452773 Clinical Trial to Evaluate the Efficacy of Food Supplement Manremyc® Against SARS- COV-2 Infection (COVID-19) in Healthcare Workers https://ClinicalTrials.gov/show/NCT04452773
NCT04448756 M5049 Study in Participants With Coronavirus Disease 2019 (COVID-19) Pneumonia https://ClinicalTrials.gov/show/NCT04448756
NCT04464486 Remote COVID-19 Symptom Tracking for Cancer Patients at Home During the Pandemic https://ClinicalTrials.gov/show/NCT04464486
NCT04463264 Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04463264
NCT04455360 Early EMDR Following Covid-19 Critical Illness: A Feasibility Trial https://ClinicalTrials.gov/show/NCT04455360
NCT04454606 The New Silicone N99 Half-Piece Respirator https://ClinicalTrials.gov/show/NCT04454606
NCT04452565 NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04452565
NCT04451174 Early Use of Corticosteroids in Non-critical Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04451174
NCT04449588 Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS https://ClinicalTrials.gov/show/NCT04449588
NCT04453657 Tele-Wellness Supported App for Family Child Care Home Providers and Families to Promote Health, Family Engagement, and School Readiness Amid COVID-19 https://ClinicalTrials.gov/show/NCT04453657
NCT04452318 Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR Assay https://ClinicalTrials.gov/show/NCT04452318
NCT04464408 Favipiravir Therapy in Adults With Mild COVID-19 https://ClinicalTrials.gov/show/NCT04464408
NCT04525742 COVID-19 Pandemic and Parents of Disabled Children https://ClinicalTrials.gov/show/NCT04525742
NCT04469621 A Phase 1b Trial to Evaluate Safety and Effect of SAR443122 on Immune System in Severe COVID-19 https://ClinicalTrials.gov/show/NCT04469621
NCT04459455 Project H-COVID: Evaluating Hyper-Brief, Online Materials During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04459455
NCT04453475 Feasibility and Benefits of Digital Services During the COVID19 Pandemic https://ClinicalTrials.gov/show/NCT04453475
NCT04452435 Safety and Efficacy of C21 in Subjects With COVID-19 https://ClinicalTrials.gov/show/NCT04452435
NCT04451889 Probe-based Confocal Laser Endomicroscopy in Critically Ill COVID-19 Patients https://ClinicalTrials.gov/show/NCT04451889
NCT04479163 Prevention of Severe Covid-19 in Infected Elderly by Early Administration of Convalescent Plasma With High-titers of Antibody Against SARS-CoV2 https://ClinicalTrials.gov/show/NCT04479163
NCT04458298 A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients https://ClinicalTrials.gov/show/NCT04458298
NCT04456153 Atovaquone for Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04456153
NCT04457388 Tele-Yoga Therapy for Chronic Pain https://ClinicalTrials.gov/show/NCT04457388
NCT04457349 Therapeutic Plasma Exchange in Resistant Cytokine Storm of COVID 19 https://ClinicalTrials.gov/show/NCT04457349
NCT04456595 Clinical Trial of Efficacy and Safety of Sinovac’s Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals https://ClinicalTrials.gov/show/NCT04456595
NCT04456452 Study of Ampion for the Treatment of Adult COVID-19 Patients Requiring Oxygen Supplementation https://ClinicalTrials.gov/show/NCT04456452
NCT04456062 Using Caring Contacts to Reduce Psychiatric Morbidity Following Hospitalization During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04456062
NCT04453514 Feasibility of a Brief Trauma-informed Yoga Intervention for Anxiety During the Coronavirus Disease (COVID-19) Pandemic https://ClinicalTrials.gov/show/NCT04453514
NCT04455308 COVID-19 and Chilblains https://ClinicalTrials.gov/show/NCT04455308
NCT04456413 Convalescent Plasma as Treatment for Subjects With Early COVID-19 Infection https://ClinicalTrials.gov/show/NCT04456413
NCT04454398 Study to Evaluate STI-1499 (COVI-GUARD) in Patients With Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04454398
NCT04482673 Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04482673
NCT04461925 Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs https://ClinicalTrials.gov/show/NCT04461925
NCT04460027 W-SUDs for COVID-19 https://ClinicalTrials.gov/show/NCT04460027
NCT04458519 Efficacy of Intranasal Probiotic Treatment to Reduce Severity of Symptoms in COVID19 Infection https://ClinicalTrials.gov/show/NCT04458519
NCT04458246 Home-based Aerobic Training Among Adolescents With Chronic Diseases During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04458246
NCT04465604 Hypertonic Saline for COVID-19 Symptoms https://ClinicalTrials.gov/show/NCT04465604
NCT04463849 Effects of COVID-19 Infection on Beta-cell Function in Euglycemic Patients https://ClinicalTrials.gov/show/NCT04463849
NCT04460703 COVID-19 Vaccine Messaging, Part 1 https://ClinicalTrials.gov/show/NCT04460703
NCT04460534 Detection of COVID-19 (SARS-CoV-2) in the Semen of COVID+ Patients (Positive RT-PCR on a Nasopharyngeal Swab) https://ClinicalTrials.gov/show/NCT04460534
NCT04457726 Part Two of Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04457726
NCT04460651 PREPARE-IT. Prevention of COVID19 With EPA in Healthcare Providers at Risk - Intervention Trial https://ClinicalTrials.gov/show/NCT04460651
NCT04461379 Prevention, Efficacy and Safety of BCG Vaccine in COVID-19 Among Healthcare Workers https://ClinicalTrials.gov/show/NCT04461379
NCT04505761 The Usability, Feasibility, and Tolerability of Virtual Reality for Rehabilitation From COVID-19 https://ClinicalTrials.gov/show/NCT04505761
NCT04470869 Impact on the OLAF Intervention to Prevent Post Traumatic Disorders During the Confinement. https://ClinicalTrials.gov/show/NCT04470869
NCT04459962 Covid-19 Breath Test https://ClinicalTrials.gov/show/NCT04459962
NCT04459676 Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04459676
NCT04459325 Tigerase® Efficacy and Safety as Part of Complex Therapy in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04459325
NCT04459286 The Nitazoxanide Plus Atazanavir for COVID-19 Study https://ClinicalTrials.gov/show/NCT04459286
NCT04459247 Short Term, High Dose Vitamin D Supplementation for COVID-19 https://ClinicalTrials.gov/show/NCT04459247
NCT04460183 A Study to Assess Efficacy and Safety of RESP301 Plus Standard of Care (SOC) Compared to SOC Alone in Hospitalized Participants With COVID-19 https://ClinicalTrials.gov/show/NCT04460183
NCT04466540 Randomized Placebo-controlled Trial of Hydroxychloroquine in Outpatient Cases With Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04466540
NCT04467918 CANnabiDiol for CoviD-19 pATiEnts With Mild to Moderate Symptoms https://ClinicalTrials.gov/show/NCT04467918
NCT04461340 Efficacy and Safety of Sirolimus in COVID-19 Infection https://ClinicalTrials.gov/show/NCT04461340
NCT04460443 Sofosbuvir With and Without Ribavirin in Treatment of COVID 19 https://ClinicalTrials.gov/show/NCT04460443
NCT04463420 Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04463420
NCT04468139 The Study of Quadruple Therapy Zinc, Quercetin, Bromelain and Vitamin C on the Clinical Outcomes of Patients Infected With COVID-19 https://ClinicalTrials.gov/show/NCT04468139
NCT04459520 Effect of Availability of COVID-19 Testing on Choice to Isolate and Socially Distance https://ClinicalTrials.gov/show/NCT04459520
NCT04479540 Assessment of the Risk of Pulmonary Embolism and Coagulation Profile in Patients With COVID-19 Lung Disease https://ClinicalTrials.gov/show/NCT04479540
NCT04472728 Testing the Efficacy and Safety of BIO101 for the Prevention of Respiratory Deterioration in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04472728
NCT04460690 Rapid, Onsite COVID-19 Detection https://ClinicalTrials.gov/show/NCT04460690
NCT04460677 ASD (Autism Spectrum Disorder) Telehealth for Distress Related to COVID-19 https://ClinicalTrials.gov/show/NCT04460677
NCT04460014 Simple Cognitive Task Intervention After Trauma During COVID-19 In Hospital Staff EKUT-P RCT https://ClinicalTrials.gov/show/NCT04460014
NCT04468646 To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients https://ClinicalTrials.gov/show/NCT04468646
NCT04464395 Study of CPI-006 as Immunotherapy for Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04464395
NCT04463602 Desidustat in the Management of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04463602
NCT04463004 Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation https://ClinicalTrials.gov/show/NCT04463004
NCT04462627 Reduction of COVID 19 Transmission to Health Care Professionals https://ClinicalTrials.gov/show/NCT04462627
NCT04514627 Neuromodulation With Percutaneous Electrical Nerve Field Stimulation for Adults With COVID-19 https://ClinicalTrials.gov/show/NCT04514627
NCT04469179 Safety, Tolerability, and Pharmacokinetics of SAB-185 in Ambulatory Participants With COVID-19 https://ClinicalTrials.gov/show/NCT04469179
NCT04466670 Hemostasis in COVID-19: an Adaptive Clinical Trial https://ClinicalTrials.gov/show/NCT04466670
NCT04466098 Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19) https://ClinicalTrials.gov/show/NCT04466098
NCT04466085 Clinical Study of Recombinant Novel Coronavirus Vaccine https://ClinicalTrials.gov/show/NCT04466085
NCT04463472 Study of COVID-19 DNA Vaccine (AG0301-COVID19) https://ClinicalTrials.gov/show/NCT04463472
NCT04473053 Rapid Experimental Medicine for COVID-19 https://ClinicalTrials.gov/show/NCT04473053
NCT04471636 Telemedicine in Outpatient Covid-19 Patients https://ClinicalTrials.gov/show/NCT04471636
NCT04470999 Changes in Cellular Immune Profile During COVID-19 Infection https://ClinicalTrials.gov/show/NCT04470999
NCT04470544 Camostat Mesilate Treating Patients With Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04470544
NCT04468009 Treatment of Critically Ill Patients With Covid-19 With Convalescent Plasma https://ClinicalTrials.gov/show/NCT04468009
NCT04466605 Effect of Tele-Yoga Therapy on Patients With Chronic Musculoskeletal Pain During Covid-19 Lockdown https://ClinicalTrials.gov/show/NCT04466605
NCT04466280 Efficacy and Safety of Mucoadhesive Sustained Release, Mucodentol, in Comparison With Hydroxychloroquine to Prevent COVID-19 https://ClinicalTrials.gov/show/NCT04466280
NCT04465695 Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19 https://ClinicalTrials.gov/show/NCT04465695
NCT04466800 Functional and Respiratory Rehabilitation and Nutritional Care of COVID-19 Patients (RECOVER-19) https://ClinicalTrials.gov/show/NCT04466800
NCT04467840 Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04467840
NCT04468893 Online Positive Psychology Intervention for Depression and Anxiety Due to COVID-19 https://ClinicalTrials.gov/show/NCT04468893
NCT04469114 Tofacitinib in Hospitalized Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04469114
NCT04468971 REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumonia https://ClinicalTrials.gov/show/NCT04468971
NCT04560231 Remdesivir in COVID-19 Lahore General Hospital https://ClinicalTrials.gov/show/NCT04560231
NCT04560205 Tocilizumab in COVID-19 Lahore General Hospital https://ClinicalTrials.gov/show/NCT04560205
NCT04471519 Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers https://ClinicalTrials.gov/show/NCT04471519
NCT04470531 Role of Co-trimoxazole in Severe COVID-19 Patients https://ClinicalTrials.gov/show/NCT04470531
NCT04470427 A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19 https://ClinicalTrials.gov/show/NCT04470427
NCT04480593 The Use of Brazilian Green Propolis Extract (EPP-AF) in Patients Affected by COVID-19. https://ClinicalTrials.gov/show/NCT04480593
NCT04470739 Is Thymus Size of Infants Who Born to COVID-19 Positive Mothers Associated With Neonatal Morbidities? https://ClinicalTrials.gov/show/NCT04470739
NCT04560257 High Flow Nasal Cannula HFNC In Covid-19 Patients https://ClinicalTrials.gov/show/NCT04560257
NCT04495933 A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults https://ClinicalTrials.gov/show/NCT04495933
NCT04479358 Low-dose Tocilizumab Versus Standard of Care in Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04479358
NCT04477993 Ruxolitinib for Acute Respiratory Disorder Syndrome Due to COVID-19 https://ClinicalTrials.gov/show/NCT04477993
NCT04476667 Online Delivery of Psychotherapy, Tailored to Patients’ Suffering From Mental Health Problems Due to COVID-19 https://ClinicalTrials.gov/show/NCT04476667
NCT04470609 Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 in People Aged ⩾60 Years https://ClinicalTrials.gov/show/NCT04470609
NCT04470622 Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1) https://ClinicalTrials.gov/show/NCT04470622
NCT04537962 Evaluationof the Load of SARS-CoV-2 Virus in Oral Cavity, Oropharinge and Saliva of Patients With Covid-19 After Disinfection With Oral Antimicrobial Solutions: a Pilot Study https://ClinicalTrials.gov/show/NCT04537962
NCT04488081 I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients https://ClinicalTrials.gov/show/NCT04488081
NCT04478539 Extracorporeal Blood Purification as a Treatment Modality for COVID-19 https://ClinicalTrials.gov/show/NCT04478539
NCT04477083 Development and Validation of “Ready-to-Use” Inhalable Forms of Hydroxychloroquine for Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04477083
NCT04475913 Digital vs Analog Impression in Cases of All-on-4 - Prosthesis https://ClinicalTrials.gov/show/NCT04475913
NCT04475107 The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients https://ClinicalTrials.gov/show/NCT04475107
NCT04473898 Telerehabilitation After Coronavirus https://ClinicalTrials.gov/show/NCT04473898
NCT04473261 Efficacy of Iodine Complex Against COVID-19 Patients https://ClinicalTrials.gov/show/NCT04473261
NCT04473170 Study Evaluating the Safety and Efficacy of Autologous Non-Hematopoietic Peripheral Blood Stem Cells in COVID-19 https://ClinicalTrials.gov/show/NCT04473170
NCT04472585 Efficacy of Subcutaneous Ivermectin With or Without Zinc and Nigella Sativa in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04472585
NCT04471766 Locally Produced Cloth Face Mask and COVID-19 Like Illness Prevention https://ClinicalTrials.gov/show/NCT04471766
NCT04473248 Spartan COVID-19 System: Evaluation of Clinical Sample Collection https://ClinicalTrials.gov/show/NCT04473248
NCT04472494 Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise https://ClinicalTrials.gov/show/NCT04472494
NCT04500067 Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment https://ClinicalTrials.gov/show/NCT04500067
NCT04481685 A Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04481685
NCT04478071 Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04478071
NCT04478019 SHIELD Study: Using Naso-oropharyngeal Antiseptic Decolonization to Reduce COVID-19 Viral Shedding https://ClinicalTrials.gov/show/NCT04478019
NCT04477655 Prone Positioning in Non-intubated Patients With COVID-19 Associated Acute Respiratory Failure https://ClinicalTrials.gov/show/NCT04477655
NCT04476953 COVID-FISETIN: Pilot in Covid-19 of Fisetin to Alleviate Dysfunction and Inflammation https://ClinicalTrials.gov/show/NCT04476953
NCT04475575 Can the Electronic Nose Smell COVID-19 Antibodies? https://ClinicalTrials.gov/show/NCT04475575
NCT04475562 Can the Electronic Nose Smell COVID-19? https://ClinicalTrials.gov/show/NCT04475562
NCT04474340 COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients https://ClinicalTrials.gov/show/NCT04474340
NCT04475185 Safety and Effectiveness Assessment of the MakAir Artificial Ventilator https://ClinicalTrials.gov/show/NCT04475185
NCT04477954 Hyperbaric Oxygen as an Adjuvant Treatment for Patients With Covid-19 Severe Hypoxemia https://ClinicalTrials.gov/show/NCT04477954
NCT04476992 Nitric Oxide Therapy for COVID-19 Patients With Oxygen Requirement https://ClinicalTrials.gov/show/NCT04476992
NCT04476979 Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19 https://ClinicalTrials.gov/show/NCT04476979
NCT04476888 Convalescent Plasma Treatment in COVID-19 https://ClinicalTrials.gov/show/NCT04476888
NCT04475588 Efficacy and Safety of Itolizumab in COVID-19 Complications https://ClinicalTrials.gov/show/NCT04475588
NCT04475302 BCG Vaccine in Reducing Morbidity and Mortality in Elderly Individuals in COVID-19 Hotspots https://ClinicalTrials.gov/show/NCT04475302
NCT04475120 Efficacy and Safety of Liposomal Lactoferrin in COVID-19 Patients With Mild-to-Moderate Disease and in COVID-19 Asymptomatic Patients https://ClinicalTrials.gov/show/NCT04475120
NCT04483375 Safety, Tolerability and Pharmacokinetics of SCTA01, an Anti-SARS-CoV-2 Monoclonal Antibody, in Healthy Chinese Subjects https://ClinicalTrials.gov/show/NCT04483375
NCT04480957 Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects https://ClinicalTrials.gov/show/NCT04480957
NCT04482595 BIO 300 Oral Suspension in Discharged COVID-19 Patients https://ClinicalTrials.gov/show/NCT04482595
NCT04480112 Impact of Covid-19 on Frequent Social Interaction Through Communication Technologies in the Cognitive Status of Socially-isolated Older Adults https://ClinicalTrials.gov/show/NCT04480112
NCT04514900 Exploring Optimal Treatment Components for Contactless Online Group-based Behavioral Weight Loss Program https://ClinicalTrials.gov/show/NCT04514900
NCT04488484 Medical and Serological Follow-up of the Staff of the Paris Saint-Joseph Hospital Group Infected With Severe Acute Respiratory Syndrome Coronavirus 2. https://ClinicalTrials.gov/show/NCT04488484
NCT04485429 Efficacy Assessment of Methylprednisolone and Heparin in Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04485429
NCT04480138 Pegylated Interferon - α2b With SARSCoV- 2 (COVID-19) https://ClinicalTrials.gov/show/NCT04480138
NCT04480424 Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04480424
NCT04492891 Cyclosporine For The Treatment Of COVID-19(+) https://ClinicalTrials.gov/show/NCT04492891
NCT04570462 Mild Hypothermia for COVID-19 ARDS https://ClinicalTrials.gov/show/NCT04570462
NCT04494724 Clazakizumab vs. Placebo - COVID-19 Infection https://ClinicalTrials.gov/show/NCT04494724
NCT04487639 Presence of SARS-CoV-2 in Semen: Impact on Fertility Preservation in Male Oncological Patients ? https://ClinicalTrials.gov/show/NCT04487639
NCT04485169 Therapeutic Plasma Exchange for Coronavirus Disease-2019 Triggered Cytokine Release Storm; https://ClinicalTrials.gov/show/NCT04485169
NCT04484207 Addressing COVID-19 Mental Health Problems Among US Veterans https://ClinicalTrials.gov/show/NCT04484207
NCT04483752 Predicting the Progression to Chronic Fibrosis of Lung Lesions Related to Covid-19 Infection From Chest CT Images https://ClinicalTrials.gov/show/NCT04483752
NCT04482647 Breathing Techniques and Meditation for Health Care Workers During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04482647
NCT04482621 Decitabine for Coronavirus (COVID-19) Pneumonia- Acute Respiratory Distress Syndrome (ARDS) Treatment: DART Trial https://ClinicalTrials.gov/show/NCT04482621
NCT04482634 Tele-rehabilitation Versus Home Exercise Program in COVID-19 https://ClinicalTrials.gov/show/NCT04482634
NCT04481633 Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04481633
NCT04488796 STAND UP to SARS-CoV-2 (COVID-19): Using Behavioural Economics to Reduce Sedentary Behaviour in At-home Office Workers https://ClinicalTrials.gov/show/NCT04488796
NCT04487444 Thymalfasin (Thymosin Alpha 1) to Treat COVID-19 Infection https://ClinicalTrials.gov/show/NCT04487444
NCT04487210 A Study to Evaluate the Safety and Immunogenicity of MVC-COV1901 Against COVID-19 https://ClinicalTrials.gov/show/NCT04487210
NCT04483830 Suloexide in the Treatment of Early Stages of COVID-19 https://ClinicalTrials.gov/show/NCT04483830
NCT04483960 Australasian COVID-19 Trial (ASCOT): An International Multi-Centre Randomised Clinical Trial to Assess the Clinical, Virological and Immunological Outcomes in Patients Diagnosed With SARS-CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04483960
NCT04487574 A Study to Assess the Efficacy and Safety of XC221 in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04487574
NCT04484493 Corticosteroid Nasal Spray in COVID-19 Anosmia https://ClinicalTrials.gov/show/NCT04484493
NCT04486508 Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04486508
NCT04490278 CoV-PICS: A Virtual Post-ICU Clinic https://ClinicalTrials.gov/show/NCT04490278
NCT04487990 CoV-Hep Study: Regional Anticoagulation Modalities in Continuous Venous Venous Hemodialysis in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04487990
NCT04486482 A Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Structure and Function https://ClinicalTrials.gov/show/NCT04486482
NCT04486313 Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04486313
NCT04488575 Safety and Efficacy of EDP1815 in the Treatment of Patients Hospitalized With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04488575
NCT04494386 Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS https://ClinicalTrials.gov/show/NCT04494386
NCT04487964 Complementary Intervention for COVID-19 https://ClinicalTrials.gov/show/NCT04487964
NCT04487171 Screening for Postpartum Depression and Associated Risk Factors Among Women Who Deliver in Four Hospital in France During the COVID-19 Epidemic https://ClinicalTrials.gov/show/NCT04487171
NCT04519437 Study Assessing the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers as Related to COVID-19 https://ClinicalTrials.gov/show/NCT04519437
NCT04492228 Eucaloric Ketogenic Diet in COVID-19 Cytokine Storm Syndrome https://ClinicalTrials.gov/show/NCT04492228
NCT04490473 Turkish of the SARS-CoV-2 Anxiety Scale https://ClinicalTrials.gov/show/NCT04490473
NCT04489446 Sildenafil in COVID-19 https://ClinicalTrials.gov/show/NCT04489446
NCT04496245 Reducing Acute Severe Respiratory Events in Health Care Workers During the Covid-19 Pandemic With OM85 https://ClinicalTrials.gov/show/NCT04496245
NCT04501796 A Trial of NT-I7 in COVID-19 (SPESELPIS) https://ClinicalTrials.gov/show/NCT04501796
NCT04499313 Dexamethasone Vs Methylprednisolone for the Treatment of Patients With ARDS Caused by COVID-19 https://ClinicalTrials.gov/show/NCT04499313
NCT04497623 Clinical Evaluation of Ventilador Innovation Product in Colombia in the SARS COVID 19 Pandemic, Unisabana Herons. https://ClinicalTrials.gov/show/NCT04497623
NCT04490824 Inhalation of KELEA Excellerated Water in Covid-19 Infected Individuals https://ClinicalTrials.gov/show/NCT04490824
NCT04491240 Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Pneumonia. https://ClinicalTrials.gov/show/NCT04491240
NCT04518514 Telemedical Risk Assessment and Preoperative Evaluation (TAPE) https://ClinicalTrials.gov/show/NCT04518514
NCT04495101 Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Subjects With COVID-19 https://ClinicalTrials.gov/show/NCT04495101
NCT04494399 IFN Beta-1b and Ribavirin for Covid-19 https://ClinicalTrials.gov/show/NCT04494399
NCT04494204 Effect of a Combination of Treatment of Reginmune Capsule and Immunofree Tablets in the Treatment of Mild to Moderate COVID-19 Patients https://ClinicalTrials.gov/show/NCT04494204
NCT04492527 Student-delivered Telehealth Program for COVID-19 Education and Health Promotion https://ClinicalTrials.gov/show/NCT04492527
NCT04492514 Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflation https://ClinicalTrials.gov/show/NCT04492514
NCT04492501 Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan https://ClinicalTrials.gov/show/NCT04492501
NCT04492410 COVID-19 Infection Screening in Cancer Patients (NEOSCREENCOVID) https://ClinicalTrials.gov/show/NCT04492410
NCT04491994 Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression https://ClinicalTrials.gov/show/NCT04491994
NCT04490850 COVID-19 Seroprevalence Study in French Guiana https://ClinicalTrials.gov/show/NCT04490850
NCT04492358 Treatment for Moderate/Severe COVID-19 in a Fragile and Vulnerable Population, Admitted to a Geriatric Hospital Unit or in a Transicional Care Center https://ClinicalTrials.gov/show/NCT04492358
NCT04492475 Adaptive COVID-19 Treatment Trial 3 (ACTT-3) https://ClinicalTrials.gov/show/NCT04492475
NCT04494867 Core Warming in COVID-19 Patients Undergoing Mechanical Ventilation https://ClinicalTrials.gov/show/NCT04494867
NCT04493359 Switch of Renin-Angiotensin System Inhibitors in Patients With Covid-19 https://ClinicalTrials.gov/show/NCT04493359
NCT04494984 A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19. https://ClinicalTrials.gov/show/NCT04494984
NCT04494646 BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04494646
NCT04535791 Efficacy of Vitamin D Supplementation to Prevent the Risk of Acquiring COVID-19 in Healthcare Workers https://ClinicalTrials.gov/show/NCT04535791
NCT04495842 The Effect of Aromatherapy on COVID-19-induced Anxiety https://ClinicalTrials.gov/show/NCT04495842
NCT04495816 COVID-19 Anosmia Study https://ClinicalTrials.gov/show/NCT04495816
NCT04525378 MSC-based Therapy in COVID-19-associated Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04525378
NCT04498377 Study of F-652 (IL-22:IgG2 Fusion Protein) in Patients With Moderate to Severe COVID-19 https://ClinicalTrials.gov/show/NCT04498377
NCT04497454 Mechanical Ventilation Strategy for Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04497454
NCT04497298 Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04497298
NCT04505722 A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants https://ClinicalTrials.gov/show/NCT04505722
NCT04500366 GERAS Frailty Rehabilitation at Home During COVID-19 https://ClinicalTrials.gov/show/NCT04500366
NCT04497987 A Study of LY3819253 (LY-CoV555) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and Staff https://ClinicalTrials.gov/show/NCT04497987
NCT04497649 Sofosbuvir Containing Regimens in Treatment of COVID 19 Patients https://ClinicalTrials.gov/show/NCT04497649
NCT04497415 The COVID-19 and Healthcare Workers: An Active Intervention https://ClinicalTrials.gov/show/NCT04497415
NCT04502056 Covid-19 Messaging to Underserved Communities - 2nd Experiment https://ClinicalTrials.gov/show/NCT04502056
NCT04526054 Morphological Abnormalities of the Olfactory Bulb on MRI and Olfactometry in Anosmic Versus Normosmic COVID-19 Patients https://ClinicalTrials.gov/show/NCT04526054
NCT04501965 Phytomedicines Versus Hydroxychloroquine as an Add on Therapy to Azythromycin in Asymptomatic Covid-19 Patients https://ClinicalTrials.gov/show/NCT04501965
NCT04498442 A Study on Prevalence, Protection and Recovery From COVID-19 in Seasoned Yoga Practitioners in Comparison to Age and Gender Matched Controls https://ClinicalTrials.gov/show/NCT04498442
NCT04498247 A Study to Assess Safety, Tolerability, and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Participants (V591-001) https://ClinicalTrials.gov/show/NCT04498247
NCT04510207 A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above https://ClinicalTrials.gov/show/NCT04510207
NCT04498273 COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 https://ClinicalTrials.gov/show/NCT04498273
NCT04501978 ACTIV-3: Therapeutics for Inpatients With COVID-19 https://ClinicalTrials.gov/show/NCT04501978
NCT04497272 Assesment of the Metabolomic Signature in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04497272
NCT04502667 Efficacy of Vitamin D Treatment in Pediatric Patients Hospitalized by COVID-19 https://ClinicalTrials.gov/show/NCT04502667
NCT04502472 Open-label Treatment of Severe Coronavirus Disease 2019 (COVID-19) With Convalescent Plasma https://ClinicalTrials.gov/show/NCT04502472
NCT04502342 Add on to Azythromycine, Phytomedicine and/or Antimalarial Drug vs Hydroxychloroquine in Uncomplicated COVID-19 Patients https://ClinicalTrials.gov/show/NCT04502342
NCT04501445 Psychological Symptoms and Families of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04501445
NCT04500418 Charité Trial of Cenicriviroc (CVC) Treatment for COVID-19 Patients https://ClinicalTrials.gov/show/NCT04500418
NCT04500132 To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia https://ClinicalTrials.gov/show/NCT04500132
NCT04504734 Bucillamine in Treatment of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04504734
NCT04504877 Burnout and Distress preventiOn With caNnabidiol in Front-line Health Care workerS deAling wIth COVID-19 https://ClinicalTrials.gov/show/NCT04504877
NCT04631380 Prayer in Commbate to Corona Virus - Covid -19 https://ClinicalTrials.gov/show/NCT04631380
NCT04534790 Anti-inflammatory Effect of Low-Dose Whole-Lung Radiation for COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04534790
NCT04508439 Effect of the Use of Anticoagulant Therapy During Hospitalization and Discharge in Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04508439
NCT04501783 Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04501783
NCT04501458 Western Kenya Integrated COVID-19 Response https://ClinicalTrials.gov/show/NCT04501458
NCT04501952 Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734â„¢) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting https://ClinicalTrials.gov/show/NCT04501952
NCT04504032 A Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVID-19) https://ClinicalTrials.gov/show/NCT04504032
NCT04527471 Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04527471
NCT04513158 Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) Infection https://ClinicalTrials.gov/show/NCT04513158
NCT04505774 Anti-thrombotics for Adults Hospitalized With COVID-19 (ACTIV-4) https://ClinicalTrials.gov/show/NCT04505774
NCT04504240 Role of Famotidine in the Symptomatic Improvement of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04504240
NCT04505592 Tenecteplase in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04505592
NCT04522492 Impact of COVID-19 on Mental Health of Patients With Skin Picking https://ClinicalTrials.gov/show/NCT04522492
NCT04509999 Bicalutamide to Block TMPRSS2 in Males With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04509999
NCT04508075 Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine https://ClinicalTrials.gov/show/NCT04508075
NCT04506268 COVID-19 SAFE Enrollment https://ClinicalTrials.gov/show/NCT04506268
NCT04511650 A Study to Evaluate the Safety and Efficacy of Razuprotafib, a Novel Tie 2 Activator, in Hospitalized Subjects With Moderate to Severe Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04511650
NCT04507256 AZD7442 - a Potential Combination Therapy for the Prevention and Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04507256
NCT04511819 Losmapimod Safety and Efficacy in COVID-19 https://ClinicalTrials.gov/show/NCT04511819
NCT04516915 IMU-838 and Oseltamivir in the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04516915
NCT04513470 Allocetra-OTS in COVID-19 https://ClinicalTrials.gov/show/NCT04513470
NCT04508868 Treatment of Depressive Symptoms in Older Individuals in Isolation During Covid-19 https://ClinicalTrials.gov/show/NCT04508868
NCT04508023 A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection https://ClinicalTrials.gov/show/NCT04508023
NCT04581018 An Evaluation of a Synbiotic Formula for Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04581018
NCT04527575 Study of the Safety, Reactogenicity and Immunogenicity of “EpiVacCorona” Vaccine for the Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT04527575
NCT04514705 Characteristics in Post Covid-19 Patients https://ClinicalTrials.gov/show/NCT04514705
NCT04512079 FREEDOM COVID-19 Anticoagulation Strategy https://ClinicalTrials.gov/show/NCT04512079
NCT04512027 Prolectin-M in COVID-19 Patients Having Mild to Moderate Symptoms Not Requiring Oxygen Support. https://ClinicalTrials.gov/show/NCT04512027
NCT04510662 Telmisartan in Respiratory Failure Due to COVID-19 https://ClinicalTrials.gov/show/NCT04510662
NCT04509973 Higher vs. Lower Doses of Dexamethasone for COVID-19 and Severe Hypoxia https://ClinicalTrials.gov/show/NCT04509973
NCT04509947 A Study of Ad26.COV2.S in Adults (COVID-19) https://ClinicalTrials.gov/show/NCT04509947
NCT04510493 Canakinumab in Patients With COVID-19 and Type 2 Diabetes https://ClinicalTrials.gov/show/NCT04510493
NCT04522089 A Study to Evaluate the Safety and Immunogenicity of COVID-19 (AdimrSC-2f) Vaccine https://ClinicalTrials.gov/show/NCT04522089
NCT04519216 Breastfeeding Education in the Time of COVID-19 https://ClinicalTrials.gov/show/NCT04519216
NCT04516811 Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19 https://ClinicalTrials.gov/show/NCT04516811
NCT04511949 COVID-19: Epidemiological Study of the Spread of SARS-CoV-2 in the Household of a Person Who Has Had a COVID-19 Disease https://ClinicalTrials.gov/show/NCT04511949
NCT04513184 Randomized Clinical Trial of Intranasal Dexamethasone as an Adjuvant in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04513184
NCT04516564 A Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects https://ClinicalTrials.gov/show/NCT04516564
NCT04515147 A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19 https://ClinicalTrials.gov/show/NCT04515147
NCT04540120 Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome https://ClinicalTrials.gov/show/NCT04540120
NCT04517123 Prone Position and Respiratory Outcomes in Non-Intubated COVID-19 PatiEnts The “PRONE” Study https://ClinicalTrials.gov/show/NCT04517123
NCT04517162 Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04517162
NCT04516759 AZD1656 in Diabetic Patients Hospitalised With Suspected or Confirmed COVID-19 https://ClinicalTrials.gov/show/NCT04516759
NCT04550351 Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2 Phase I Clinical Trial (≥60 Years Old) https://ClinicalTrials.gov/show/NCT04550351
NCT04517422 Efficacy of L. Plantarum and P. Acidilactici in Adults With SARS-CoV-2 and COVID-19 https://ClinicalTrials.gov/show/NCT04517422
NCT04516837 Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19) https://ClinicalTrials.gov/show/NCT04516837
NCT04547634 Telerehabilitation in Oncology Patients https://ClinicalTrials.gov/show/NCT04547634
NCT04530578 Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19 https://ClinicalTrials.gov/show/NCT04530578
NCT04519385 Toclizumam Versus Dexamethasone in Severe Covid-19 Cases https://ClinicalTrials.gov/show/NCT04519385
NCT04517396 FEnofibRate as a Metabolic INtervention for COVID-19 https://ClinicalTrials.gov/show/NCT04517396
NCT04516954 Convalescent Plasma for COVID-19 Patients https://ClinicalTrials.gov/show/NCT04516954
NCT04541680 Nintedanib for the Treatment of SARS-Cov-2 Induced Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT04541680
NCT04518410 ACTIV-2: A Study for Outpatients With COVID-19 https://ClinicalTrials.gov/show/NCT04518410
NCT04540419 Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Against COVID-19 https://ClinicalTrials.gov/show/NCT04540419
NCT04516746 Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults https://ClinicalTrials.gov/show/NCT04516746
NCT04587921 Feasibility and Impact of Remote Oximetry in Patients Hospitalized With Covid-19 https://ClinicalTrials.gov/show/NCT04587921
NCT04527614 Influence of Prior Infection With COVID-19 on Occurrence of Influenza-like Illness or Acute Respiratory Infection https://ClinicalTrials.gov/show/NCT04527614
NCT04519411 Transpulmonary Pressure Measurements in Intubated Children With Covid-19 Respiratory Failure https://ClinicalTrials.gov/show/NCT04519411
NCT04519320 Medium and Long Term Follow-up of COVID-19 Infected Patients: Research and Characterization of Pulmonary Sequelae https://ClinicalTrials.gov/show/NCT04519320
NCT04612972 Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Adult Population In Peru https://ClinicalTrials.gov/show/NCT04612972
NCT04522830 A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19 https://ClinicalTrials.gov/show/NCT04522830
NCT04523571 Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b1) in Chinese Healthy Subjects https://ClinicalTrials.gov/show/NCT04523571
NCT04581161 Proportional Open Ventilation (POV) Device and Its Efficacy in Managing Acute Respiratory Failure in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04581161
NCT04531618 Mother-infant Bonding During COVID-19 https://ClinicalTrials.gov/show/NCT04531618
NCT04529499 Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients https://ClinicalTrials.gov/show/NCT04529499
NCT04528641 GRAd-COV2 Vaccine Against COVID-19 https://ClinicalTrials.gov/show/NCT04528641
NCT04528368 Convalescent Plasma for Treating Patients With COVID-19 Pneumonia Without Indication of Ventilatory Support https://ClinicalTrials.gov/show/NCT04528368
NCT04524715 LLLT Treatment of Lung Inflammation in COVID-19 https://ClinicalTrials.gov/show/NCT04524715
NCT04523831 Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 Infection https://ClinicalTrials.gov/show/NCT04523831
NCT04523181 Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients https://ClinicalTrials.gov/show/NCT04523181
NCT04522466 Evaluation of the Pharmacokinetics and Pharmacodynamics of Hydroxychloroquine in COVID-19 Intensive Care Unit Patients https://ClinicalTrials.gov/show/NCT04522466
NCT04521322 Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Prophylaxis of COVID-19 Disease in Health Personnel Dedicated to Patients Care With COVID-19 Disease https://ClinicalTrials.gov/show/NCT04521322
NCT04530448 Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization https://ClinicalTrials.gov/show/NCT04530448
NCT04524598 A CBT-based Mobile Intervention as First Line Treatment for Adolescent Depression During COVID-19 https://ClinicalTrials.gov/show/NCT04524598
NCT04523090 Catalysing the Containment of COVID-19 https://ClinicalTrials.gov/show/NCT04523090
NCT04522817 CLBS119 for Repair of COVID-19 Induced Pulmonary Damage https://ClinicalTrials.gov/show/NCT04522817
NCT04523246 Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents https://ClinicalTrials.gov/show/NCT04523246
NCT04529525 Ivermectin to Prevent Hospitalizations in COVID-19 https://ClinicalTrials.gov/show/NCT04529525
NCT04526912 Treatment and Prevention of Acute Lung Injury (ALI) in Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04526912
NCT04525417 Rapid Screening Test for Covid-19 Antibodies in Healthcare Workers https://ClinicalTrials.gov/show/NCT04525417
NCT04524507 COVID-19 Antibody Plasma Research Study in Hospitalized Patients https://ClinicalTrials.gov/show/NCT04524507
NCT04535167 First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending Dose And Extended Infusion of PF 07304814 In Hospitalized Participants With COVID-19. https://ClinicalTrials.gov/show/NCT04535167
NCT04568031 Study of AZD1222 for the Prevention of COVID-19 in Japan https://ClinicalTrials.gov/show/NCT04568031
NCT04526990 Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above https://ClinicalTrials.gov/show/NCT04526990
NCT04527133 An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19 https://ClinicalTrials.gov/show/NCT04527133
NCT04527081 Study of COVID-19 DNA Vaccine (AG0302-COVID19) https://ClinicalTrials.gov/show/NCT04527081
NCT04530409 Timing of Corticosteroids in COVID-19 https://ClinicalTrials.gov/show/NCT04530409
NCT04527354 Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04527354
NCT04530604 Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS) https://ClinicalTrials.gov/show/NCT04530604
NCT04530435 PEP Flute-selfcare in COVID-19 https://ClinicalTrials.gov/show/NCT04530435
NCT04530396 Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 https://ClinicalTrials.gov/show/NCT04530396
NCT04527562 Colchicine in Moderate Symptomatic COVID-19 Patients https://ClinicalTrials.gov/show/NCT04527562
NCT04537351 The MEseNchymal coviD-19 Trial: a Pilot Study to Investigate Early Efficacy of MSCs in Adults With COVID-19 https://ClinicalTrials.gov/show/NCT04537351
NCT04536441 Ultra-brief Online Mindfulness-based Intervention During COVID-19 Movement Control Order https://ClinicalTrials.gov/show/NCT04536441
NCT04532931 COVID-19 Treatment in South Africa https://ClinicalTrials.gov/show/NCT04532931
NCT04531774 RECHARGE: A Brief Psychological Intervention to Build Resilience in Healthcare Workers During COVID-19 https://ClinicalTrials.gov/show/NCT04531774
NCT04530617 Camostat and Artemisia Annua vs Placebo in COVID-19 Outpatients https://ClinicalTrials.gov/show/NCT04530617
NCT04530422 Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment https://ClinicalTrials.gov/show/NCT04530422
NCT04530370 Efficacy and Safety of Recovered Covid 19 Plasma Transfusion to Covid 19 Severly Ill Patients https://ClinicalTrials.gov/show/NCT04530370
NCT04530357 Reactogenicity, Safety and Immunogenicity of QazCovid-in® COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04530357
NCT04554992 Convalescent Plasma for the Treatment of COVID-19 (Coronavirus Disease 2019) https://ClinicalTrials.gov/show/NCT04554992
NCT04559074 Personalised Electronic Record Supported Optimisation When Alone for Patients With Hypertension- Pilot Study for Remote Medical Management of Hypertension During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04559074
NCT04539262 Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation https://ClinicalTrials.gov/show/NCT04539262
NCT04535453 A Study to Evaluate a Range of Dose Levels and Vaccination Intervals of Ad26.COV2.S in Healthy Adults https://ClinicalTrials.gov/show/NCT04535453
NCT04539275 COVID-19 (VA CURES-1) https://ClinicalTrials.gov/show/NCT04539275
NCT04532294 Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants https://ClinicalTrials.gov/show/NCT04532294
NCT04535700 Clinical Trial of Pioglitazone Treatment in Patients With Type 2 Diabetes Mellitus and Covid-19 https://ClinicalTrials.gov/show/NCT04535700
NCT04537663 Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults https://ClinicalTrials.gov/show/NCT04537663
NCT04533399 A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults https://ClinicalTrials.gov/show/NCT04533399
NCT04537858 Virtual Reality Therapy Influence on Heart Rate Variability of Inpatients With COVID-19 https://ClinicalTrials.gov/show/NCT04537858
NCT04535063 Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04535063
NCT04542941 Assessment of Safety and Efficacy of CCP https://ClinicalTrials.gov/show/NCT04542941
NCT04535674 Asunercept in Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04535674
NCT04536051 A Study of a Candidate COVID-19 Vaccine (COV003) https://ClinicalTrials.gov/show/NCT04536051
NCT04554264 Complicated Grief in ICU in the Aftermath of COVID-19 https://ClinicalTrials.gov/show/NCT04554264
NCT04545749 A Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04545749
NCT04537949 A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults https://ClinicalTrials.gov/show/NCT04537949
NCT04537208 Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older https://ClinicalTrials.gov/show/NCT04537208
NCT04577534 COVID-19: Salvage TOcilizumab as a Rescue Measure https://ClinicalTrials.gov/show/NCT04577534
NCT04558463 The Effectivity and Safety of Favipiravir Compared to Oseltamivir as Adjuvant Therapy for COVID-19 https://ClinicalTrials.gov/show/NCT04558463
NCT04542213 Dipeptidyl Peptidase-4 Inhibitor (DPP4i) for the Control of Hyperglycemia in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04542213
NCT04539795 COVID-19 Study of Safety and Tolerability of Alvelestat https://ClinicalTrials.gov/show/NCT04539795
NCT04539821 Virtual Pain Care Management (COVID-19) https://ClinicalTrials.gov/show/NCT04539821
NCT04569188 Convalescent Plasma in COVID-19 Elderly Patients https://ClinicalTrials.gov/show/NCT04569188
NCT04542967 Study on the Safety and Efficacy of Convalescent Plasma in Patients With Severe COVID-19 Disease https://ClinicalTrials.gov/show/NCT04542967
NCT04542421 Lung Ultrasound Implementation in the Management of Patients Hospitalized With COVID-19 https://ClinicalTrials.gov/show/NCT04542421
NCT04540185 A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 https://ClinicalTrials.gov/show/NCT04540185
NCT04545060 VIR-7831 for the Early Treatment of COVID-19 in Outpatients https://ClinicalTrials.gov/show/NCT04545060
NCT04540939 Neural Mechanisms of Mindfulness-based Cognitive Therapy (MBCT) for Posttraumatic Stress Disorder (PTSD) - COVID Related Substudy https://ClinicalTrials.gov/show/NCT04540939
NCT04542694 Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04542694
NCT04545541 Nebulised Heparin in Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04545541
NCT04542447 To Evaluate Safety and Efficacy of Nuvastatic as an Immunomodulator Adjuvant Therapy in COVID-19 Patients. https://ClinicalTrials.gov/show/NCT04542447
NCT04542408 Hamburg Edoxaban for Anticoagulation in COVID-19 Study https://ClinicalTrials.gov/show/NCT04542408
NCT04542330 Using BCG to Protect Senior Citizens During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04542330
NCT04587414 eHealth Intervention on Physical Activity for Type 2 Diabetics - Frustrated by COVID-19 https://ClinicalTrials.gov/show/NCT04587414
NCT04543760 Effect of Prone Positioning Combined With High Flow Oxygen Therapy on Oxygenation During Acute Respiratory Failure Due to COVID-19 https://ClinicalTrials.gov/show/NCT04543760
NCT04542993 Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy https://ClinicalTrials.gov/show/NCT04542993
NCT04542876 Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection https://ClinicalTrials.gov/show/NCT04542876
NCT04546581 Inpatient Treatment With Anti-Coronavirus Immunoglobulin (ITAC) https://ClinicalTrials.gov/show/NCT04546581
NCT04561154 Identifying Functional and Psycho-social Complaints After Hospitalization for SARS-CoV-2 Infection( COVID 19)- REPERCOV https://ClinicalTrials.gov/show/NCT04561154
NCT04557605 Effects of a Face Mask on Oxygenation During Exercise https://ClinicalTrials.gov/show/NCT04557605
NCT04551339 Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19 https://ClinicalTrials.gov/show/NCT04551339
NCT04549922 Antisense Therapy to Block the Kallikrein-kinin Pathway in COVID-19 https://ClinicalTrials.gov/show/NCT04549922
NCT04548531 Engaging Patients in Colon Cancer Screening Decisions During COVID-19 https://ClinicalTrials.gov/show/NCT04548531
NCT04547660 Convalescent Plasma for Severe COVID-19 Patients https://ClinicalTrials.gov/show/NCT04547660
NCT04547283 Awake-Prone Positioning Strategy for Hypoxic Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04547283
NCT04552483 Effects of Early Use of Nitazoxanide in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04552483
NCT04569266 Effectiveness of an Exercise Re-training Program on Dyspnea in Patients After Acute Respiratory Distress Syndrome Secondary to Severe COVID-19 Pneumonia in Post-ICU https://ClinicalTrials.gov/show/NCT04569266
NCT04550325 Safety, PK and PD of Kamada Anti-SARS-CoV-2 in COVID-19 https://ClinicalTrials.gov/show/NCT04550325
NCT04546737 Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients https://ClinicalTrials.gov/show/NCT04546737
NCT04547140 Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04547140
NCT04547127 A Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04547127
NCT04549376 Virucidal Effect of Povidone Iodine on COVID-19 In-Vivo https://ClinicalTrials.gov/show/NCT04549376
NCT04548544 A Randomized Controlled Feasibility Study of Emotional Well-being of Adolescents Undergoing a Mindfulness Training During COVID-19 https://ClinicalTrials.gov/show/NCT04548544
NCT04551781 Short Term Low Dose Corticosteroids for Management of Post covid19 Pulmonary Fibrosis https://ClinicalTrials.gov/show/NCT04551781
NCT04558476 Efficacy of CONvalescent Plasma in Patients With COVID-19 Treated With Mechanical Ventilation https://ClinicalTrials.gov/show/NCT04558476
NCT04591158 COVID-19 and Lung Ultrasound Utility https://ClinicalTrials.gov/show/NCT04591158
NCT04559113 Methylprednisolone in COVID-19 Patients (Methyl19LGH) https://ClinicalTrials.gov/show/NCT04559113
NCT04553705 Omega-3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice, Artemisinin, Febrifugine on Immunity of Patients With (COVID-19) https://ClinicalTrials.gov/show/NCT04553705
NCT04552366 A Clinical Trial of a Recombinant Adenovirus 5 Vectored COVID-19 Vaccine (Ad5-nCoV) With Two Doses in Healthy Adults https://ClinicalTrials.gov/show/NCT04552366
NCT04565249 Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19 https://ClinicalTrials.gov/show/NCT04565249
NCT04551911 Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04551911
NCT04551547 Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT04551547
NCT04610502 Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04610502
NCT04581915 PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19 https://ClinicalTrials.gov/show/NCT04581915
NCT04555213 A Dose Escalation and Dose Expansion Study of NOX66 in the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04555213
NCT04555148 COVIDIG (COVID-19 Hyper-ImmunoGlobulin) https://ClinicalTrials.gov/show/NCT04555148
NCT04555096 A Trial of GC4419 in Patients With Critical Illness Due to COVID-19 https://ClinicalTrials.gov/show/NCT04555096
NCT04560881 Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19) https://ClinicalTrials.gov/show/NCT04560881
NCT04557046 Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag Test https://ClinicalTrials.gov/show/NCT04557046
NCT04570384 Intravenous L-Citrulline to Delay and Potentially Prevent the Need for Invasive Mechanical Ventilation for Acute Hypoxemic Respiratory Failure in Patients With COVID-19 (SARS-CoV-2) Illness https://ClinicalTrials.gov/show/NCT04570384
NCT04568564 Telerehabilitation in Lung Surgery Patients https://ClinicalTrials.gov/show/NCT04568564
NCT04567810 Safety, Tolerability, and Pharmacokinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Chicken Egg Antibody (IgY) (COVID-19) https://ClinicalTrials.gov/show/NCT04567810
NCT04563650 COVID-19 Serology and Immunosenescence https://ClinicalTrials.gov/show/NCT04563650
NCT04558021 A Study To Evaluate The Efficacy And Safety Of a Novel Niclosamide Suspension Formulation For COVID-19 https://ClinicalTrials.gov/show/NCT04558021
NCT04563065 Active Pregnancy Against COVID-19 https://ClinicalTrials.gov/show/NCT04563065
NCT04558125 Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism https://ClinicalTrials.gov/show/NCT04558125
NCT04558411 Pilot Study of a Brief, Scaleable Intervention for Coronavirus (COVID-19) Mental Health Sequelae in College Students https://ClinicalTrials.gov/show/NCT04558411
NCT04558372 Genosvid Diagnostic Test for Early Detection of COVID-19 https://ClinicalTrials.gov/show/NCT04558372
NCT04559035 Nasal Irrigation to Reduce COVID-19 Morbidity https://ClinicalTrials.gov/show/NCT04559035
NCT04563702 Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults https://ClinicalTrials.gov/show/NCT04563702
NCT04565665 Cord Blood-Derived Mesenchymal Stem Cells for the Treatment of COVID-19 Related Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04565665
NCT04566770 A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) https://ClinicalTrials.gov/show/NCT04566770
NCT04561219 Nitazoxanide Therapy for Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04561219
NCT04563689 Pilot Study to Evaluate Effect of CHX0.12/CPC 0.05 of SARS-CoV-2 Viral Load in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04563689
NCT04573270 Mesenchymal Stem Cells for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04573270
NCT04568525 Passive Microwave Radiometry (MWR) and AI for COVID-19 Complications Early Diagnostics of Lungs https://ClinicalTrials.gov/show/NCT04568525
NCT04565379 Clinical Trial to Investigate the Efficacy and Safety of NuSepin® in COVID-19 Pneumonia Patients https://ClinicalTrials.gov/show/NCT04565379
NCT04563676 Physiopathology and Sequelae of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04563676
NCT04593940 Immune Modulators for Treating COVID-19 https://ClinicalTrials.gov/show/NCT04593940
NCT04567173 Convalescent Plasma as Adjunctive Therapy for Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04567173
NCT04565197 Convalescent Plasma Therapy for COVID-19 Patients https://ClinicalTrials.gov/show/NCT04565197
NCT04564716 Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus https://ClinicalTrials.gov/show/NCT04564716
NCT04568876 Micronized and Ultramicronized Palmitoylethanolamide in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04568876
NCT04609462 High-Flow Nasal Cannula in Severe COVID-19 With Acute Hypoxemic Respiratory Failure. https://ClinicalTrials.gov/show/NCT04609462
NCT04576728 Efficacy and Safety of Trimodulin in Subjects With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04576728
NCT04569786 Dose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001) https://ClinicalTrials.gov/show/NCT04569786
NCT04570488 Predicting Favorable Outcomes in Hospitalized Covid-19 Patients https://ClinicalTrials.gov/show/NCT04570488
NCT04569877 GM-CSF Inhalation to Prevent ARDS in COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04569877
NCT04567953 COVID-19 Tests With Saliva Specimens https://ClinicalTrials.gov/show/NCT04567953
NCT04568122 Rapid Turnaround, Home-based Saliva Testing for COVID-19 https://ClinicalTrials.gov/show/NCT04568122
NCT04570254 Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04570254
NCT04568356 A Clinical Evaluation of COVID-19 Rapid Point of Care Antigen Tests https://ClinicalTrials.gov/show/NCT04568356
NCT04576312 Study to Assess the Safety of Ascending Doses of UNI911 INHALATION in Healthy Volunteers in Preparation for Evaluation in Adults With COVID-19 https://ClinicalTrials.gov/show/NCT04576312
NCT04568863 Efficacy of Intravenous Melatonin on Mortality in Adult Patients Admitted to the Intensive Care Unit With COVID-19 https://ClinicalTrials.gov/show/NCT04568863
NCT04568811 The Phase I Clinical Trial of Booster Vaccination of Adenovirus Type-5 Vectored COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04568811
NCT04570202 Health cAre woRkers exposeD to COVID-19 https://ClinicalTrials.gov/show/NCT04570202
NCT04583410 Efficacy of Nicotine in Preventing COVID-19 Infection in Caregivers https://ClinicalTrials.gov/show/NCT04583410
NCT04572399 UVA Light Device to Treat COVID-19 https://ClinicalTrials.gov/show/NCT04572399
NCT04577235 Correlation Between Thoracic Ultrasound and Thorax Computed Tomography Scores. https://ClinicalTrials.gov/show/NCT04577235
NCT04573361 Access to Chiropractic Care During the COVID-19 Healthcare Emergency in Spain https://ClinicalTrials.gov/show/NCT04573361
NCT04573322 Safety and Efficacy of Trans Sodium Crocetinate (TSC) in SARS-CoV-2 (COVID-19) Infected Subjects https://ClinicalTrials.gov/show/NCT04573322
NCT04569825 Effect of Nasal Steroid in the Treatment of Anosmia Due to COVID-19 Disease https://ClinicalTrials.gov/show/NCT04569825
NCT04629105 Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Longeveron Mesenchymal Stem Cells (LMSCs) (RECOVER) https://ClinicalTrials.gov/show/NCT04629105
NCT04575064 An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY https://ClinicalTrials.gov/show/NCT04575064
NCT04573153 Metabolic Cofactor Supplementation and Hydroxychloroquine Combination in Covid-19 Patients https://ClinicalTrials.gov/show/NCT04573153
NCT04575597 Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002) https://ClinicalTrials.gov/show/NCT04575597
NCT04575584 Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001) https://ClinicalTrials.gov/show/NCT04575584
NCT04583189 Evaluation of the Performance of the Covid-19 Ag BSS Rapid Antigenic Test in Symptomatic Children in a Pediatric Emergency Department https://ClinicalTrials.gov/show/NCT04583189
NCT04582344 Clinical Trial For SARS-CoV-2 Vaccine (COVID-19) https://ClinicalTrials.gov/show/NCT04582344
NCT04578210 Safety Infusion of NatuRal KillEr celLs or MEmory T Cells as Adoptive Therapy in COVID-19 pnEumonia or Lymphopenia https://ClinicalTrials.gov/show/NCT04578210
NCT04575038 CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19 https://ClinicalTrials.gov/show/NCT04575038
NCT04583449 Mental Imagery to Increase Face Covering Use in UK-based Public Places During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04583449
NCT04597034 Efficacy and Safety of a Highly Selective Semipermeable Membrane (AN-69 Oxiris) vs (Standard AN-69) in COVID-19 https://ClinicalTrials.gov/show/NCT04597034
NCT04581291 The Effect of Aerobic Exercise on Immune Biomarkers and Symptoms Severity and Progression in Patients With COVID-19: A Pilot Randomized Control Trial https://ClinicalTrials.gov/show/NCT04581291
NCT04594330 Virgin Coconut Oil (VCO) as a Potential Adjuvant Therapy in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04594330
NCT04593641 This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04593641
NCT04581954 Inflammatory Signal Inhibitors for COVID-19 (MATIS) https://ClinicalTrials.gov/show/NCT04581954
NCT04589936 Prone Position to Improve Oxygenation in COVID-19 Patients Outside Critical Care https://ClinicalTrials.gov/show/NCT04589936
NCT04584580 D-dimer Adjusted Versus Therapeutic Dose Low-molecular-weight Heparin in Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04584580
NCT04582214 Oscillation and Lung Expansion Therapy in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04582214
NCT04579549 Repeat Testing for SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04579549
NCT04582201 An Experiment to Evaluate the Safety of agenT-797 in COVID-19 Patients With Severe Difficulty Breathing. https://ClinicalTrials.gov/show/NCT04582201
NCT04579640 Trial of Vitamin D to Reduce Risk and Severity of COVID-19 and Other Acute Respiratory Infections https://ClinicalTrials.gov/show/NCT04579640
NCT04578158 Trial to Study the Adjuvant Benefits of Quercetin Phytosome in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04578158
NCT04579393 Fostamatinib for Hospitalized Adults With COVID-19 https://ClinicalTrials.gov/show/NCT04579393
NCT04594668 Senicapoc in COVID-19 Patients With Severe Respiratory Insufficiency https://ClinicalTrials.gov/show/NCT04594668
NCT04623671 Intravenous Infusion of CAP-1002 in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04623671
NCT04582318 A Phase 1/2 Study to Assess the Safety, Tolerability and Pharmacokinetics of NGM621 in Healthy Subjects, and to Assess the Safety, PK and Efficacy in Subjects With Moderate to Severe ARDS Caused by COVID-19 https://ClinicalTrials.gov/show/NCT04582318
NCT04581811 Prolonged Prone Positioning for COVID-19-induced Acute Respiratory Distress Syndrome (ARDS) https://ClinicalTrials.gov/show/NCT04581811
NCT04583592 Camostat Efficacy vs. Placebo for Outpatient Treatment of COVID-19 (CAMELOT) https://ClinicalTrials.gov/show/NCT04583592
NCT04600999 Clinical Trial of Favipiravir Treatment of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04600999
NCT04590430 Study to Assess the Safety, Tolerability, and Pharmacokinetics of HFB30132A Against COVID-19 in Healthy Adults https://ClinicalTrials.gov/show/NCT04590430
NCT04584710 A Phase 2 Study of RTB101 as COVID-19 Post-Exposure Prophylaxis in Older Adults https://ClinicalTrials.gov/show/NCT04584710
NCT04583995 A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom https://ClinicalTrials.gov/show/NCT04583995
NCT04583969 ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04583969
NCT04583956 ACTIV-5 / Big Effect Trial (BET-A) for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04583956
NCT04610541 REMdesivir-HU Clinical Study and Severe Covid-19 Patients https://ClinicalTrials.gov/show/NCT04610541
NCT04593069 The COGCOV Study in ICU Patients https://ClinicalTrials.gov/show/NCT04593069
NCT04589949 Early Convalescent Plasma Therapy for High-risk Patients With COVID-19 in Primary Care (the CoV-Early Study) https://ClinicalTrials.gov/show/NCT04589949
NCT04589117 Expressive Writing for COVID-19 Resilience for Parents https://ClinicalTrials.gov/show/NCT04589117
NCT04589104 Expressive Writing for COVID-19 Resilience https://ClinicalTrials.gov/show/NCT04589104
NCT04584593 Pilot Study to Detect SARS-CoV-2 Virus in Sperm https://ClinicalTrials.gov/show/NCT04584593
NCT04587219 The Study of “Gam-COVID-Vac” Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and Older https://ClinicalTrials.gov/show/NCT04587219
NCT04591717 Study of the Safety of Prophylactic Vaccination With 2nd Generation E1/E2B/E3-Deleted Adenoviral-COVID-19 in Normal Healthy Volunteers https://ClinicalTrials.gov/show/NCT04591717
NCT04588480 Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Japanese Adults https://ClinicalTrials.gov/show/NCT04588480
NCT04592354 Anhydrous Enol-Oxaloacetate (AEO) on Improving Fatigue in Post-COVID-19 Survivors https://ClinicalTrials.gov/show/NCT04592354
NCT04591600 Effectiveness of Ivermectin and Doxycycline on COVID-19 Patients https://ClinicalTrials.gov/show/NCT04591600
NCT04590053 Allocetra-OTS in COVID-19, Phase II https://ClinicalTrials.gov/show/NCT04590053
NCT04598594 Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Intensive Care Unit Patients https://ClinicalTrials.gov/show/NCT04598594
NCT04602000 To Evaluate the Safety and Efficacy of CT-P59 in Patients With Mild to Moderate Syptoms of Severe Acute Respiratory Syndrome COVID-19 https://ClinicalTrials.gov/show/NCT04602000
NCT04597047 Research & Evaluation of LumiraDx SARS-CoV-2 (COVID-19) Point of Care Ab Test https://ClinicalTrials.gov/show/NCT04597047
NCT04596085 Study to Evaluate Efficacy and Safety of “VIRACIDE” IN THE MANAGEMENT OF CORONA VIRUS DISEASE 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04596085
NCT04602312 How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Healthy Sample) https://ClinicalTrials.gov/show/NCT04602312
NCT04602286 How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Pain Sample) https://ClinicalTrials.gov/show/NCT04602286
NCT04609371 PanDirect: Self-care Tools and Telephone Coaching for Depression and Anxiety During Pandemics https://ClinicalTrials.gov/show/NCT04609371
NCT04604977 Feasibility and Effectiveness of Home-behavioral Program for Adolescents With Migraine https://ClinicalTrials.gov/show/NCT04604977
NCT04600440 Convalescent Plasma in the Treatment of Covid-19 https://ClinicalTrials.gov/show/NCT04600440
NCT04596839 Antiviral Activity and Safety of Remdesivir in Bangladeshi Patients With Severe Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04596839
NCT04603924 Study of Niclosamide in Moderate Hospitalized Coronavirus-19 (COVID-19) Patients https://ClinicalTrials.gov/show/NCT04603924
NCT04598581 Low Dose Radiation Therapy for Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2), COVID-19 https://ClinicalTrials.gov/show/NCT04598581
NCT04603794 Efficacy of Mouthwash in Reducing Salivary Carriage of COVID-19 https://ClinicalTrials.gov/show/NCT04603794
NCT04603729 Comparison of Efficacy of Dexamethasone and Methylprednisolone in Moderate to Severe Covid 19 Disease https://ClinicalTrials.gov/show/NCT04603729
NCT04602871 Early Detection of COVID-19 Using Breath Analysis - Feasibility Study https://ClinicalTrials.gov/show/NCT04602871
NCT04602442 Safety and Efficiency of Method of Exosome Inhalation in COVID-19 Associated Pneumonia https://ClinicalTrials.gov/show/NCT04602442
NCT04609423 Cod Liver Oil for Covid-19 Prevention Study https://ClinicalTrials.gov/show/NCT04609423
NCT04604327 Comparison of Two Different Doses of Bemiparin in COVID-19 https://ClinicalTrials.gov/show/NCT04604327
NCT04602832 Enduring Happiness and Continued Self-Enhancement (ENHANCE) for COVID-19 https://ClinicalTrials.gov/show/NCT04602832
NCT04625985 Metformin Glycinate, Treatment of Patients With COVID-19 and Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2. https://ClinicalTrials.gov/show/NCT04625985
NCT04610567 Treatment of Patients With Mild Coronavirus-19 (COVID-19) Disease With Methotrexate Associated to LDL Like Nanoparticles (Nano-COVID19) https://ClinicalTrials.gov/show/NCT04610567
NCT04603963 Inspiratory Muscle Training in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04603963
NCT04613271 Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia https://ClinicalTrials.gov/show/NCT04613271
NCT04615429 Clinical Trial to Assess the Efficacy of MSC in Patients With ARDS Due to COVID-19 https://ClinicalTrials.gov/show/NCT04615429
NCT04608305 Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine https://ClinicalTrials.gov/show/NCT04608305
NCT04615416 Emotion Regulation Training Via Telehealth During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04615416
NCT04609722 Effect of Solution-Focused Support Program on Anxiety Levels of Parents During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04609722
NCT04605588 A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19 https://ClinicalTrials.gov/show/NCT04605588
NCT04610801 Evaluation of the Efficacy of Xylitol Nasal Spray Against SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04610801
NCT04613310 PCR and Rapid Diagnostic Test on Saliva and Nasopharyngeal Swabs for the Detection of SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04613310
NCT04632706 Exploratory Ph I Trial of the Active IMP in Healthy Volunteers in Relation to COVID-19 https://ClinicalTrials.gov/show/NCT04632706
NCT04604184 ACTION ON COVID-19: A Study to Test Whether BI 764198 Helps Lung Health of People Hospitalised With COVID-19 https://ClinicalTrials.gov/show/NCT04604184
NCT04606563 Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan on Outcomes of Coronavirus Infection? https://ClinicalTrials.gov/show/NCT04606563
NCT04608097 Understanding Reactions to Emotional Material in the Media During COVID-19 https://ClinicalTrials.gov/show/NCT04608097
NCT04609969 Diagnostic Performance Evaluation of a Novel SARS-CoV-2 (COVID-19) Antigen Detection Test https://ClinicalTrials.gov/show/NCT04609969
NCT04607928 Pirfenidone Compared to Placebo in Post-COVID19 Pulmonary Fibrosis COVID-19 https://ClinicalTrials.gov/show/NCT04607928
NCT04615052 Home-based Exercise in COVID-19 Survivors https://ClinicalTrials.gov/show/NCT04615052
NCT04615741 Finding Wellness in the Pandemic https://ClinicalTrials.gov/show/NCT04615741
NCT04611256 Mesenchymal Stem Cells in Patients Diagnosed With COVID-19 https://ClinicalTrials.gov/show/NCT04611256
NCT04613050 Effect of Respiratory Versus Aerobic Training on Respiratory and Immunity Efficiency in Recovered COVID- 19 Patients https://ClinicalTrials.gov/show/NCT04613050
NCT04627467 Prevention With Chloroquine in Health Personnel Exposed to Infection With Coronavirus Disease 2019 (COVID-19) (TS-COVID) https://ClinicalTrials.gov/show/NCT04627467
NCT04615975 Ketogenic Diet as Protective Factor During COVID-19 https://ClinicalTrials.gov/show/NCT04615975
NCT04644705 Safety and Pharmacokinetics of a Novel Niclosamide Solution in Combination With Camostat https://ClinicalTrials.gov/show/NCT04644705
NCT04614025 Open-label Multicenter Study to Evaluate the Efficacy of PLX-PAD for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04614025
NCT04614012 Hyperimmune Plasma for Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04614012
NCT04613297 HLA-G Immuno-Inhibitor Checkpoint Study in Patients With COVID-19 Infection: Molecular and Cellular Assessment https://ClinicalTrials.gov/show/NCT04613297
NCT04615936 Nasal Photodisinfection COVID Proof of Concept Study https://ClinicalTrials.gov/show/NCT04615936
NCT04614883 Analysis of Volatile Organic Compounds in Exhaled Air and in Sweat in the Context of Suspicion of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04614883
NCT04616846 Thromboembolic Risk Screening in Patients With Cancer and COVID-19 https://ClinicalTrials.gov/show/NCT04616846
NCT04614948 A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults https://ClinicalTrials.gov/show/NCT04614948
NCT04639466 A Synthetic MVA-based SARS-CoV-2 Vaccine, COH04S1, for the Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT04639466
NCT04617483 Study of the Commercial Scale SARS-CoV-2 Vaccine Against the Pilot Scale Among Adults, and Bridging Study of the Immunogenicity in Elderly Against That in Adults https://ClinicalTrials.gov/show/NCT04617483
NCT04622826 plasmApuane CoV-2 : Efficacy and Safety of Immune Covid-19 Plasma in Covid-19 Pneumonia in Non ITU Patients https://ClinicalTrials.gov/show/NCT04622826
NCT04621123 Plasma for Early Treatment in Non-hospitalised Mild or Moderate COVID-19 Patients https://ClinicalTrials.gov/show/NCT04621123
NCT04620798 Longitudinal COVID-19 Antibody Testing in Indiana University Undergraduate Students https://ClinicalTrials.gov/show/NCT04620798
NCT04619290 Outpatient Treatment With CoVid-19 With Prexablu https://ClinicalTrials.gov/show/NCT04619290
NCT04629157 The LAVA (Lateral Flow Antigen Validation and Applicability) Study for COVID-19 https://ClinicalTrials.gov/show/NCT04629157
NCT04623021 A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04623021
NCT04619680 The Study Will Evaluate the Use of Nintedanib in Slowing Lung Fibrosis in Patients With Pulmonary Infiltrates Related to COVID-19 https://ClinicalTrials.gov/show/NCT04619680
NCT04625114 The Potential of Oral Camostat in Early COVID-19 Disease in an Ambulatory Setting to Reduce Viral Load and Disease Burden https://ClinicalTrials.gov/show/NCT04625114
NCT04635618 Psychotherapy Strategies for the Treatment of Professionals and Students From Essential Services With High Levels of Emotional Distress in the Context of COVID-19 https://ClinicalTrials.gov/show/NCT04635618
NCT04632082 Telepsychoeducation for the Prevention of Emotional Distress in Professionals and Students From Essential Services in the Context of COVID-19 https://ClinicalTrials.gov/show/NCT04632082
NCT04633772 Use of Angiotensin-(1-7) in COVID-19 https://ClinicalTrials.gov/show/NCT04633772
NCT04622891 Clarithromycin Versus Azithromycin in Treatment of Mild COVID-19 Infection https://ClinicalTrials.gov/show/NCT04622891
NCT04621058 Efficacy of Vitamin D Treatment in Mortality Reduction Due to COVID-19. https://ClinicalTrials.gov/show/NCT04621058
NCT04637477 Virtual Enhanced Lifestyle for Metabolic Syndrome (ELM) Proof-of-Concept Study https://ClinicalTrials.gov/show/NCT04637477
NCT04621903 A Pilot Study on Efficacy and Safety of Ayurveda Combination in Patients With Mild-to-Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04621903
NCT04641481 An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers https://ClinicalTrials.gov/show/NCT04641481
NCT04622865 Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19 https://ClinicalTrials.gov/show/NCT04622865
NCT04635943 Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19 https://ClinicalTrials.gov/show/NCT04635943
NCT04634903 Testing Scalable, Single-Session Interventions for Adolescent Depression in the Context of COVID-19 https://ClinicalTrials.gov/show/NCT04634903
NCT04643964 Brief Video Interventions for Depression https://ClinicalTrials.gov/show/NCT04643964
NCT04630054 Face Masks to Reduce COVID-19 in Bangladesh https://ClinicalTrials.gov/show/NCT04630054
NCT04629989 Comparison of the Surgical Facemask With the Double-trunk Mask on Oxygenation in COVID-19 https://ClinicalTrials.gov/show/NCT04629989
NCT04646044 A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19 https://ClinicalTrials.gov/show/NCT04646044
NCT04632719 The MentalPlus® for Assessment and Rehabilitation of Cognitive Function After Remission of the Symptoms of COVID-19 https://ClinicalTrials.gov/show/NCT04632719
NCT04635241 Inhaled Heparin for Hospitalised COVID-19 Patients https://ClinicalTrials.gov/show/NCT04635241
NCT04646109 Ivermectin for Severe COVID-19 Management https://ClinicalTrials.gov/show/NCT04646109
NCT04642326 Study Investigating the Effects of UVC Beam and Laser Beam Therapy According to Standard Therapy in Patients With Covid-19 Diagnosis https://ClinicalTrials.gov/show/NCT04642326
NCT04639375 Polio Vaccine (IPV) for SARS-CoV-2 and Prevention of Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04639375
NCT04632602 Awake Prone Position to Reduce Ventilation Inhomogeneity in COVID-19 Acute Respiratory Failure https://ClinicalTrials.gov/show/NCT04632602
NCT04634760 Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Japanese Adults https://ClinicalTrials.gov/show/NCT04634760
NCT04636333 Phase I Trial of a Recombinant SARS-CoV-2 Vaccine (CHO Cell) https://ClinicalTrials.gov/show/NCT04636333
NCT04636086 Effect of Vitamin D on Hospitalized Adults With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04636086
NCT04637828 A Study to Compare the Efficacy of GNS561 Versus Standard of Care in Patients With SARS-CoV-2 (COVID-19) Infection https://ClinicalTrials.gov/show/NCT04637828
NCT04634799 Study To antagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19 https://ClinicalTrials.gov/show/NCT04634799
NCT04634409 A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness https://ClinicalTrials.gov/show/NCT04634409
NCT04636320 Prevalence of Myocardial Scars on CMR After COVID-19 Infection https://ClinicalTrials.gov/show/NCT04636320
NCT04640402 A Phase â…¡ Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells) https://ClinicalTrials.gov/show/NCT04640402
NCT04640038 Contrast Enhanced Ultrasound in COVID-19 https://ClinicalTrials.gov/show/NCT04640038
NCT04640168 Adaptive COVID-19 Treatment Trial 4 (ACTT-4) https://ClinicalTrials.gov/show/NCT04640168
NCT04639349 Effect of Home Exercise Activity on Cortisol and Depression in COPD During the Pandemic COVID https://ClinicalTrials.gov/show/NCT04639349
NCT04642040 Effectiveness of Pulmonary Rehabilitation Program in Patients With SARS-CoV-2 Pneumonia https://ClinicalTrials.gov/show/NCT04642040
NCT04644172 Improving Thinking in Everyday Life After Covid-19 https://ClinicalTrials.gov/show/NCT04644172
NCT04643691 Losartan and Spironolactone Treatment for ICU Patients With COVID-19 Suffering From ARDS https://ClinicalTrials.gov/show/NCT04643691
NCT04643678 Anakinra in the Management of COVID-19 Infection: A Randomized Clinical Trial https://ClinicalTrials.gov/show/NCT04643678
NCT04643561 Using Travelan to Boost Immune Response in Vitro to COVID-19 https://ClinicalTrials.gov/show/NCT04643561

Observational Studies

nct_id brief_title link
NCT04245631 Development of a Simple, Fast and Portable Recombinase Aided Amplification Assay for 2019-nCoV https://ClinicalTrials.gov/show/NCT04245631
NCT04256395 Efficacy of a Self-test and Self-alert Mobile Applet in Detecting Susceptible Infection of COVID-19 https://ClinicalTrials.gov/show/NCT04256395
NCT04260308 A Survey of Psychological Status of Medical Workers and Residents in the Context of 2019 Novel Coronavirus Pneumonia https://ClinicalTrials.gov/show/NCT04260308
NCT04255940 2019-nCoV Outbreak and Cardiovascular Diseases https://ClinicalTrials.gov/show/NCT04255940
NCT04259892 Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection. COVID-19. https://ClinicalTrials.gov/show/NCT04259892
NCT04262921 French COVID Cohort https://ClinicalTrials.gov/show/NCT04262921
NCT04283396 Study for Novel Coronavirus Pneumonia (NCP) https://ClinicalTrials.gov/show/NCT04283396
NCT04279782 Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection https://ClinicalTrials.gov/show/NCT04279782
NCT04274322 Identifying Critically-ill Patients With COVID-19 Who Will Benefit Most From Nutrition Support Therapy: Validation of the NUTRIC Nutritional Risk Assessment Tool https://ClinicalTrials.gov/show/NCT04274322
NCT04275947 The COVID-19 Mobile Health Study (CMHS) https://ClinicalTrials.gov/show/NCT04275947
NCT04279899 The Investigation of the Neonates With or With Risk of COVID-19 https://ClinicalTrials.gov/show/NCT04279899
NCT04279795 Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical Manifestations https://ClinicalTrials.gov/show/NCT04279795
NCT04282135 Detection of Influenza or SARS-CoV-2 Infection by IMS of Nasal Air Sampling https://ClinicalTrials.gov/show/NCT04282135
NCT04284046 CT Scores Predict Mortality in 2019-nCoV Pneumonia https://ClinicalTrials.gov/show/NCT04284046
NCT04292327 Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus https://ClinicalTrials.gov/show/NCT04292327
NCT04285801 Critically Ill Patients With COVID-19 in Hong Kong: a Multicentre Observational Cohort Study https://ClinicalTrials.gov/show/NCT04285801
NCT04292340 Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04292340
NCT04290780 COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus https://ClinicalTrials.gov/show/NCT04290780
NCT04306497 TCM Differentiation and Treatment Protocol of COVID-19 https://ClinicalTrials.gov/show/NCT04306497
NCT04292964 Prognostic Factors of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04292964
NCT04312464 Myocardial Damage in COVID-19 https://ClinicalTrials.gov/show/NCT04312464
NCT04302688 Accurate Classification System for Patients With COVID-19 Pneumonitis https://ClinicalTrials.gov/show/NCT04302688
NCT04306705 Tocilizumab vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19 https://ClinicalTrials.gov/show/NCT04306705
NCT04305574 Social Media Use During COVID-19 https://ClinicalTrials.gov/show/NCT04305574
NCT04307459 Acute Respiratory Failure and COVID-19 in Real Life https://ClinicalTrials.gov/show/NCT04307459
NCT04316884 Mechanisms for Organ Dysfunction in Covid-19 https://ClinicalTrials.gov/show/NCT04316884
NCT04312100 Sequential Oxygen Therapy Strategy for Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04312100
NCT04319315 Social Media Effect on Knowledge Dissemination During COVID-19 Virus Outbreak https://ClinicalTrials.gov/show/NCT04319315
NCT04316299 Acute Kidney Injury in Patients Hospitalized With COVID-19 https://ClinicalTrials.gov/show/NCT04316299
NCT04314817 Adverse Events Related to Treatments Used Against Coronavirus Disease 2019 https://ClinicalTrials.gov/show/NCT04314817
NCT04314232 Mechanisms for Covid-19 Disease Complications https://ClinicalTrials.gov/show/NCT04314232
NCT04313946 Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays https://ClinicalTrials.gov/show/NCT04313946
NCT04347369 A Retrospective Study of Neural Network Model to Dynamically Quantificate the Severity in COVID-19 Disease https://ClinicalTrials.gov/show/NCT04347369
NCT04318418 ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and Severity of COVID-19 https://ClinicalTrials.gov/show/NCT04318418
NCT04318366 COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor https://ClinicalTrials.gov/show/NCT04318366
NCT04316949 Predictors of Respiratory Failure in SARS-Cov-2 Infection https://ClinicalTrials.gov/show/NCT04316949
NCT04321265 Outcomes and Prognostic Factors in COVID-19 https://ClinicalTrials.gov/show/NCT04321265
NCT04320017 Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19 https://ClinicalTrials.gov/show/NCT04320017
NCT04319172 Multicentric Study of Coronavirus Disease 2019 (COVID-2019) in Solid Organ Transplant Recipients https://ClinicalTrials.gov/show/NCT04319172
NCT04318301 Hypertension in Patients Hospitalized With COVID-19 https://ClinicalTrials.gov/show/NCT04318301
NCT04322513 Biomarkers for Identification of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04322513
NCT04322487 Simple, Safe, Same: Lung Ultrasound for COVID-19 https://ClinicalTrials.gov/show/NCT04322487
NCT04321369 Impact of Swab Site and Sample Collector on Testing Sensitivity for COVID-19 Virus in Symptomatic Individuals https://ClinicalTrials.gov/show/NCT04321369
NCT04320862 COVID-19 Pandemic Response Network https://ClinicalTrials.gov/show/NCT04320862
NCT04320732 Risk Factors for Community- and Workplace Transmission of COVID-19 https://ClinicalTrials.gov/show/NCT04320732
NCT04320511 Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2 https://ClinicalTrials.gov/show/NCT04320511
NCT04325919 Coronavirus Disease 2019 (COVID-19) Study of Hospitalized Patients in Hong Kong https://ClinicalTrials.gov/show/NCT04325919
NCT04323787 Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry https://ClinicalTrials.gov/show/NCT04323787
NCT04322279 Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection. COVID19. https://ClinicalTrials.gov/show/NCT04322279
NCT04322188 An Observational Study of the Use of Siltuximab (SYLVANT) in Patients Diagnosed With COVID-19 Infection Who Have Developed Serious Respiratory Complications https://ClinicalTrials.gov/show/NCT04322188
NCT04327180 PREdiction of DIagnosed Covid-19 infecTion in IUC Patients https://ClinicalTrials.gov/show/NCT04327180
NCT04323878 Early CPAP in COVID-19 Patients With Respiratory Failure. A Prospective Cohort Study. https://ClinicalTrials.gov/show/NCT04323878
NCT04324684 Prognostic Factors Keeping Track for COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04324684
NCT04324047 Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04324047
NCT04323644 Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg) https://ClinicalTrials.gov/show/NCT04323644
NCT04324736 “COVID-19 and Diabetes Outcomes” https://ClinicalTrials.gov/show/NCT04324736
NCT04332913 Efficacy and Safety of Tocilizumab in the Treatment of SARS-Cov-2 Related Pneumonia https://ClinicalTrials.gov/show/NCT04332913
NCT04329507 Non-invasive Detection of Pneumonia in Context of Covid-19 Using Gas Chromatography - Ion Mobility Spectrometry (GC-IMS) https://ClinicalTrials.gov/show/NCT04329507
NCT04327804 A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research https://ClinicalTrials.gov/show/NCT04327804
NCT04326725 Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia https://ClinicalTrials.gov/show/NCT04326725
NCT04326387 Evaluation of Novel Diagnostic Tests for COVID-19 https://ClinicalTrials.gov/show/NCT04326387
NCT04325646 Sero-epidemiological Study of the SARS-CoV-2 Virus Responsible for COVID-19 in France https://ClinicalTrials.gov/show/NCT04325646
NCT04331106 Survey of the Anxiety Associated With the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04331106
NCT04328454 Clinical Characteristics and Prognostic Factors of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04328454
NCT04327531 Evaluation of Covid 19 Knowledge Anxiety and Expectation Levels of Turkish Physicians, Survey Study https://ClinicalTrials.gov/show/NCT04327531
NCT04329546 Understanding COVID-19 https://ClinicalTrials.gov/show/NCT04329546
NCT04337983 Hemodynamic Characteristics of Patients With SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04337983
NCT04336384 Impact of Covid-19 in Congenital Heart Disease https://ClinicalTrials.gov/show/NCT04336384
NCT04332016 COVID-19 Biological Samples Collection https://ClinicalTrials.gov/show/NCT04332016
NCT04330521 Impact of the Coronavirus (COVID-19) on Patients With Cancer https://ClinicalTrials.gov/show/NCT04330521
NCT04330261 Clinical Characteristics and Outcomes of Pediatric COVID-19 https://ClinicalTrials.gov/show/NCT04330261
NCT04340219 Oncology-patient-reported Anxiety, Mood, and QoL During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04340219
NCT04335188 COVID-19 Registry Rhineland-Palatinate (Germany) https://ClinicalTrials.gov/show/NCT04335188
NCT04331886 An Observational Study of Patients With Coronavirus Disease 2019 https://ClinicalTrials.gov/show/NCT04331886
NCT04331509 COVID-19 Symptom Tracker https://ClinicalTrials.gov/show/NCT04331509
NCT04330599 Longitudinal Population-based Observational Study of COVID-19 in the UK Population https://ClinicalTrials.gov/show/NCT04330599
NCT04333862 Assessment of Covid-19 Infection Rates in Healthcare Workers Using a Desynchronization Strategy https://ClinicalTrials.gov/show/NCT04333862
NCT04333849 Telephony Or Videophony for Isolated elDerly in Maine-Et-Loire 49 During COVID-19 https://ClinicalTrials.gov/show/NCT04333849
NCT04336215 Rutgers COVID-19 Cohort Study https://ClinicalTrials.gov/show/NCT04336215
NCT04335630 Cardiovascular Manifestations of COVID-19 https://ClinicalTrials.gov/show/NCT04335630
NCT04334252 Descriptive Study Regarding Ambulant Screening During COVID-19 Pandemia https://ClinicalTrials.gov/show/NCT04334252
NCT04335162 Cardiovascular Complications and COVID-19 (CovCardioVasc-Study) https://ClinicalTrials.gov/show/NCT04335162
NCT04344925 Non Invasive Positive Pressure Ventilation to Minimize Aerosolization for COVID 19 https://ClinicalTrials.gov/show/NCT04344925
NCT04340921 The Role of Adaptive Immunity in COVID-19 Associated Myocardial Injury https://ClinicalTrials.gov/show/NCT04340921
NCT04337190 Impact of Angiotensin II Receptor Blockers Treatment in Patients With COVID 19 (COVID-ARA2) https://ClinicalTrials.gov/show/NCT04337190
NCT04337151 Blood Titanium Analysis of Patients With MAGEC Spine Rods in the COVID-19 Environment https://ClinicalTrials.gov/show/NCT04337151
NCT04337047 Distress in Crisis Situations During COVID-19 https://ClinicalTrials.gov/show/NCT04337047
NCT04336761 Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France https://ClinicalTrials.gov/show/NCT04336761
NCT04336657 Corona-Like Illness: Did we Got it Before WHO Announcement of the Disease? https://ClinicalTrials.gov/show/NCT04336657
NCT04335747 COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases https://ClinicalTrials.gov/show/NCT04335747
NCT04334954 SARS-COV2 Pandemic Serosurvey and Blood Sampling https://ClinicalTrials.gov/show/NCT04334954
NCT04342702 A Study on the Prospective Cohort Library of COVID-19 in Southeran https://ClinicalTrials.gov/show/NCT04342702
NCT04338672 The Impact of the Covid-19 Outbreak on Emergency Room Attendances of Surgical Patients https://ClinicalTrials.gov/show/NCT04338672
NCT04337320 Maternal And Neonatal Outcome of Pregnant Patients With COVID-19 in Istanbul, Turkey: A Single-Center, Retrospective, Descriptive Study https://ClinicalTrials.gov/show/NCT04337320
NCT04337424 Evaluation of Quickly Diagnostic Saliva Tests for SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04337424
NCT04366765 COVID-19 Survival - The COVIVA Study https://ClinicalTrials.gov/show/NCT04366765
NCT04354558 French Single Centre Experience of Critically Ill Patients With Covid 19 https://ClinicalTrials.gov/show/NCT04354558
NCT04346602 A Study on the Clinical and Psychological Characteristics of Patients With COVID-2019 https://ClinicalTrials.gov/show/NCT04346602
NCT04339998 Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS) https://ClinicalTrials.gov/show/NCT04339998
NCT04337762 Beat COVID-19 - Observational Trial https://ClinicalTrials.gov/show/NCT04337762
NCT04339387 COVID-19 Risk Stratification https://ClinicalTrials.gov/show/NCT04339387
NCT04337502 Clinical and Radiomic Model of COVID-19 https://ClinicalTrials.gov/show/NCT04337502
NCT04347408 Seroprevalence of SARS-Cov-2 Antibodies in Children https://ClinicalTrials.gov/show/NCT04347408
NCT04343742 Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19 https://ClinicalTrials.gov/show/NCT04343742
NCT04342637 COVID-19 Endoscopy Survey https://ClinicalTrials.gov/show/NCT04342637
NCT04341792 Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient https://ClinicalTrials.gov/show/NCT04341792
NCT04341519 Psychological Burden in ICU Survivors of Severe COVID-19 Pneumonia, Their Relatives and Their Healthcare Providers https://ClinicalTrials.gov/show/NCT04341519
NCT04341506 Non-contact ECG Sensor System for COVID19 https://ClinicalTrials.gov/show/NCT04341506
NCT04341480 The Safety of Chemotherapy for Patients With Gynecological Malignancy in High-risk Region of COVID-19 https://ClinicalTrials.gov/show/NCT04341480
NCT04341012 Breath Analysis Based Disease Biomarkers of COVID-19 and Other Diseases https://ClinicalTrials.gov/show/NCT04341012
NCT04339634 Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy https://ClinicalTrials.gov/show/NCT04339634
NCT04339608 Max COVID19- Study https://ClinicalTrials.gov/show/NCT04339608
NCT04338945 Impact of Pandemic COVID-19 on Surgical Specialities Residents in Italy https://ClinicalTrials.gov/show/NCT04338945
NCT04338932 COVID-19 and Deep Venous Thrombosis https://ClinicalTrials.gov/show/NCT04338932
NCT04339790 Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers https://ClinicalTrials.gov/show/NCT04339790
NCT04352634 The Covid-19 HEalth caRe wOrkErS (HEROES) Study https://ClinicalTrials.gov/show/NCT04352634
NCT04347460 Establishing a COVID-19 Prospective Cohort for Identification of Secondary HLH https://ClinicalTrials.gov/show/NCT04347460
NCT04343404 Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19 https://ClinicalTrials.gov/show/NCT04343404
NCT04343339 Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment https://ClinicalTrials.gov/show/NCT04343339
NCT04342884 COVID-19 Community Research Partnership https://ClinicalTrials.gov/show/NCT04342884
NCT04342195 Acquiring Convalescent Specimens for COVID-19 Antibodies https://ClinicalTrials.gov/show/NCT04342195
NCT04342104 NIV and CPAP Failure Predictors in COVID-19 Associated Respiratory Failure https://ClinicalTrials.gov/show/NCT04342104
NCT04341714 Efficiency and Satisfaction With Telephone Consultation in Neuro-urology: Experience of the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04341714
NCT04339686 Multicentric Retrospective Observational Study of Thoracic Scanner Performance in COVID Screening. https://ClinicalTrials.gov/show/NCT04339686
NCT04347928 Respiratory and Hemodynamic Changes Induced in Mechanically Ventilated Patients for COVID-19 https://ClinicalTrials.gov/show/NCT04347928
NCT04358952 Myocardial Involvement of Severe Acute Respiratory Syndrome-Cov-2 (Covid19) Infected Patients https://ClinicalTrials.gov/show/NCT04358952
NCT04352556 COVID19-hematological Malignancies: the Italian Hematology Alliance https://ClinicalTrials.gov/show/NCT04352556
NCT04350710 Description of Respiratory Mechanics in Patients With SARS-CoV-2 Associated ARDS https://ClinicalTrials.gov/show/NCT04350710
NCT04347850 A Cohort of Patients With Possible or Confirmed SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04347850
NCT04347824 Predict Adverse Events by Covid-19 Nephritis https://ClinicalTrials.gov/show/NCT04347824
NCT04346342 PRactice of VENTilation in COVID-19 Patients (PRoVENT-COVID) https://ClinicalTrials.gov/show/NCT04346342
NCT04344327 Early Risk Stratification of Patient Hospitalized for SARS-CoV2 Infection: Critical COVID-19 France CCF https://ClinicalTrials.gov/show/NCT04344327
NCT04344197 Surgery During Covid-19: The Role of Asymptomatic Patients, a Survey https://ClinicalTrials.gov/show/NCT04344197
NCT04344145 Exhaustion and Needs in Frontline COVID-19 Healthcare Workers: Cross-sectional Study in a Belgian Population https://ClinicalTrials.gov/show/NCT04344145
NCT04344119 Assessment of Chilbains Occuring During Covid-19 Infection https://ClinicalTrials.gov/show/NCT04344119
NCT04343781 National Survey of Symptoms of People Aged 70 and Overs Diagnosed With COVID-19 https://ClinicalTrials.gov/show/NCT04343781
NCT04357847 Assessment of Endothelial and Haemostatic Changes During Severe SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04357847
NCT04343898 Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04343898
NCT04381312 Direct and Indirect Impact of COVID-19 In Older Populations https://ClinicalTrials.gov/show/NCT04381312
NCT04352517 Influence Physical Activity Psychological Responses COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04352517
NCT04351711 Immunological Profiling of Patients With COVID-19 in Respiratory Distress https://ClinicalTrials.gov/show/NCT04351711
NCT04348396 Clinical and Biological Predictors of COVID-19 Disease in Older Patients https://ClinicalTrials.gov/show/NCT04348396
NCT04347070 Implementation of Physiotherapy on COVID-19 Patients in ICU https://ClinicalTrials.gov/show/NCT04347070
NCT04346212 Oropharyngeal Dysphagia in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04346212
NCT04346121 Non-COVID Patient-safety Incidents Reported by General Practitioners in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study.cRisis https://ClinicalTrials.gov/show/NCT04346121
NCT04345640 The Spectrum and Profile of COVID-19 Infection and Its Impact on Liver. https://ClinicalTrials.gov/show/NCT04345640
NCT04345315 Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent. https://ClinicalTrials.gov/show/NCT04345315
NCT04345159 Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease https://ClinicalTrials.gov/show/NCT04345159
NCT04344964 Endoscopy-related Phone Consultation During the COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04344964
NCT04344171 CovidDB: The Covid-19 Inpatient Database https://ClinicalTrials.gov/show/NCT04344171
NCT04569851 Clinical Characteristics and Prognostic Factors of Patients With COVID-19 (Coronavirus Disease 2019) https://ClinicalTrials.gov/show/NCT04569851
NCT04346186 COVID-19: Investigation of Transmission and Immunisation Among Hospital Staff https://ClinicalTrials.gov/show/NCT04346186
NCT04353934 The Ariel University Survey on Dietary Changes and Anxiety During the Coronavirus Pandemic https://ClinicalTrials.gov/show/NCT04353934
NCT04347694 Study to Determine the Immunization Status Among Nephrological Health Care Personnel Against SARS-CoV-2 in a Single Center Over the Course of 12 Months During the Worldwide COVID-19 Pandemic. https://ClinicalTrials.gov/show/NCT04347694
NCT04356560 COVID-19 Surveillance of Patients and Healthcare Workers in a Hospital Department https://ClinicalTrials.gov/show/NCT04356560
NCT04354584 Compartmental Inflammation in Mechanically Ventilated Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04354584
NCT04349202 Beaumont Health Large-scale Automated Serologic Testing for COVID-19 https://ClinicalTrials.gov/show/NCT04349202
NCT04349163 Resilience Evaluation of Caregivers During the SARS-CoV2 Epidemic Period : Prospective Cohort. https://ClinicalTrials.gov/show/NCT04349163
NCT04348552 Non-COVID Patient-safety Incidents Reported by Primary Care Professionals in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study https://ClinicalTrials.gov/show/NCT04348552
NCT04348214 Screening & Risk Assessment of Healthcare Workers & Infection Control in University & COVID-19 Quarantine Hospitals https://ClinicalTrials.gov/show/NCT04348214
NCT04346264 CoVid-19 - Infection and Antibody Formation in the Viennese Population https://ClinicalTrials.gov/show/NCT04346264
NCT04346056 Retrospective Study on Severe Respiratory Illness to Access the Presence of COVID-19 https://ClinicalTrials.gov/show/NCT04346056
NCT04373889 COVID-19 Among Healthcare Workers in Belgian Hospitals https://ClinicalTrials.gov/show/NCT04373889
NCT04348422 Evaluating the Immune Response for COVID-19 https://ClinicalTrials.gov/show/NCT04348422
NCT04344977 Collection of Anti-SARS-CoV-2 Immune Plasma https://ClinicalTrials.gov/show/NCT04344977
NCT04352582 COVID-19 and Vaccination Attitudes https://ClinicalTrials.gov/show/NCT04352582
NCT04386369 Evaluation of Airway Pressure Release Ventilation in COVID-19 ARDS https://ClinicalTrials.gov/show/NCT04386369
NCT04352699 Outcomes of Urological Surgery During Periods of Social COVID-19 Containemnt: is it Reasonable to Limit Access to Surgical Care for All? https://ClinicalTrials.gov/show/NCT04352699
NCT04352491 An Online Survey to Understand Feelings Related to COVID-19 Among ILBS Patients With Liver Disease https://ClinicalTrials.gov/show/NCT04352491
NCT04351568 Professional and Ethical Challenges of Social Media Usage in Providing Healthcare Services During the Period of 19 Covid Pandemics; https://ClinicalTrials.gov/show/NCT04351568
NCT04351399 Psychological Impact of Quarantine in Rheumatoid Arthritis Patient During COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04351399
NCT04350073 Longitudinal Energy Expenditure and Metabolic Effects in Patients With COVID-19 (LEEP-COVID) https://ClinicalTrials.gov/show/NCT04350073
NCT04349540 Role of Immune and Inflammatory Response in Recipients of Allogeneic Haematopoietic Stem Cell Transplantation (SCT) Affected by Severe COVID19 https://ClinicalTrials.gov/show/NCT04349540
NCT04347876 Outcome of COVID-19 Cases Based on Tuberculin Test: Can Previous BCG Alter the Prognosis? https://ClinicalTrials.gov/show/NCT04347876
NCT04407169 Prevalence of Critical Forms of CoVid-19 in Patients With Chronic Respiratory Disease https://ClinicalTrials.gov/show/NCT04407169
NCT04568148 COVID-19 Biorepository https://ClinicalTrials.gov/show/NCT04568148
NCT04386109 Neonatal Complications of Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04386109
NCT04355741 Gut Microbiota, “Spark and Flame” of COVID-19 Disease https://ClinicalTrials.gov/show/NCT04355741
NCT04353609 Covid-19 in Patients With Chronic Inflammatory Rheumatism, Auto-immune or Auto-inflammatory Rare and Non-rare Diseases https://ClinicalTrials.gov/show/NCT04353609
NCT04353011 Psychological Impact of Quarantine in Chronic Pain Patient During COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04353011
NCT04351633 Psychological Impact of Quarantine in Osteoporosis Patient During COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04351633
NCT04351503 A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City; COVID-19 https://ClinicalTrials.gov/show/NCT04351503
NCT04351139 Impact of the COVID-19 Pandemic in Gynecological Oncology https://ClinicalTrials.gov/show/NCT04351139
NCT04348240 Transmissibility and Viral Load of SARS-CoV-2 in Oral Secretions https://ClinicalTrials.gov/show/NCT04348240
NCT04353401 WGS Analysis of COVID-19 Positive Patients https://ClinicalTrials.gov/show/NCT04353401
NCT04385121 Psychological Impact of the Hospitalization of a Family Member in Intensive Care for Covid-19 Infection https://ClinicalTrials.gov/show/NCT04385121
NCT04376905 Extra Vascular Lung Water and Pulmonary Permeability in Critically Ill Patients With SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04376905
NCT04373109 Stroke Rehabilitation Outcome During COVID-19 Lockdown https://ClinicalTrials.gov/show/NCT04373109
NCT04367129 Electrocardiogram Analysis in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04367129
NCT04366154 Impact of the COVID-19 Infectious Epidemic on the Management of Oncology and Onco-hematology Patients and on the Psychological Consequences for Patients and Caregivers https://ClinicalTrials.gov/show/NCT04366154
NCT04360538 Long Term Outcomes of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04360538
NCT04357769 COVID-19 Pandemic Burden in Severe Mental Disease Patients https://ClinicalTrials.gov/show/NCT04357769
NCT04357418 Psychological Outcome of COVID-19 Lockdown on Psychiatric Hospital Staff and Close Relatives https://ClinicalTrials.gov/show/NCT04357418
NCT04356950 Analysis of the Coagulopathy Developed by COVID-19 Infected Patients https://ClinicalTrials.gov/show/NCT04356950
NCT04356443 Non-Invasive Monitoring of Respiratory Function in Spontaneously Breathing Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04356443
NCT04355442 Evolution of Facial Trauma During COVID Containment Measures https://ClinicalTrials.gov/show/NCT04355442
NCT04354792 Asymptomatic COVID-19 Infection Among Healthcare Workers https://ClinicalTrials.gov/show/NCT04354792
NCT04353141 International Lung UltraSound Analysis (ILUSA) Study https://ClinicalTrials.gov/show/NCT04353141
NCT04352842 Echocardiographic Manifestation in Patient With COVID-19 (EARLY-MYO COVID-19) https://ClinicalTrials.gov/show/NCT04352842
NCT04351659 Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04351659
NCT04359667 Serum IL-6 and Soluble IL-6 Receptor in Severe COVID-19 Pneumonia Treated With Tocilizumab https://ClinicalTrials.gov/show/NCT04359667
NCT04354753 AiM COVID for Covid 19 Tracking and Prediction https://ClinicalTrials.gov/show/NCT04354753
NCT04367402 COST (COvid STudio) ACTION: Study for the Evaluation of Specific Antibodies Anti Covid-19 Linked to Covid-19 Infection, Symptoms and Genetic Expression of ACE2 Polymorphisms in Patients (COST ACTION) https://ClinicalTrials.gov/show/NCT04367402
NCT04366921 European/Euro-ELSO Survey on Adult and Neonatal/ Pediatric COVID-19 Patients in ECMO https://ClinicalTrials.gov/show/NCT04366921
NCT04361786 Acral Cutaneous Thrombotic Vasculopathy and Covid-19 Infection https://ClinicalTrials.gov/show/NCT04361786
NCT04357041 COVID-19 Survey Study on Dietary Intake, Physical Activity and Overall Well-being https://ClinicalTrials.gov/show/NCT04357041
NCT04356378 Long Term Physical Functional Limitations in Daily Living in SARS-CoV2 Infected Patients Hospitalized in the Acute Phase Then Requiring Rehabilitation https://ClinicalTrials.gov/show/NCT04356378
NCT04355715 Combination of Chest Scanography and Nasal Viral Detection Test to Detect COVID-19 Positive Patients Before Surgical Intervention in a University Hospital During Coronavirus Pandemia https://ClinicalTrials.gov/show/NCT04355715
NCT04355702 Covid-19 in Lupus Patients https://ClinicalTrials.gov/show/NCT04355702
NCT04355624 Kidney Involvement in COVID-19 Disease (COVKID) https://ClinicalTrials.gov/show/NCT04355624
NCT04355611 Epidemiological Characteristics of COVID-19 in Patients With MS or NMO https://ClinicalTrials.gov/show/NCT04355611
NCT04355481 Dissemination of SARS-COV-2 (COVID-19) in the Environment of Infected Patients Admitted to Intensive Care Unit https://ClinicalTrials.gov/show/NCT04355481
NCT04354857 Qualitative and Quantitative Evaluation of Anosmia Over Time in Clinically Symptomatic Patients Tested for COVID-19 Infection https://ClinicalTrials.gov/show/NCT04354857
NCT04354779 Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel. https://ClinicalTrials.gov/show/NCT04354779
NCT04354766 COVID-19 : Neutralizing Human Monoclonal Antibodies Against SARS-Cov-2 https://ClinicalTrials.gov/show/NCT04354766
NCT04357834 WAVE. Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories https://ClinicalTrials.gov/show/NCT04357834
NCT04367363 Social Media and COVID-19 https://ClinicalTrials.gov/show/NCT04367363
NCT04355338 Assessment of Incidence of SARS-CoV-2 Infection and COVID-19 in Brazil (AVISA) https://ClinicalTrials.gov/show/NCT04355338
NCT04358380 Liver Injury in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04358380
NCT04365166 Study of Clinical and Immune Severity Profiles of Patients Infected With SARS-Cov2 (COVID-19) https://ClinicalTrials.gov/show/NCT04365166
NCT04363333 Obstructive Sleep Apnea & Covid-19 Outcomes https://ClinicalTrials.gov/show/NCT04363333
NCT04359914 Neurocognitive Impairment in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04359914
NCT04357535 Prognosis of Coronavirus Disease 2019 (COVID-19) Patients Receiving Receiving Antihypertensives https://ClinicalTrials.gov/show/NCT04357535
NCT04357314 Myocardial Infarction Rates Overview During COVID-19 Pandemic In France: MODIF Study https://ClinicalTrials.gov/show/NCT04357314
NCT04356885 COVID-19 and Psychotic Symptoms in France https://ClinicalTrials.gov/show/NCT04356885
NCT04355871 Characteristics and Outcomes of Hospitalized Patients With COVID-19 in Spain https://ClinicalTrials.gov/show/NCT04355871
NCT04385069 COVID-19 Hyperinflammation Syndrome (COV-HI): Protocol for a Rapidly Executed Cohort Study https://ClinicalTrials.gov/show/NCT04385069
NCT04384029 The Geneva Covid-19 CVD Study https://ClinicalTrials.gov/show/NCT04384029
NCT04376853 CoronaWatch - Early Detection of Cardiovascular Risks in COVID-19 Via SmartWatch https://ClinicalTrials.gov/show/NCT04376853
NCT04374123 COVID-19 Serology Screening and Strict Protocol in the Endoscopy Unit https://ClinicalTrials.gov/show/NCT04374123
NCT04369690 The Psychological, Social, and Economic Impacts of COVID-19 https://ClinicalTrials.gov/show/NCT04369690
NCT04362345 Clinical Features and Risk Factors Associated With Worse Outcome in Patients Hospitalized for Covid-19 Pneumonia https://ClinicalTrials.gov/show/NCT04362345
NCT04361877 Cardiovascular Prevention During COVID-19 Pandemic Lockdown in Young Adults (COLA Trial) https://ClinicalTrials.gov/show/NCT04361877
NCT04360954 Evaluation of Antibody Tests for COVID-19 https://ClinicalTrials.gov/show/NCT04360954
NCT04359849 Sequencing and Tracking of Phylogeny in COVID-19 Study https://ClinicalTrials.gov/show/NCT04359849
NCT04359836 A Study to Explore the Role of Gut Flora in COVID-19 Infection https://ClinicalTrials.gov/show/NCT04359836
NCT04359407 Prone Positioning and Regional Ventilation in Mechanically Ventilated COVID-19 Patients https://ClinicalTrials.gov/show/NCT04359407
NCT04358536 Classification of COVID-19 Infection in Posteroanterior Chest X-rays https://ClinicalTrials.gov/show/NCT04358536
NCT04358510 COVID-19 Mortality Prediction Model https://ClinicalTrials.gov/show/NCT04358510
NCT04358029 Cardiac Arrhythmias In Patients With Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04358029
NCT04357938 Risk Stratification With Chest CT to Rule-out Suspected SARS-CoV-2 Infections https://ClinicalTrials.gov/show/NCT04357938
NCT04357574 Assessing the System for High-Intensity Evaluation During Radiotherapy During Changes in Response to COVID-19 https://ClinicalTrials.gov/show/NCT04357574
NCT04363047 Immune Cells in Inflammatory Arthritis With Coronaviruses, Including COVID-19 https://ClinicalTrials.gov/show/NCT04363047
NCT04375748 Hospital Registry of Acute Myocarditis: Evolution of the Proportion of Positive SARS-COV-2 (COVID19) Cases https://ClinicalTrials.gov/show/NCT04375748
NCT04403009 The Clinical Difference Between the Nonfatal Patients and the Fatal Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04403009
NCT04397835 Psychological Impact of COVID-19 Quarantine and Worsening of Cardiovascular Risk in the French General Population https://ClinicalTrials.gov/show/NCT04397835
NCT04366024 A Novel Nomogram to Predict Severity of COVID-19 https://ClinicalTrials.gov/show/NCT04366024
NCT04363008 COVID 19 Biomarkers https://ClinicalTrials.gov/show/NCT04363008
NCT04362956 Clinical and Immunologic Impact of Perinatal SARS-CoV-2 (COVID-19) Infection https://ClinicalTrials.gov/show/NCT04362956
NCT04360850 Use of Telehealth Technology by Mental Health Care Professionals in Times of COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04360850
NCT04359706 Bacterial and Fungal Microbiota of Patients With Severe Viral Pneumonia With COVID-19 https://ClinicalTrials.gov/show/NCT04359706
NCT04359693 Impact of COVID-19 Infection on the Incidence of Ventilator-acquired Infections https://ClinicalTrials.gov/show/NCT04359693
NCT04359212 Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19 https://ClinicalTrials.gov/show/NCT04359212
NCT04359121 COVID-19 and the Developement of Phobic Fears of Disease https://ClinicalTrials.gov/show/NCT04359121
NCT04358640 Anxiety and Work Resilience Among Tertiary University Hospital Workers During the COVID-19 Outbreak: An Online Survey https://ClinicalTrials.gov/show/NCT04358640
NCT04357431 COVID-19 Among Egyptian Health Care Providers https://ClinicalTrials.gov/show/NCT04357431
NCT04356365 The Mental Health Status of the General Population During the COVID-19 Pandemic and Its Association With Adherence to Government-initiated Non-pharmacological Epidemiological Interventions (NPI’s) https://ClinicalTrials.gov/show/NCT04356365
NCT04365959 The Prone Position in Covid-19 Affected Patients https://ClinicalTrials.gov/show/NCT04365959
NCT04393233 Drug Management of Rheumatoid Arthritis in Covid-19 Context : Impact on Therapeutic De-escalation https://ClinicalTrials.gov/show/NCT04393233
NCT04371848 Impact of the COVID-19 Pandemic on Diet Quality and Food Insecurity: a NutriQuébec Sub-study https://ClinicalTrials.gov/show/NCT04371848
NCT04371250 Study of Resilience and Loneliness in Youth (18 - 25 Years Old) During the COVID-19 Pandemic Lock-down Measures. https://ClinicalTrials.gov/show/NCT04371250
NCT04369807 Mapping Organ Health Following COVID-19 Disease Due to SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04369807
NCT04366934 Study of the Pathogenesis of Olfactory Disorders in COVID-19 https://ClinicalTrials.gov/show/NCT04366934
NCT04362995 St. Jude Tracking of Viral and Host Factors Associated With COVID-19 https://ClinicalTrials.gov/show/NCT04362995
NCT04362943 Clinical-epidemiological Characterization of COVID-19 Disease in Hospitalized Older Adults https://ClinicalTrials.gov/show/NCT04362943
NCT04361565 Frequency and Clinical Evolution of Olfactory and Taste Disorders in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04361565
NCT04361123 Atrium COVID-19 Syndromic and Serologic Surveillance https://ClinicalTrials.gov/show/NCT04361123
NCT04361019 Physical Activity in University Students Around COVID-19 Confinement https://ClinicalTrials.gov/show/NCT04361019
NCT04360733 Precision Immunology to Determine the Immune Response in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04360733
NCT04360707 Solid Organ Transplant Recipients With SARS-CoV-2 French Registry https://ClinicalTrials.gov/show/NCT04360707
NCT04360278 Plasma Collection From Convalescent and/or Immunized Donors for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04360278
NCT04360863 The Impact of COVID-19 Pandemic on the Smoking Behaviour of Young Smokers and the Youth Quitline Service in Hong Kong https://ClinicalTrials.gov/show/NCT04360863
NCT04396600 The Professional Peer Resilience Initiative https://ClinicalTrials.gov/show/NCT04396600
NCT04381286 Transpulmonary Driving Pressure in ARDS COVID19 Patients https://ClinicalTrials.gov/show/NCT04381286
NCT04368793 Clinical Effects of Internet Assisted Pulmonary Rehabilitation of COVID-2019 Pneumonia Patients After Discharge https://ClinicalTrials.gov/show/NCT04368793
NCT04366778 Thrombosis and Covid-19 https://ClinicalTrials.gov/show/NCT04366778
NCT04363788 Needle Stick Injuries in Emergency Medical Service Practice https://ClinicalTrials.gov/show/NCT04363788
NCT04363268 ACCESS A Master Digital Surveillance Protocol for COVID-19 https://ClinicalTrials.gov/show/NCT04363268
NCT04363099 Multicentre Observational Study on Management COVID 19 Positive Outpatients in a French Cluster. https://ClinicalTrials.gov/show/NCT04363099
NCT04362319 Burnout and Medical Errors in the Anaesthesiology Fraternity During Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04362319
NCT04362267 Longitudinal Study of Covid-19 Infection Among HCW in a French University Hospital https://ClinicalTrials.gov/show/NCT04362267
NCT04362150 Long-term Impact of Infection With Novel Coronavirus (COVID-19) https://ClinicalTrials.gov/show/NCT04362150
NCT04492943 To Observe Whether Isoflurane Can Treat COVID-19 Patients https://ClinicalTrials.gov/show/NCT04492943
NCT04377815 Finding Out if COVID-19 Infection Can be pREdicted by ChAnges in Smell and/or Taste https://ClinicalTrials.gov/show/NCT04377815
NCT04371315 Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children https://ClinicalTrials.gov/show/NCT04371315
NCT04370678 Changes in Preference for Surgery of Patients Signed up for Arthroscopic Procedures https://ClinicalTrials.gov/show/NCT04370678
NCT04368221 Characterization of Fungal Infections in COVID-19 Infected and Mechanically Ventilated Patients in ICU https://ClinicalTrials.gov/show/NCT04368221
NCT04366167 Patient Recovery From Heart Surgery During the Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04366167
NCT04365816 NutriCovid30 : Nutritional Evaluation for Covid-19 Infection at D30 https://ClinicalTrials.gov/show/NCT04365816
NCT04365595 SARS-CoV-2 Associated Respiratory Failure Recovery (COVID-19 CAir) https://ClinicalTrials.gov/show/NCT04365595
NCT04365335 Stress Biomarkers Leading to Professional Burnout Among People Involved in a Mobile Intensive Care Unit During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04365335
NCT04364698 Observational Cohort of COVID-19 Patients at Raymond-Poincare https://ClinicalTrials.gov/show/NCT04364698
NCT04362930 Cohort of Patients With Covid-19 Presenting Neurological or Psychiatric Disorders (CoCo-Neurosciences) https://ClinicalTrials.gov/show/NCT04362930
NCT04362865 Investigation of the B- and T-cell Repertoire and Immune Response in Patients With Acute and Resolved COVID-19 Infection https://ClinicalTrials.gov/show/NCT04362865
NCT04365361 The Psychological Impact of the COVID-19 on Students. https://ClinicalTrials.gov/show/NCT04365361
NCT04365764 Effect of Treatments in Patients Hospitalized for Severe COVID-19 Pneumonia: a Multicenter Cohort Study https://ClinicalTrials.gov/show/NCT04365764
NCT04365725 Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections https://ClinicalTrials.gov/show/NCT04365725
NCT04365634 A Single-center Retrospective Study to Find Prediction Factors Related to Mortality of COVID-19 Patients. https://ClinicalTrials.gov/show/NCT04365634
NCT04365348 The Psychological Impact of COVID-19 Outbreak on COVID-19 Survivors and Their Families https://ClinicalTrials.gov/show/NCT04365348
NCT04382534 A Cross-sectional and Cohort Study of COVID-19 Patients With Post - Discharge Dysfunction https://ClinicalTrials.gov/show/NCT04382534
NCT04368637 Acute Cardiovascular Events Triggered by COVID-19-Related Stress https://ClinicalTrials.gov/show/NCT04368637
NCT04367064 To Study the Clinical Characteristics and Treatment Outcome of COVID-19 Patients Admitted in Hospitals of Max Healthcare (SCOPe Study) https://ClinicalTrials.gov/show/NCT04367064
NCT04365881 Loneliness During the NPIs for the COVID-19 Pandemic in Norway: Risk Factors and Associations With Psychopathology https://ClinicalTrials.gov/show/NCT04365881
NCT04365530 Become of Patients Infected or Suspected of Being Infected by Covid-19 and Supported by the GHPSJ and the Establishments of the Paris Plaisance Hospital City https://ClinicalTrials.gov/show/NCT04365530
NCT04373811 One-Year Quality of Life and Functional Prognosis of COVID-19 Patients in Post-ICU Setting https://ClinicalTrials.gov/show/NCT04373811
NCT04604769 Perceived Stress Among ICU Medical Staff During COVID-19 Crisis https://ClinicalTrials.gov/show/NCT04604769
NCT04383470 Collaborative Outcomes Study on Health and Functioning During Infection Times During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04383470
NCT04368897 In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity https://ClinicalTrials.gov/show/NCT04368897
NCT04368351 Bacteriotherapy in the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04368351
NCT04367896 COVID-19 OUTBREAK AND SOLID ORGAN TRANSPLANTATION (SOT) : AN INTERNATIONAL WEB-BASED SURVEY https://ClinicalTrials.gov/show/NCT04367896
NCT04368026 SARS-CoV-2 (COVID-19) and Surgery https://ClinicalTrials.gov/show/NCT04368026
NCT04367805 COVID-19 Infection in Patients With Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT04367805
NCT04367792 Cardiac Injury in COVID-19: a Pathology Study https://ClinicalTrials.gov/show/NCT04367792
NCT04367740 ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19 https://ClinicalTrials.gov/show/NCT04367740
NCT04366752 Thrombo Embolic Events in Critical Care Patients With Covid-19 Serious Acute Pneumopathy https://ClinicalTrials.gov/show/NCT04366752
NCT04370171 Management of Diabetic Patients With Telemedicine in the Context of the Covid-19 Epidemic https://ClinicalTrials.gov/show/NCT04370171
NCT04375670 COVID19-FOIE National Observatory https://ClinicalTrials.gov/show/NCT04375670
NCT04371835 COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings https://ClinicalTrials.gov/show/NCT04371835
NCT04371354 Outcomes of Covid-19 Protective Measures in Endoscopy https://ClinicalTrials.gov/show/NCT04371354
NCT04369989 Observational Study of COVID-19 Treatment Efficacy https://ClinicalTrials.gov/show/NCT04369989
NCT04368208 Impact of Giving Birth During the Covid 19 Pandemia on Postnatal Women’s Depression https://ClinicalTrials.gov/show/NCT04368208
NCT04368390 Neuroradiolological Analysis of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04368390
NCT04368338 Lung Ultrasound to Diagnose COVID-19 https://ClinicalTrials.gov/show/NCT04368338
NCT04367883 Influenza Vaccination, ACEI and ARB in the Evolution of SARS-Covid19 Infection https://ClinicalTrials.gov/show/NCT04367883
NCT04367870 COVID-19 Detection Test in Oncology https://ClinicalTrials.gov/show/NCT04367870
NCT04367337 Health Behavior Change During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04367337
NCT04370249 Construction of a Composite Clinical-echo Score Predictive of a Risk of Short-term Aggravation of Respiratory Impairment in Patients Suspected of Covid-19 https://ClinicalTrials.gov/show/NCT04370249
NCT04385212 Outcomes in Hospitalized Older Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04385212
NCT04374422 COVID-19 Pandemic and Female Sexual Behavior https://ClinicalTrials.gov/show/NCT04374422
NCT04372576 Epidemiology and Outcome of Ventilator-associated Pneumonia Among Critically Ill COVID-19 Patients https://ClinicalTrials.gov/show/NCT04372576
NCT04372472 SQuISH-COVID: A Pilot Study https://ClinicalTrials.gov/show/NCT04372472
NCT04372056 The COVID-ICU Healthcare Professional Study https://ClinicalTrials.gov/show/NCT04372056
NCT04370275 Accuracy of Lung Ultrasound in the Diagnosis of covid19 Pneumonia https://ClinicalTrials.gov/show/NCT04370275
NCT04370210 Sleep Quality During COVID-19 Containment in Children Whether or Not Usually Followed in Child Psychiatry https://ClinicalTrials.gov/show/NCT04370210
NCT04370197 Covid-19 Epidemic on Acute Stroke Management https://ClinicalTrials.gov/show/NCT04370197
NCT04370119 Screening for SARS-CoV-2-Infections and Monitoring of Serological Responses to SARS-CoV-2 in Healthcare Workers https://ClinicalTrials.gov/show/NCT04370119
NCT04369859 Obstetric and Perinatal Outcomes of Women With COVID-19 https://ClinicalTrials.gov/show/NCT04369859
NCT04368884 Assess the Seroconversion Status of Health Care Workers Suspected or Confirmed Cases of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04368884
NCT04368871 Radiographic Findings and Their Temporal Changes in COVID-19 Positive Changes Patients: A Prospective Study https://ClinicalTrials.gov/show/NCT04368871
NCT04371432 Genetics of COVID-19 Susceptibility and Manifestations https://ClinicalTrials.gov/show/NCT04371432
NCT04376580 Use of the Nasal Cannula During COVID-19 https://ClinicalTrials.gov/show/NCT04376580
NCT04380987 Luxembourg Cohort of Positive Patients for COVID-19: a Stratification Study to Predict Patient Prognosis https://ClinicalTrials.gov/show/NCT04380987
NCT04379089 Neurologic Manifestations of COVID 19 in Children https://ClinicalTrials.gov/show/NCT04379089
NCT04377581 COVID-19 Health Messaging Efficacy and Its Impact on Public Perception, Anxiety, and Behavior https://ClinicalTrials.gov/show/NCT04377581
NCT04375761 COVID-19: Human Epidemiology and Response to SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04375761
NCT04375410 Consequences of Intensified Handwash and Hand Disinfection Among Children During the COVID19 Pandemic https://ClinicalTrials.gov/show/NCT04375410
NCT04374071 Early Short Course Corticosteroids in COVID-19 https://ClinicalTrials.gov/show/NCT04374071
NCT04373486 Incidence of Acute Pulmonary Embolism in Covid-19 Patients on CT Angiography and Relationship to D-dimer Levels https://ClinicalTrials.gov/show/NCT04373486
NCT04373005 Screening of Cancer Patients to Assess Impact of COVID-19 https://ClinicalTrials.gov/show/NCT04373005
NCT04371679 Changes in Cardiac and Pulmonary Hemodynamics as Predictor of Outcome in Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04371679
NCT04371562 Predicting Death and ICU Admission in COVID-19 Patients in ED https://ClinicalTrials.gov/show/NCT04371562
NCT04371471 Covid-19 Pandemic Triage Score https://ClinicalTrials.gov/show/NCT04371471
NCT04373148 Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19 https://ClinicalTrials.gov/show/NCT04373148
NCT04384471 Covid-19 Pandemic: Patients’ Experience in T1D https://ClinicalTrials.gov/show/NCT04384471
NCT04378777 Immunophenotyping Assessment in a COVID-19 Cohort https://ClinicalTrials.gov/show/NCT04378777
NCT04374838 Effect of COVID-19 Pandemic on Pediatric Cancer Care https://ClinicalTrials.gov/show/NCT04374838
NCT04374656 Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04374656
NCT04374058 Less Frequency Hemodialysis and COVID-19 https://ClinicalTrials.gov/show/NCT04374058
NCT04373798 C-reactive Protein Levels Among Individuals With COVID-19 https://ClinicalTrials.gov/show/NCT04373798
NCT04377035 The Role of Ultrasound in COVID-19 https://ClinicalTrials.gov/show/NCT04377035
NCT04377412 Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04377412
NCT04374617 Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04374617
NCT04374513 Community Pharmacists Behaviour During Covid-19 https://ClinicalTrials.gov/show/NCT04374513
NCT04374097 Level and Predictors of Trauma-symptoms Among Health Workers and Public Service Providers During the COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04374097
NCT04378829 Platelet Count, Platelet, Mean Platelet Volume and Platelet Distribution Width in COVID-19 https://ClinicalTrials.gov/show/NCT04378829
NCT04375176 Monocytes and NK Cells Activity in Covid-19 Patients https://ClinicalTrials.gov/show/NCT04375176
NCT04375137 Correlation Between Oxidative Stress Status and COVID-19 Severity https://ClinicalTrials.gov/show/NCT04375137
NCT04386083 Neurologic Manifestations of COVID-19 https://ClinicalTrials.gov/show/NCT04386083
NCT04381819 Norwegian SARS-CoV-2 Study - Virological, Clinical and Immunological Characterisation of COVID-19 https://ClinicalTrials.gov/show/NCT04381819
NCT04380896 COVID-19 Staff Testing of Antibody Responses Study (Co-Stars) https://ClinicalTrials.gov/show/NCT04380896
NCT04379466 Effector and Regulatory T Cell Receptor Repertoire Analyses in Patients Affected by COVID-19 https://ClinicalTrials.gov/show/NCT04379466
NCT04379310 Evaluation of Clinical Parameters on Admission and Medications in Covid-19 Pneumonia (Corona Virus Disease 2019) https://ClinicalTrials.gov/show/NCT04379310
NCT04379284 Risks of COVID19 in the Pregnant Population https://ClinicalTrials.gov/show/NCT04379284
NCT04379245 COVID-19 Infection in Patients Infected With HIV and/or on PrEP https://ClinicalTrials.gov/show/NCT04379245
NCT04379232 Surgical Activity During the Covid-19 Pandemic: Results for 112 Patients in a French Tertiary Care Center https://ClinicalTrials.gov/show/NCT04379232
NCT04377607 Haemoglobin Concentration on COVID-19 https://ClinicalTrials.gov/show/NCT04377607
NCT04377074 Parental Stress During the COVID-19 Pandemic and Its Association With Depression and Anxiety https://ClinicalTrials.gov/show/NCT04377074
NCT04376996 Slovenian National COVID-19 Prevalence Study https://ClinicalTrials.gov/show/NCT04376996
NCT04376944 Barrier Measures to Limit Covid-19.Nosocomial Transmission: a Cross-sectional Evaluation https://ClinicalTrials.gov/show/NCT04376944
NCT04376879 Predicting the Need for Intubation in Hospitalised COVID-19 Patients (PRED ICU COVID19) https://ClinicalTrials.gov/show/NCT04376879
NCT04376775 Assessment of the Impact of COVID-19 on Transplant Patients and on Patients Awaiting Transplantation https://ClinicalTrials.gov/show/NCT04376775
NCT04376710 Surgical Telemedicine in the COVID-19 Pandemic Era https://ClinicalTrials.gov/show/NCT04376710
NCT04375709 Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19); https://ClinicalTrials.gov/show/NCT04375709
NCT04375501 A Study of Outcomes in Patients With Fractured Neck of Femur During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04375501
NCT04382417 Prospective Observational Cohort Study of Critically Ill Patients With Covid-19 in Sweden https://ClinicalTrials.gov/show/NCT04382417
NCT04388813 Predictors of Severe COVID-19 Outcomes https://ClinicalTrials.gov/show/NCT04388813
NCT04410718 Glycaemia and Cardiac Function in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04410718
NCT04384419 Death Number Perception in Depression, Anxiety, and Schizoypal Personnality in General Population (Covid-19 Pandemic) https://ClinicalTrials.gov/show/NCT04384419
NCT04382469 Egyptian Initial Experience About 2019 Novel Corona Virus: Study of 48 Patients in Alexandria-Egypt Using Chest CT https://ClinicalTrials.gov/show/NCT04382469
NCT04380870 Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19 https://ClinicalTrials.gov/show/NCT04380870
NCT04379063 COVID-19 Pandemic Short Interval National Survey Gauging Psychological Distress https://ClinicalTrials.gov/show/NCT04379063
NCT04378881 Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Adults With Polypharmacy Using Data From Large Medicare and Commercially Insured Populations https://ClinicalTrials.gov/show/NCT04378881
NCT04378842 COVID-19 and ICU-acquired MDR Bacteria https://ClinicalTrials.gov/show/NCT04378842
NCT04378686 Serological Testing for COVID-19 (SARS-CoV-2) in ESKD https://ClinicalTrials.gov/show/NCT04378686
NCT04378595 Assessing Pediatric Food Insecurity During the COVID-19 Pandemic in Austin https://ClinicalTrials.gov/show/NCT04378595
NCT04378582 Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICU https://ClinicalTrials.gov/show/NCT04378582
NCT04377776 Observational Study Concerning COVID-19 Infection in Transplanted Kidney, Pancreas or Pancreatic Islet Patients https://ClinicalTrials.gov/show/NCT04377776
NCT04377763 Developement and Evaluation of Serological Assays for COVID-19 https://ClinicalTrials.gov/show/NCT04377763
NCT04377724 Spread and Course of COVID-19 Infections https://ClinicalTrials.gov/show/NCT04377724
NCT04377685 Prediction of Clinical Course in COVID19 Patients https://ClinicalTrials.gov/show/NCT04377685
NCT04377490 Thrombo Embolic Events in Hospitalized Patients With Covid-19 Serious Acute Pneumopathy https://ClinicalTrials.gov/show/NCT04377490
NCT04382235 Non-invasive Ventilatory Support of Patients Affected by COVID-19 https://ClinicalTrials.gov/show/NCT04382235
NCT04416347 COVID19 Clinical Predictors and Outcome https://ClinicalTrials.gov/show/NCT04416347
NCT04407156 Epidemiology of Acute Kidney Injury in COVID19 Disease in United Kingdom https://ClinicalTrials.gov/show/NCT04407156
NCT04393155 Longitudinal COVID-19 Cohort Study https://ClinicalTrials.gov/show/NCT04393155
NCT04386395 Immune Changes in Severe COVID-19 Pulmonary Infections https://ClinicalTrials.gov/show/NCT04386395
NCT04384705 HDL Target of CoViD19 ? Analysis on the Caregivers of the Reunion University Hospital https://ClinicalTrials.gov/show/NCT04384705
NCT04382781 Immunosupressive Treatment in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04382781
NCT04382508 Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults. https://ClinicalTrials.gov/show/NCT04382508
NCT04381273 Oral Health and Psychosocial Factors During the Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04381273
NCT04379297 COvid-19 National Survey for Assessing VIral Spread by Nonaffected CarriErs (CON-VINCE) https://ClinicalTrials.gov/show/NCT04379297
NCT04401254 Recovery of Patients From COVID-19 After Critical Illness https://ClinicalTrials.gov/show/NCT04401254
NCT04383899 Role of Ibuprofen and Other Medicines on Severity of Coronavirus Disease 2019 https://ClinicalTrials.gov/show/NCT04383899
NCT04383678 Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04383678
NCT04383652 Collection of Coronavirus COVID-19 Outbreak Samples in New South Wales https://ClinicalTrials.gov/show/NCT04383652
NCT04383483 CoV-ICU Score, Intensive Care Unit, SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04383483
NCT04381351 Noncoding RNAs in COVID-19 and COVID-19 Related Kidney Dysfunction https://ClinicalTrials.gov/show/NCT04381351
NCT04380792 Prevalence of DVT or PE in Patients Infected With COVID-19 Admitted to Hospital https://ClinicalTrials.gov/show/NCT04380792
NCT04380779 Prevalence of Severe Bleeding in COVID-19 Patients Treated With Higher Than Recommended Thromboprophylaxis Doses https://ClinicalTrials.gov/show/NCT04380779
NCT04380714 Changes in the Consumption of Psychoactive Substances During Containment Linked to COVID-19 https://ClinicalTrials.gov/show/NCT04380714
NCT04385251 International SARS-CoV-2 (COVID-19) Infection Observational Study https://ClinicalTrials.gov/show/NCT04385251
NCT04385004 Clinical, Biological and Histological Pulmonary and Renal Damage Associated With the SARS-CoV-2 Syndrome in Patients Admitted in ICU https://ClinicalTrials.gov/show/NCT04385004
NCT04384055 Predicting Outcomes for Covid-19 Using Sonography https://ClinicalTrials.gov/show/NCT04384055
NCT04383886 Evaluation of Emergency Department (ED) Staff Stress Level During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04383886
NCT04383730 Inhaled Sedation in COVID-19-related Acute Respiratory Distress Syndrome (ISCA): an International Research Data Study in the Recent Context of Widespread Disease Resulting From the 2019 (SARS-CoV2) Coronavirus Pandemics (COVID-19) https://ClinicalTrials.gov/show/NCT04383730
NCT04382794 Sitagliptin Treatment in Diabetic COVID-19 Positive Patients https://ClinicalTrials.gov/show/NCT04382794
NCT04382495 The Impact of COVID-19 Pandemic on Cancer Care https://ClinicalTrials.gov/show/NCT04382495
NCT04382196 Impact of COVID-19 on Mental Health of Health Care Workers https://ClinicalTrials.gov/show/NCT04382196
NCT04383444 Surveillance of Individuals Following SARS-CoV-2 Exposure https://ClinicalTrials.gov/show/NCT04383444
NCT04384250 Genetic Basis of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04384250
NCT04385238 Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04385238
NCT04384406 COVID-19 Outbreak Consequences for Outpatients Followed in PRM https://ClinicalTrials.gov/show/NCT04384406
NCT04383626 Fear Among Dentists During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04383626
NCT04431310 Seroconversion Among Staff at a Large Acute Care Hospital in Denmark During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04431310
NCT04409535 Effects of the COVID-19 Health Emergency on Biopsychosocial Health https://ClinicalTrials.gov/show/NCT04409535
NCT04389320 Antimalarial and Covid 19 in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT04389320
NCT04386720 Measurement of Airway Opening Pressure (AOP) in Patients With Acute Respiratory Distress Syndrom and With or Without Covid 19. https://ClinicalTrials.gov/show/NCT04386720
NCT04386564 Kidney Injury Severity and COVID-19 https://ClinicalTrials.gov/show/NCT04386564
NCT04386551 Detection of COVID-19 in Saliva Collection https://ClinicalTrials.gov/show/NCT04386551
NCT04385823 Use of High Flow Nasal Cannula Oxygen and Covid-19 Acute Hypoxemic Respiratory Failure https://ClinicalTrials.gov/show/NCT04385823
NCT04385160 Myeloproliferative Neoplasms (MPN) and COVID-19 https://ClinicalTrials.gov/show/NCT04385160
NCT04385147 Advanced Endoscopy During COVID-19 https://ClinicalTrials.gov/show/NCT04385147
NCT04384926 Outcomes of Elective Cancer Surgery During the COVID-19 Pandemic Crisis https://ClinicalTrials.gov/show/NCT04384926
NCT04384887 “Investigation of the Relationship Between New Coronary Virus Disease (COVID-19) and Anxiety and Depressive Symptoms in Pregnant Women” https://ClinicalTrials.gov/show/NCT04384887
NCT04387786 Dornase Alfa Administered to Patients With COVID-19 (DACOVID) https://ClinicalTrials.gov/show/NCT04387786
NCT04388670 Epidemiological and Clinical Characteristics of Critically Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04388670
NCT04388644 Survey of Satisfaction on Traditional Chinese Medicine Jing-Guan-Fang (JGF) for COVID-19 Prevention https://ClinicalTrials.gov/show/NCT04388644
NCT04388579 Screening Patients for a Strategic Shift to Pulmonary Telerehabilitation Because of COVID-19 https://ClinicalTrials.gov/show/NCT04388579
NCT04387968 Epidemiological Study of the Covid-19 Presto Test - The “COVIDOR” Study https://ClinicalTrials.gov/show/NCT04387968
NCT04387279 The Impact of COVID-19 on the Health Care Utilization of Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT04387279
NCT04387214 COVID-19 Pandemic and Academic Performance of Veterinary Students https://ClinicalTrials.gov/show/NCT04387214
NCT04386512 Clinical Epidemiology and Characteristics Of Covid-19 Cases Occurred In A Lymphoma Setting In The First Epidemic Phase (LymphoCov1) https://ClinicalTrials.gov/show/NCT04386512
NCT04386460 Covid-19 and Prevention of Malnutrition After Confinement by Dentists https://ClinicalTrials.gov/show/NCT04386460
NCT04406324 COVID-19: Respiratory and Sleep Follow-up https://ClinicalTrials.gov/show/NCT04406324
NCT04392401 COVID-19 - Study of the Kinetics of the Immune Response During the Intensive Care Unit Stay in Adult Patients Infected With SARS-CoV-2: Multicentric Non Interventional Study https://ClinicalTrials.gov/show/NCT04392401
NCT04389645 Interferon Gamma Induced Protein 10 (IP-10) in a Clinical Decision Support Protocol in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04389645
NCT04389567 Famotidine Outpatient COVID-19 Treatment Study https://ClinicalTrials.gov/show/NCT04389567
NCT04388657 COVID-19, bLOod Coagulation and Thrombosis https://ClinicalTrials.gov/show/NCT04388657
NCT04388618 Investigating Anosmia and Ageusia in COVID-19 Adult Patients in Saudi Arabia https://ClinicalTrials.gov/show/NCT04388618
NCT04387838 Study of the SARS-COV-2 (COVID-19) Serological Profile of an Army Training Hospital Staff https://ClinicalTrials.gov/show/NCT04387838
NCT04387799 Determinants of COVID-19 Pneumonia (MC-19) https://ClinicalTrials.gov/show/NCT04387799
NCT04387643 Protecting Health Care Workers During the COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04387643
NCT04387656 NCI COVID-19 in Cancer Patients, NCCAPS Study https://ClinicalTrials.gov/show/NCT04387656
NCT04410835 Psychological Impact of the Corona Virus (SARS-CoV-2) and COVID-19 Pandemic in Individuals With Psychiatric Disorders https://ClinicalTrials.gov/show/NCT04410835
NCT04393428 Urinary Biomarkers for AKI Diagnosis in Patients With SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04393428
NCT04392089 Effects of Cardiovascular and Pulmonary Optimization on Cerebral Oxygenation in COVID-19 Patients With Severe ARDS https://ClinicalTrials.gov/show/NCT04392089
NCT04391881 Oral Manifestation of COVID 19 Patient: A Cross Sectional Study on Egyptian Population https://ClinicalTrials.gov/show/NCT04391881
NCT04391738 Association Between BMI and COVID-19 https://ClinicalTrials.gov/show/NCT04391738
NCT04390126 COVID-19 Related Lockdown Effects On Chronic Diseases https://ClinicalTrials.gov/show/NCT04390126
NCT04390074 COVID-19 in the Swedish ICU-cohort: Risk Factors of Critical Care Admission and Intensive Care Mortality https://ClinicalTrials.gov/show/NCT04390074
NCT04389684 Clinical and Psycho-social Impact of COVID-19 Related Confinement on Patients With Digestive Tumors https://ClinicalTrials.gov/show/NCT04389684
NCT04389658 Contagiousness and Immunogenicity Status of COVID-19 in Asymptomatic Population (COVID-19 CONDITION) https://ClinicalTrials.gov/show/NCT04389658
NCT04389515 Postoperative Recovery Index, Patient Expectations and Satisfaction With Prenatal Care Instrument in Pregnant Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04389515
NCT04389489 Postpartum Sexual Function in Pregnant Women With COVID-19 https://ClinicalTrials.gov/show/NCT04389489
NCT04389463 Patient Outcome of Cardiac Surgery During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04389463
NCT04453670 Neuropathology in Adults Intensive Care Unit Patients With COVID 19 https://ClinicalTrials.gov/show/NCT04453670
NCT04395833 National Survey on the Lockdown of Children With Disabilities https://ClinicalTrials.gov/show/NCT04395833
NCT04394026 Imaging Feature of SARS-CoV2 Infection https://ClinicalTrials.gov/show/NCT04394026
NCT04393402 Lung Ultrasound Score in Covid 19 Infectious Disease in Critical Care (LUS-COVID19) https://ClinicalTrials.gov/show/NCT04393402
NCT04392245 Proctologic Practice and Covid-19 https://ClinicalTrials.gov/show/NCT04392245
NCT04392388 Health, Perception, Practices, Relations and Social Inequalities in the General Population During the Covid-19 Crisis https://ClinicalTrials.gov/show/NCT04392388
NCT04391166 Validity of at Home Visual Acuity Measurements for Telemedicine During Corona Virus (COVID-19) Pandemic https://ClinicalTrials.gov/show/NCT04391166
NCT04391816 COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study https://ClinicalTrials.gov/show/NCT04391816
NCT04394195 sFlt1: a Biomarker of Organ Dysfunction in Critically-ill Patients With COVID-19? https://ClinicalTrials.gov/show/NCT04394195
NCT04393805 Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO Study in Veneto https://ClinicalTrials.gov/show/NCT04393805
NCT04393558 Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms https://ClinicalTrials.gov/show/NCT04393558
NCT04396197 Physical Activity Levels in COVID-19 Patients Admitted to Intensive Care https://ClinicalTrials.gov/show/NCT04396197
NCT04414319 Severe Acute Respiratory Syndrome-Coronavirus-2 and Loss of Autonomy in the Elderly https://ClinicalTrials.gov/show/NCT04414319
NCT04410263 Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches https://ClinicalTrials.gov/show/NCT04410263
NCT04409197 Evaluation of Changes in Weight, Sleep, and Other Psycho-behavioural Parameters During Covid-19 Confinement in Subjects Monitored by the RNPC Network https://ClinicalTrials.gov/show/NCT04409197
NCT04401241 How Routine Biomarkers and Blood Leucocytes Count Can Assist Diagnosis of COVID-19 in Emergency Department https://ClinicalTrials.gov/show/NCT04401241
NCT04396353 EXercise TRAining and Sedentary Lifestyle on Clinical Outcomes in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04396353
NCT04395859 Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents https://ClinicalTrials.gov/show/NCT04395859
NCT04394429 Endotracheal Tube Obstruction in Covid-19 Patients Requiring Mechanical Ventilation https://ClinicalTrials.gov/show/NCT04394429
NCT04394078 Impact of COVID-19 Pandemic on Depression and Quality of Life https://ClinicalTrials.gov/show/NCT04394078
NCT04393974 COVID-19 and Cancer Patients https://ClinicalTrials.gov/show/NCT04393974
NCT04395482 Lung CT Scan Analysis of SARS-CoV2 Induced Lung Injury https://ClinicalTrials.gov/show/NCT04395482
NCT04396210 Patients Perspectives on Discontinuation of Their Fertility Treatment Due to the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04396210
NCT04517682 COVID-19 and SARS-CoV-2 Detection in Saliva https://ClinicalTrials.gov/show/NCT04517682
NCT04405466 A Study to Assess the Feasibility of Screening for SARS-CoV-2 Among Healthy Workers https://ClinicalTrials.gov/show/NCT04405466
NCT04397939 Myocardial Injury and Major Adverse Outcomes in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04397939
NCT04397900 Blood Collection Study From COVID-19 Convalescents Previously Hospitalized to Identify Immunogenic Viral Epitopes https://ClinicalTrials.gov/show/NCT04397900
NCT04397822 COVID-19: Study of INFLAmmasome and PLAtelets Functions https://ClinicalTrials.gov/show/NCT04397822
NCT04397588 Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19 https://ClinicalTrials.gov/show/NCT04397588
NCT04395924 Maternal-foetal Transmission of SARS-Cov-2 https://ClinicalTrials.gov/show/NCT04395924
NCT04395885 Sexual Function During COVID 19 Pandemic https://ClinicalTrials.gov/show/NCT04395885
NCT04395755 Impact of COVID-19 on Psychological Status in Case of IVF Interrupted or Postponed https://ClinicalTrials.gov/show/NCT04395755
NCT04395664 Arrhythmias in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04395664
NCT04395391 Home Usability Study of the SARS-CoV-2 (COVID-19) Test https://ClinicalTrials.gov/show/NCT04395391
NCT04395300 Sleep Quality in Healthcare Personnel During COVID-19 https://ClinicalTrials.gov/show/NCT04395300
NCT04394884 Pathogenesis of BTK-mediated Hyper-Inflammatory Responses in COVID-19 (RESPOND) https://ClinicalTrials.gov/show/NCT04394884
NCT04397848 Mental Health Outcomes in Healthcare Workers During COVID-19 https://ClinicalTrials.gov/show/NCT04397848
NCT04473105 Optimising Resource Allocation Via Prediction of Outcomes for Covid-19 https://ClinicalTrials.gov/show/NCT04473105
NCT04412460 Echocardiography in Patients With Covid-19 https://ClinicalTrials.gov/show/NCT04412460
NCT04411511 COVID-19, Obesity and Lifestyle in Children https://ClinicalTrials.gov/show/NCT04411511
NCT04403607 Cardiac Imaging in SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04403607
NCT04402905 Observational Study in Diagnosed Patients COVID-19, Supported on an Outpatient Basis. (COVID-PSL) https://ClinicalTrials.gov/show/NCT04402905
NCT04400812 Attitude and Perception Towards COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04400812
NCT04400461 Short-term Physical Function Outcomes in Severe COVID-19 Patients Admitted to ICU for Invasive Mechanical Ventilation https://ClinicalTrials.gov/show/NCT04400461
NCT04397614 Mobile Health Study and Enhanced Symptom Monitoring in COVID-19 Cancer Patients https://ClinicalTrials.gov/show/NCT04397614
NCT04397172 Intensive Care Associated Complications and Outcome of Acute Respiratory Distress Syndrome Due to COVID-19 https://ClinicalTrials.gov/show/NCT04397172
NCT04427280 Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04427280
NCT04425382 Darunavir/Cobicistat vs. Lopinavir/Ritonavir in COVID-19 Pneumonia in Qatar https://ClinicalTrials.gov/show/NCT04425382
NCT04408196 QoL and the Emotional-affective Sphere o in Rehabilitation Setting During COVID-19 Quarantine https://ClinicalTrials.gov/show/NCT04408196
NCT04403035 Comparison of the ID NOW and Accula Point-of-Care Assays for Detection of COVID-19 https://ClinicalTrials.gov/show/NCT04403035
NCT04401371 Distance Learning for Dental Student During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04401371
NCT04401228 Predictive Models for Intensive Care Admission and Death of COVID-19 https://ClinicalTrials.gov/show/NCT04401228
NCT04401085 COVID-19: Herd Immunity Study in the Czech Republic https://ClinicalTrials.gov/show/NCT04401085
NCT04400006 Ozone Therapy in the Prevention of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04400006
NCT04402229 Psychological Impact of the Covid-19 Pandemic on Student Nurses https://ClinicalTrials.gov/show/NCT04402229
NCT04401449 Cardiopulmonary Inflammation and Multi-System Imaging During the Clinical Course of COVID-19 Infection in Asymptomatic and Symptomatic Persons https://ClinicalTrials.gov/show/NCT04401449
NCT04410939 COVID-19 PCR Test Results in Asymptomatic Pregnants https://ClinicalTrials.gov/show/NCT04410939
NCT04409847 COVID-19 Blood Pressure Endothelium Interaction Study (OBELIX) https://ClinicalTrials.gov/show/NCT04409847
NCT04404062 Validation of COVID-19 Tests https://ClinicalTrials.gov/show/NCT04404062
NCT04402853 SARS Cov-2 in Conjunctival Secretion https://ClinicalTrials.gov/show/NCT04402853
NCT04402814 IgG/IgM Antibody Test in Patients Who Have Tested Negative or Positive for COVID-19 With the Standard Method of COVID19 Testing. https://ClinicalTrials.gov/show/NCT04402814
NCT04401436 COVID-19 Associated Lymphopenia Pathogenesis Study in Blood (CALYPSO) https://ClinicalTrials.gov/show/NCT04401436
NCT04401111 One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia (CO-Qo-ICU) https://ClinicalTrials.gov/show/NCT04401111
NCT04401098 Changing Of Egyptian Population Behaviour Towards COVID 19 Outbreak https://ClinicalTrials.gov/show/NCT04401098
NCT04401072 Attitude of Egyptian Population Toward COVID 19 in Ramadan https://ClinicalTrials.gov/show/NCT04401072
NCT04400877 Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04400877
NCT04403880 Characterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered From COVID-19 https://ClinicalTrials.gov/show/NCT04403880
NCT04556149 imPulseâ„¢ Una Full-spectrum, Over Clothing E-stethoscope https://ClinicalTrials.gov/show/NCT04556149
NCT04413071 Cardiac COVID-19 Health Care Workers https://ClinicalTrials.gov/show/NCT04413071
NCT04407299 COVID-19 Impact on Rheumatic Patients https://ClinicalTrials.gov/show/NCT04407299
NCT04406545 Microvascular Flow and Reactivity in Patients Presenting in the Acute Phase of COVID-19. https://ClinicalTrials.gov/show/NCT04406545
NCT04406233 Muscle Mass and Strength as Predictors of Time to Discharge in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04406233
NCT04403438 Familial Mediterranean Fever and Behçet: Analysis Before and After Covid19 Pandemic https://ClinicalTrials.gov/show/NCT04403438
NCT04403386 Prospective Natural History Study of Smoking, Immune Cell Profiles, Epigenetics and COVID-19 https://ClinicalTrials.gov/show/NCT04403386
NCT04403061 Th1/Th2/Th17/TREG and TLRs Activation/KIR for COVID 19 Prediction of Outcome https://ClinicalTrials.gov/show/NCT04403061
NCT04402827 Different Susceptibility to SARS CoV-2 Infection Among Health Care Workers Highly Exposed to COVID-19. https://ClinicalTrials.gov/show/NCT04402827
NCT04406558 Psychological Impact of the Health Measures Generated by the COVID19 in Adolescents https://ClinicalTrials.gov/show/NCT04406558
NCT04404179 Setting up a COVID-19 Care Facility at a Prison in Pakistan https://ClinicalTrials.gov/show/NCT04404179
NCT04403932 Increased Risk of Severe Coronavirus Disease 2019 in Patients With Vitamin D Deficiency https://ClinicalTrials.gov/show/NCT04403932
NCT04403828 Impact of COVID-19 on Personal Protection Among Dentist in Egypt https://ClinicalTrials.gov/show/NCT04403828
NCT04422262 Analysis of Long Term Risk of Coronavirus Disease-19 Emergency https://ClinicalTrials.gov/show/NCT04422262
NCT04413435 Clinical Characteristics of Critically Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04413435
NCT04410107 Lung Function, Exercise Capacity and Health-Related Quality of Life After Severe COVID-19 https://ClinicalTrials.gov/show/NCT04410107
NCT04408222 Awake Proning in COVID-19 Patients With Hypoxemic Respiratory Failure https://ClinicalTrials.gov/show/NCT04408222
NCT04407143 Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection https://ClinicalTrials.gov/show/NCT04407143
NCT04406844 Issues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04406844
NCT04405869 Thromboembolic Events in Severe COVID-19 Patients https://ClinicalTrials.gov/show/NCT04405869
NCT04405726 Prognostic Factors of COVID19 https://ClinicalTrials.gov/show/NCT04405726
NCT04404270 Study of SARS-CoV2 Virus (COVID-19) Seroprevalence in the Population of Creil Air Force Base (BA110) https://ClinicalTrials.gov/show/NCT04404270
NCT04404244 Extraordinary Measures for Egyptian Children With Hemato-Oncological Disorders During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04404244
NCT04405973 Clinical Scores for Outcome Prediction in Patients With Severe COVID-19 Pneumonia Requiring ECMO https://ClinicalTrials.gov/show/NCT04405973
NCT04405284 The Use of Disinfectants Among Women in Egypt and the Toxicity by Bleach During the Coronavirus Lock-down. https://ClinicalTrials.gov/show/NCT04405284
NCT04435106 Compassionate Use of Opaganib in Patients With Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04435106
NCT04416100 Development of Interstitial Lung Disease (ILD) in Patients With Severe SARS-CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04416100
NCT04411576 Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare https://ClinicalTrials.gov/show/NCT04411576
NCT04409899 The Utility of Enhanced Pre and Post-surgical Work-out to Prevent the Spread of COVID-19 in a Large Urology Department https://ClinicalTrials.gov/show/NCT04409899
NCT04408170 Facilitating AcceLerated Clinical Validation Of Novel Diagnostics for COVID-19 (FALCON-C19) https://ClinicalTrials.gov/show/NCT04408170
NCT04406090 Endovascular Thrombectomy in COVID-19 Infected Patients https://ClinicalTrials.gov/show/NCT04406090
NCT04406038 Study of the Spread of COVID-19 in Saint Petersburg, Russia https://ClinicalTrials.gov/show/NCT04406038
NCT04405232 Coagulopathy in COVID19 - A Multi-Centre Observational Study in UK https://ClinicalTrials.gov/show/NCT04405232
NCT04445259 Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19 and High Risk of Acute Kidney Injury https://ClinicalTrials.gov/show/NCT04445259
NCT04423640 Analysis of the Inflammatory Response and the Development of Humoral and Cellular Immunity in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04423640
NCT04414410 Echocardiography in Critically-ill Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04414410
NCT04412473 COVID-19 Respiratory Distress and Antithrombotic Drugs in Subject’s Habits https://ClinicalTrials.gov/show/NCT04412473
NCT04408378 Change in the Ratio of Mean Platelet Volume (MPV) to Platellet(PLT) in Covid-19 Pneumonia Patients https://ClinicalTrials.gov/show/NCT04408378
NCT04408326 Efficacy and Safety of Angiotensin II Use in Coronavirus Disease(COVID)-19 Patients With Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04408326
NCT04408248 AKI Biomarkers in Coronavirus(COVID)-19 https://ClinicalTrials.gov/show/NCT04408248
NCT04407663 Outpatient Clinic in Obesity Care During COVID-19 Outbreak: Physically Far, Virtually Near https://ClinicalTrials.gov/show/NCT04407663
NCT04407585 Testing the Accuracy of a Digital Test to Diagnose Covid-19 https://ClinicalTrials.gov/show/NCT04407585
NCT04407572 Evaluation of the Relationship Between Zinc Vitamin D and b12 Levels in the Covid-19 Positive Pregnant Women https://ClinicalTrials.gov/show/NCT04407572
NCT04407559 COVID-SErology in Rheumatoid Arthritis (COVID-19) https://ClinicalTrials.gov/show/NCT04407559
NCT04407546 Role of Children in Transmission of COVID-19 to Immunocompromised Patients https://ClinicalTrials.gov/show/NCT04407546
NCT04407533 Dietary Intake and Eating Habits During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04407533
NCT04407494 Diagnostic Value of Patient - Reported and Clinically Verified Olfactory Disorders (COVID-19) https://ClinicalTrials.gov/show/NCT04407494
NCT04407468 Awake Prone Positioning and Oxygen Therapy in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04407468
NCT04407429 Vienna Versus SARS-CoV-2 Virus Study https://ClinicalTrials.gov/show/NCT04407429
NCT04407273 STATIN THERAPY AND COVID-19 INFECTION https://ClinicalTrials.gov/show/NCT04407273
NCT04407260 The Use of Oxygen Hoods as Compared to Conventional High-flow Oxygen Delivery Systems, the Effects on Oxygenation, Mechanical Ventilation and Mortality Rates in Hypoxic Patients With COVID-19. A Prospective Controlled Cohort Study. https://ClinicalTrials.gov/show/NCT04407260
NCT04407195 COVID-19 and Mental Health https://ClinicalTrials.gov/show/NCT04407195
NCT04407117 Appendicitis During the National Lockdown During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04407117
NCT04406571 Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer https://ClinicalTrials.gov/show/NCT04406571
NCT04407598 COPD in the Time of COVID-19 https://ClinicalTrials.gov/show/NCT04407598
NCT04413058 Menstrual Cycle Characteristics of Healthcare Professionals https://ClinicalTrials.gov/show/NCT04413058
NCT04418609 Neuro-COVID-19: Neurological Complications of COVID-19 https://ClinicalTrials.gov/show/NCT04418609
NCT04425213 Obesity and Mortality of Critically Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04425213
NCT04409275 LUNG FIBROTIC CHANGES ASSOCIATED WITH SARS-CoV-2 INFECTION https://ClinicalTrials.gov/show/NCT04409275
NCT04409249 Prognosis in Pregnant With COVID-19 https://ClinicalTrials.gov/show/NCT04409249
NCT04408001 Study of Kinetics and Efficacy of the Immune Response Against COVID-19 Among Hospital Staff https://ClinicalTrials.gov/show/NCT04408001
NCT04407923 Drug Management of Juvenile Idiopathic Arthritis in Covid-19 Context : Impact on Therapeutical Managment https://ClinicalTrials.gov/show/NCT04407923
NCT04416373 COVID-19 and Pregnancy Outcomes https://ClinicalTrials.gov/show/NCT04416373
NCT04416256 COVID-19 Pandemic and Worldwide Organ Procurement https://ClinicalTrials.gov/show/NCT04416256
NCT04412031 Prediction of Unfavourable Outcome in Newly Covid-19 Hospitalized Patient https://ClinicalTrials.gov/show/NCT04412031
NCT04411784 PROTECT-ASUC: Covid-19 Pandemic Response Of assessmenT, EndosCopy and Treatment in Acute Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT04411784
NCT04411459 Risk Factors for Prolonged Invasive Mechanical Ventilation in COVID-19 Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04411459
NCT04410484 PREPARE-IBD: Physician Responses to Disease Flares and Patient Adaptation in Relation to Events in Inflammatory Bowel Disease During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04410484
NCT04581070 The COVID-IYON Study - Study Examining Data Pertaining to Clinical Outcomes and Organisational Responses to the 2020 SARS-CoV-2 Pandemic" https://ClinicalTrials.gov/show/NCT04581070
NCT04410432 Immune Response and Risk of Serious Infection to SARS-Cov2 https://ClinicalTrials.gov/show/NCT04410432
NCT04412304 Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients https://ClinicalTrials.gov/show/NCT04412304
NCT04412278 Impact of COVID-19 Pandemic on Perceived Exercise Benefits and Barriers https://ClinicalTrials.gov/show/NCT04412278
NCT04412265 Frailty in Elderly Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04412265
NCT04411147 A Longitudinal Study of COVID-19 Sequelae and Immunity https://ClinicalTrials.gov/show/NCT04411147
NCT04448418 The Impact of COVID-19 Outbreak on Trans-population’s Health in Italy https://ClinicalTrials.gov/show/NCT04448418
NCT04416061 The Role of a Private Hospital in Hong Kong Amid COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04416061
NCT04413045 Novel COVID-19, A National Analysis https://ClinicalTrials.gov/show/NCT04413045
NCT04412746 Covid-19 and Diabetes in West of Algeria https://ClinicalTrials.gov/show/NCT04412746
NCT04412655 Primary Angioplasty for STEMI During COVID-19 Pandemic (ISACS-STEMI COVID-19) Registry https://ClinicalTrials.gov/show/NCT04412655
NCT04418544 Vocal Feature Analysis Algorithm for COVID-19 Detection https://ClinicalTrials.gov/show/NCT04418544
NCT04418375 Establishment of a Biological Collection During COVID-19 Serological Screening in APHP Professionals (COVID-HOP) https://ClinicalTrials.gov/show/NCT04418375
NCT04418193 Patient Preference Trial for COVID-19 (PPT-COVID) https://ClinicalTrials.gov/show/NCT04418193
NCT04414657 USZ BioResource COVID https://ClinicalTrials.gov/show/NCT04414657
NCT04443075 Alterations of Gut Microbiome in the Frontline Medical Staff Under the Stress https://ClinicalTrials.gov/show/NCT04443075
NCT04422535 Effects on the Qt Interval of COVID-19 Coronavirus Infection https://ClinicalTrials.gov/show/NCT04422535
NCT04418284 Online Learning of Veterinary Anatomy During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04418284
NCT04417374 Caracteristics of the Patients Hospitalized With Unvonluntary Commitment Procedure, in the Context COVID-19 https://ClinicalTrials.gov/show/NCT04417374
NCT04416438 COVID-19 Epidemic and Patients With Myeloproliferative Neoplasias https://ClinicalTrials.gov/show/NCT04416438
NCT04422418 Impact of Burnout on Cardiovascular and Immune Biomarkers in Healthcare Professionals - Covid-19 Pandemic in Abu Dhabi https://ClinicalTrials.gov/show/NCT04422418
NCT04424992 The Natural History of Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04424992
NCT04422769 Needs of Persons With Spinal Cord Injury (SCI) https://ClinicalTrials.gov/show/NCT04422769
NCT04420637 Impact of the Covid-19 Pandemic on Gastrointestinal and Liver Diseases https://ClinicalTrials.gov/show/NCT04420637
NCT04420416 Mental Health and Academic Performance in COVID-19 https://ClinicalTrials.gov/show/NCT04420416
NCT04419571 Outcomes in Emergency Laparotomies During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04419571
NCT04419545 Covid Radiographic Images Data-set for A.I https://ClinicalTrials.gov/show/NCT04419545
NCT04418245 CT Biomarkers Identification by Artificial Intelligence for COVID-19 Prognosis https://ClinicalTrials.gov/show/NCT04418245
NCT04422873 The Impact of COVID-19 on Dialysis Users https://ClinicalTrials.gov/show/NCT04422873
NCT04427345 Predictive Factors COVID-19 Patients https://ClinicalTrials.gov/show/NCT04427345
NCT04422691 Ultrasonography in Norwegian Emergency Department Patients With Suspected Covid-19 Infection https://ClinicalTrials.gov/show/NCT04422691
NCT04424355 Magnetic Resonance Imaging to Detect Signs of Viral Pneumonia in Patients With Coronavirus Infection. https://ClinicalTrials.gov/show/NCT04424355
NCT04423315 Thrombosis Risk Assessment and Clinical Presentation of Covid-19 Pneumonia https://ClinicalTrials.gov/show/NCT04423315
NCT04420312 Prevalence and Characteristics of Pulmonary Embolism on COVID-19 Patients Presenting Respiratory Symptoms https://ClinicalTrials.gov/show/NCT04420312
NCT04420286 Study of the Increase in ICU Beds Capacity During COVID-19 Pandemic in France https://ClinicalTrials.gov/show/NCT04420286
NCT04419870 Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity During the COVID19 Pandemic https://ClinicalTrials.gov/show/NCT04419870
NCT04425889 COVID-19 Antibodies Among Healthcare Workers https://ClinicalTrials.gov/show/NCT04425889
NCT04434014 Proper Nutrition And Its Relation To Oral Diseases In Covid -19 Era https://ClinicalTrials.gov/show/NCT04434014
NCT04427969 Early Prone Position on Coronavirus Disease 2019 Pneumonia https://ClinicalTrials.gov/show/NCT04427969
NCT04424836 HFNC Treatment in COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04424836
NCT04424771 Post-traumatic Stress Disease in Health Workers During COVID-19 Pandemia https://ClinicalTrials.gov/show/NCT04424771
NCT04423692 Knowledge About Covid-19 Infection in Pregnant Women https://ClinicalTrials.gov/show/NCT04423692
NCT04422522 Fibromyalgia During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04422522
NCT04426266 Psychological Effects of the COVID-19 Pandemic on the Hungarian Adult Population https://ClinicalTrials.gov/show/NCT04426266
NCT04425863 Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of Covid 19 https://ClinicalTrials.gov/show/NCT04425863
NCT04425850 USEFULNESS of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid 19 https://ClinicalTrials.gov/show/NCT04425850
NCT04424849 Thorax Computed Tomography Severity Score and Outcome in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04424849
NCT04424017 Sero-prevalence of Coronavirus Disease 2019 (COVID-19) in Healthcare Workers https://ClinicalTrials.gov/show/NCT04424017
NCT04423978 Implications of Covid-19 on the Lifestyle Changes https://ClinicalTrials.gov/show/NCT04423978
NCT04423770 COVID-19 Related Health and Infection Control Practices Among Dentists https://ClinicalTrials.gov/show/NCT04423770
NCT04422574 COVID 19 Serology in Pulmonologists https://ClinicalTrials.gov/show/NCT04422574
NCT04422340 Senior-COVID-Rea Multicentric Survey https://ClinicalTrials.gov/show/NCT04422340
NCT04424004 MURDOCK Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study https://ClinicalTrials.gov/show/NCT04424004
NCT04433260 COVID19 and Physical and Emotional Wellbeing of HCP https://ClinicalTrials.gov/show/NCT04433260
NCT04427735 Effect of Covid-19 Epidemic on Primary PCI in Patients With STEMI https://ClinicalTrials.gov/show/NCT04427735
NCT04426279 Morbimortality of Covid-19 in Patients With Chronic Inflammatory Rheumatism Treated With Immunosuppressants https://ClinicalTrials.gov/show/NCT04426279
NCT04426253 Identification of Genetic Factors Determining Disease Course in the New Type of Coronavirus Infection, COVID-19 https://ClinicalTrials.gov/show/NCT04426253
NCT04425044 AiM Covid Self Monitoring https://ClinicalTrials.gov/show/NCT04425044
NCT04424446 Saliva as Source of Detection for SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04424446
NCT04431414 A Study of Immune Responses to the Virus That Causes COVID-19 https://ClinicalTrials.gov/show/NCT04431414
NCT04558437 COVID-Impact “Psychological IMPACT of Covid-19 on AP-HP Staff” https://ClinicalTrials.gov/show/NCT04558437
NCT04431284 Impact of COVID-19 Lockdown on Obesity and Eating Behaviors https://ClinicalTrials.gov/show/NCT04431284
NCT04438239 Rehabilitation Needs After COVID-19 Hospital Treatment https://ClinicalTrials.gov/show/NCT04438239
NCT04427358 RT-PCR SARS-CoV-2 at 1 Month of COVID-19 Infection in the Geriatric Population https://ClinicalTrials.gov/show/NCT04427358
NCT04430023 Epidemiological and Demographic Data From 150 Patients Diagnosed With Coronavirus Disease 2019 Pneumonia https://ClinicalTrials.gov/show/NCT04430023
NCT04429620 Prospective Assay for SARS-CoV-2 (COVID-19) Antibody Detection Indirectly by Immunofluorescence: SARS-CoV2 IIF Method https://ClinicalTrials.gov/show/NCT04429620
NCT04427267 Assessment of Thermal Condition of Health Workers Who Use Personal Protective Equipment From Biological Hazards During Their Work With COVID-19 Patients https://ClinicalTrials.gov/show/NCT04427267
NCT04427176 Evaluation of ARFC Masks Equipped With CF5 Filter in the Care Unit to Allow a Wider Distribution of FFP2 Masks (Covid-19). https://ClinicalTrials.gov/show/NCT04427176
NCT04427332 Smell and Taste Disorders in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04427332
NCT04447222 Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors https://ClinicalTrials.gov/show/NCT04447222
NCT04430322 Covid-19 at the Regional Medical Center Metz-Thionville: a Descriptive Study https://ClinicalTrials.gov/show/NCT04430322
NCT04430062 Short-term Outcome of Covid-19 Surgical Patients: Case-series of a High-risk Area Community Hospital https://ClinicalTrials.gov/show/NCT04430062
NCT04459975 Acute Kidney Injury and Renal Outcomes for COVID-19 Patients in Intensive Care Units https://ClinicalTrials.gov/show/NCT04459975
NCT04441502 Identification of Predictors for the Evolution of COVID-19 Related Pneumonia by Transcriptomic and Seroproteomic https://ClinicalTrials.gov/show/NCT04441502
NCT04436484 Immune Biomarkers of Outcome From COVID-19 https://ClinicalTrials.gov/show/NCT04436484
NCT04435119 Covid-19 and Vitamin D in Nursing-home https://ClinicalTrials.gov/show/NCT04435119
NCT04434157 Association of the Neutrophil/Lymphocyte Ratio With Clinical Complications and Mortality in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04434157
NCT04433754 The Development of Pancreatic Injury in the Course of Severe Acute Respiratory Syndrome Coronavirus 2 Infection https://ClinicalTrials.gov/show/NCT04433754
NCT04433000 Reliability of a Pocket Sized Ultrasound Scanner in the Evaluation Covid-19 Pneumonia https://ClinicalTrials.gov/show/NCT04433000
NCT04432870 Patients’ Preferences About Rescheduling Colonoscopies Delayed Due to COVID-19: Cross Sectional Study https://ClinicalTrials.gov/show/NCT04432870
NCT04431908 Validation of a Rapid Quantitative Test for Loss of Smell in COVID-19 Subjects https://ClinicalTrials.gov/show/NCT04431908
NCT04435327 Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19) https://ClinicalTrials.gov/show/NCT04435327
NCT04434118 Anti-rheumatic Drug Use and Risk of COVID-19 Infection in Rheumatoid Arthritis Patients https://ClinicalTrials.gov/show/NCT04434118
NCT04433039 COVID19 Versus H1N1: Radiological Challenge During Next Influenza Season Rising https://ClinicalTrials.gov/show/NCT04433039
NCT04432948 Maternal Psychological Implications of Covid-19 Pandemic and Possible Effect on Anaesthetic Management. https://ClinicalTrials.gov/show/NCT04432948
NCT04456010 COVID-19 in ART: Perception and Experience https://ClinicalTrials.gov/show/NCT04456010
NCT04451694 Nutritional Follow up After Hospital Discharge for Coronavirus Disease-19 https://ClinicalTrials.gov/show/NCT04451694
NCT04432922 Perceptions, Representations and Experiences of Septic Isolation of Hospitalized Patients for COVID-19 Infection https://ClinicalTrials.gov/show/NCT04432922
NCT04438967 Brain Health in the Time of COVID-19 https://ClinicalTrials.gov/show/NCT04438967
NCT04437121 Dietary and Lifestyle Habits During the Pandemic of COVID-19 in Greece https://ClinicalTrials.gov/show/NCT04437121
NCT04435080 Physical Rehabilitation in ICU in ARDS Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04435080
NCT04435028 Ketotifen: as a Cardioprotective Agent in Breast Cancer Patients Receiving Anthracycline-containing Chemotherapy https://ClinicalTrials.gov/show/NCT04435028
NCT04437342 Postpartum Depression in the Covid-19 Pandemic and the Impact of Anaesthesia https://ClinicalTrials.gov/show/NCT04437342
NCT04434261 Oncological Surgery in Times of COVID-19: Effectiveness of Preoperative Screening for Sars-Cov-2 https://ClinicalTrials.gov/show/NCT04434261
NCT04444609 PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected Cohort https://ClinicalTrials.gov/show/NCT04444609
NCT04443712 Screening for Patients Admitted to Ain-Shams University Hospitals for SARS-COV-2 (COVID19) https://ClinicalTrials.gov/show/NCT04443712
NCT04441489 Assessment of Lung Inflammation With FDG PET/CT in COVID-19 https://ClinicalTrials.gov/show/NCT04441489
NCT04438629 Evaluation of Immune Response in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04438629
NCT04435223 Lipid Metabolism in COVID-19 Severe Pneumonia Compared With Severe Pneumonia Caused by Other Pathogen https://ClinicalTrials.gov/show/NCT04435223
NCT04448782 Characterization of Reverse Triggering and Other Asynchronies in COVID-19 Patients Under Invasive Mechanical Ventilation https://ClinicalTrials.gov/show/NCT04448782
NCT04447209 Dietary Diversity of Young Children During CoVID-19 Outbreak: A Longitudinal Study https://ClinicalTrials.gov/show/NCT04447209
NCT04441476 Ethical and Psychological Support for Health Care Professions in Intensive Care Units in the COVID19 Pandemic Context: Adequacy With Needs and Psychological Impact Crisis and Post-crisis https://ClinicalTrials.gov/show/NCT04441476
NCT04439084 COVID-19 in Patients With Chronic Liver Diseases https://ClinicalTrials.gov/show/NCT04439084
NCT04438954 Investigation of Fatigue, Physical Activity, Sleep Quality and Anxiety Levels https://ClinicalTrials.gov/show/NCT04438954
NCT04438941 Contribution of a Prone Team in Intensive Care During the Covid-19 Epidemic https://ClinicalTrials.gov/show/NCT04438941
NCT04438863 Daily Home Spirometry for Early Detection of Pulmonary Complications in Patients With COVID19 https://ClinicalTrials.gov/show/NCT04438863
NCT04437940 Evaluation of Vaginal Fluid for Covid-19 Positivity in Women With Positive Nasofarengeal Covid-19 Test https://ClinicalTrials.gov/show/NCT04437940
NCT04447131 Effect of COVID-19 on Platelet Aggregation https://ClinicalTrials.gov/show/NCT04447131
NCT04624997 Coagulopathy and Vasculopathy Assessment as a Predictor of the Severity of SARS-CoV-2 / COVID-19 Infection https://ClinicalTrials.gov/show/NCT04624997
NCT04587375 Diagnosis of Endocrine Dysfunctions in Covid-19 https://ClinicalTrials.gov/show/NCT04587375
NCT04459351 PHenotyping patiENts Admitted to Hospital With cOvid-19 Infection and idenTifYing Prognostic markErs https://ClinicalTrials.gov/show/NCT04459351
NCT04448717 Longitudinal Study of Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in School Children https://ClinicalTrials.gov/show/NCT04448717
NCT04442789 Sequelae of Sars-CoV-2 Infections https://ClinicalTrials.gov/show/NCT04442789
NCT04441814 FOUND - Ancillary Study to Smile Protocol NCT03654105 https://ClinicalTrials.gov/show/NCT04441814
NCT04440098 Isolated During COVID-19: Effects of COVID-19’s Social Restrictions on Loneliness and Psychosocial Symptomatology https://ClinicalTrials.gov/show/NCT04440098
NCT04438993 The COVID-19 Disease and CARdiac Events Study https://ClinicalTrials.gov/show/NCT04438993
NCT04462120 IL-12RB and TNF-alpha Gene Polymorphism and Susceptibility and Progress of Covid-19 SARS-CoV-2: A Case Control Study https://ClinicalTrials.gov/show/NCT04462120
NCT04448405 Covid-19 Lockdown and Deviant Sexual Fantasies https://ClinicalTrials.gov/show/NCT04448405
NCT04445506 Short Term Corticosteroids in SARS-CoV2 Patients https://ClinicalTrials.gov/show/NCT04445506
NCT04444661 Effects of COVID-19 Induced Deconditioning After Long-term High Intensity Resistance Exercise https://ClinicalTrials.gov/show/NCT04444661
NCT04490811 Seroprevalence and Immunoprotection Against COVID-19 in Parisian Children https://ClinicalTrials.gov/show/NCT04490811
NCT04443257 REassessement After Hospitalization for Sars-COV-2 disordER https://ClinicalTrials.gov/show/NCT04443257
NCT04446169 COVID-19 (SARS-CoV-2) in Urine and Semen https://ClinicalTrials.gov/show/NCT04446169
NCT04452682 The Impact of COVID-19 Pandemic on Critical Limb Threatening Ischemia and Emergency Vascular Practice https://ClinicalTrials.gov/show/NCT04452682
NCT04444557 Effect of COvid-19 on Mental Health in Syrian and Turkish Maintenance HemoDialysis Patients: COST-HD Study https://ClinicalTrials.gov/show/NCT04444557
NCT04468308 VRQOL in Cataract Patients During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04468308
NCT04459533 Sparing in Neuromuscular Blockade in COVID 19 ICU https://ClinicalTrials.gov/show/NCT04459533
NCT04446338 Immune Status SARS-CoV-2 in a Sample of a Tertiary Eye Health Centre https://ClinicalTrials.gov/show/NCT04446338
NCT04445961 Respiratory Mechanics and Gas Exchange in Patients With COVID-19 and Hypoxemic Acute Respiratory Failure https://ClinicalTrials.gov/show/NCT04445961
NCT04445441 An Observational Study to Assess the Protocol for the COVID-19 Treatment in Burkina Faso https://ClinicalTrials.gov/show/NCT04445441
NCT04445233 COVID-19 Household Transmission Study https://ClinicalTrials.gov/show/NCT04445233
NCT04444531 Ozone Therapy and Coronavirus Disease of 2019 (COVID-19) Pneumonia https://ClinicalTrials.gov/show/NCT04444531
NCT04444401 Registry on NEN Patients and COVID-19 https://ClinicalTrials.gov/show/NCT04444401
NCT04516486 Coronavirus Studied by Metagenomics in ARDS COVID-19 Patients https://ClinicalTrials.gov/show/NCT04516486
NCT04452487 Study of the Consequences of Infection on Compliance of Modalities of Decisions of Limitations and Stops of Treatments (COVID-19-LAT) https://ClinicalTrials.gov/show/NCT04452487
NCT04452422 Deep Venous Thrombosis in Non-severe COVID-19 Patients Hospitalized for a Neurovascular Pathology https://ClinicalTrials.gov/show/NCT04452422
NCT04450017 Clinical Features of Severe Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04450017
NCT04449978 TARGet Kids! COVID-19 Study of Children and Families https://ClinicalTrials.gov/show/NCT04449978
NCT04449783 Preoperative Shielding and N/T RT-PCR Swabbing for Elective Cancer Surgery https://ClinicalTrials.gov/show/NCT04449783
NCT04448054 Imaging SARS-CoV-2 Involvement of Leptomeninges, Olfactory and Limbic Areas https://ClinicalTrials.gov/show/NCT04448054
NCT04447144 Nutritional Habits, and Coronavirus Disease 2019 (COVID-19) Outcome https://ClinicalTrials.gov/show/NCT04447144
NCT04446286 Bicentric Study on the Use of ECMO-VV or VA for Severe ARDS Associated With Covid-19 https://ClinicalTrials.gov/show/NCT04446286
NCT04445870 Oncology Care Pathway’s Modifications Impact During COVID-19 Pandemic : the ONCOCARE-COV Study https://ClinicalTrials.gov/show/NCT04445870
NCT04449731 Changes in Dietary Behaviours During the COVID-19 Outbreak Confinement in the Adult Population (COVIDiet_Int) https://ClinicalTrials.gov/show/NCT04449731
NCT04466839 Evaluation of the Containment Impact Linked to the Covid-19 Pandemic in a Population of Parkinson Patients https://ClinicalTrials.gov/show/NCT04466839
NCT04448145 Determinants of SARS-COV2 (COVID-19) Persistence After Convalescence https://ClinicalTrials.gov/show/NCT04448145
NCT04447638 Percutaneous Tracheostomy With COVID-19 https://ClinicalTrials.gov/show/NCT04447638
NCT04493307 The Evaluation of Hemostasis in Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04493307
NCT04453527 The CASCADE Study - Measures of Complement Activation and Inflammation in Patients With Covid-19 https://ClinicalTrials.gov/show/NCT04453527
NCT04453501 Anti Infective Agents Impact in COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04453501
NCT04451577 Epidemiologic, Clinical, Molecular Characteristics of Hospital Employees With or Without Covid-19 Infection https://ClinicalTrials.gov/show/NCT04451577
NCT04449094 Emergence of the COVID 19 Epidemic in the City of Nice https://ClinicalTrials.gov/show/NCT04449094
NCT04449081 Knowledge, Attitude and Practice of Dental Students About COVID-19 https://ClinicalTrials.gov/show/NCT04449081
NCT04448704 Understanding the Mental Health of Migrant Workers During the COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04448704
NCT04452617 Safety of Short-term Hydroxychloroquine Plus Azithromycin Treatment in Critically Ill Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04452617
NCT04452630 Cardiovascular Consequences After COVID-19 https://ClinicalTrials.gov/show/NCT04452630
NCT04451993 Physical Activity Level in Patients With OSAS During Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04451993
NCT04451317 Physical Activity Following the Containment Period Imposed by the COVID-19 Pandemic in Patients https://ClinicalTrials.gov/show/NCT04451317
NCT04458337 SURgical Outcomes in COvid Patients - the SUROCO Multicenter Cohort Study (COVID-19) https://ClinicalTrials.gov/show/NCT04458337
NCT04459819 Respiratory Physiotherapy in Severe COVID-19 Patients https://ClinicalTrials.gov/show/NCT04459819
NCT04497779 Analysis of Coronavirus Disease 19 (COVID-19) Convalescent Plasma https://ClinicalTrials.gov/show/NCT04497779
NCT04474249 Follow-up of Critical COVID-19 Patients https://ClinicalTrials.gov/show/NCT04474249
NCT04469153 Interest of the Dosage of Ferritin / Glycosylated Ferritin in COVID-19 https://ClinicalTrials.gov/show/NCT04469153
NCT04463628 Impacts of the Covid-19 Epidemic and Associated Lockdown Measures on the Management, Health and Behaviors of Cystic Fibrosis Patients During the 2020 Epidemic https://ClinicalTrials.gov/show/NCT04463628
NCT04456075 Risk Prediction and Therapy Monitoring in Patients With SARS-Cov-2 Infection / COVID 19 https://ClinicalTrials.gov/show/NCT04456075
NCT04453982 Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1b https://ClinicalTrials.gov/show/NCT04453982
NCT04453969 Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1a https://ClinicalTrials.gov/show/NCT04453969
NCT04453566 Effect of COVID-19 Pandemic on Perceived Stress, Anxiety, Mood, and Training Quality in Elite Athletes. https://ClinicalTrials.gov/show/NCT04453566
NCT04452708 HFNC and NIV for COVID-19 Complicated by Respiratory Failure https://ClinicalTrials.gov/show/NCT04452708
NCT04452695 Acceptability of Telehealth Triage Using Robotic Systems in COVID-19 https://ClinicalTrials.gov/show/NCT04452695
NCT04611243 Lung Function, Exercise Capacity, and Serology Responses in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04611243
NCT04467112 Non Inferiority Trial for Detection of nCOVID-19 Through Analysis of Exhaled Breath Aerosols https://ClinicalTrials.gov/show/NCT04467112
NCT04465656 Registry of the Evolution of Diagnosed and/or Hospitalized Patients for Pulmonary Embolism During the Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04465656
NCT04460664 Coagulation Changes Associated With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04460664
NCT04456933 Intracorporeal Anastomosis in Laparoscopic Left Colectomy. Cohort Comparative Study https://ClinicalTrials.gov/show/NCT04456933
NCT04456556 Combined Endophthalmitis and Orbital Cellulitis in Patients With Novel Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04456556
NCT04456101 Study on the Recovery of Pulmonary Function, Chest CT, Hematologic, and Immune & Inflammatory Conditions in COVID-19 Rehabilitation Patients https://ClinicalTrials.gov/show/NCT04456101
NCT04454333 COVID-19 in Pain Perspective https://ClinicalTrials.gov/show/NCT04454333
NCT04453280 Antibody Detection in COVID-19 Cured Patients (SARS-CoV-2-CZ-Immunity) https://ClinicalTrials.gov/show/NCT04453280
NCT04481516 Yoga in NHS Health Care Workers With COVID-19 Related Stress https://ClinicalTrials.gov/show/NCT04481516
NCT04475471 WORLD HEART FEDERATION (WHF) COVID-19 and Cardiovascular Disease Survey https://ClinicalTrials.gov/show/NCT04475471
NCT04455451 Intensive Care Therapy of Covid-19 Disease in Germany https://ClinicalTrials.gov/show/NCT04455451
NCT04485351 Assessing the Impact of the COVID-19 Lockdown on Metabolic Control and Access to Health Care in Patients With Diabetes https://ClinicalTrials.gov/show/NCT04485351
NCT04459403 Psychiatric Disturbances and COVID-19 Infection https://ClinicalTrials.gov/show/NCT04459403
NCT04457570 Excess Risk of Morbi-mortality Due to COVID-19 in Patients With Cancer https://ClinicalTrials.gov/show/NCT04457570
NCT04460274 Forecast Number of Covid-19 Cases Worldwide https://ClinicalTrials.gov/show/NCT04460274
NCT04459312 National Covid-19 Surveillance Physicians https://ClinicalTrials.gov/show/NCT04459312
NCT04460469 Anxiety Level and Oral Hygiene Practice in Dental Students During Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04460469
NCT04459390 Association of Comorbidities With COVID19 https://ClinicalTrials.gov/show/NCT04459390
NCT04522037 Measurement of the Efficacy of MORPHINE in the Early Management of Dyspnea in COVID-19 Positive Patients https://ClinicalTrials.gov/show/NCT04522037
NCT04475484 Online Survey on Psychological Impact of COVID-19 Epidemic on School-age Children https://ClinicalTrials.gov/show/NCT04475484
NCT04463706 COVID19 Severity Prediction and Health Services Research Evaluation https://ClinicalTrials.gov/show/NCT04463706
NCT04462393 Characteristics and Outcomes of Patients Admitted to Swedish Intensive Care Units for COVID-19 https://ClinicalTrials.gov/show/NCT04462393
NCT04460638 SARS-CoV2 (COVID-19) Diagnosis in Human Saliva by MALDI-TOF MS Profiling https://ClinicalTrials.gov/show/NCT04460638
NCT04460599 Neurological Features During COVID19 https://ClinicalTrials.gov/show/NCT04460599
NCT04467931 ACEI or ARB and COVID-19 Severity and Mortality in US Veterans https://ClinicalTrials.gov/show/NCT04467931
NCT04474236 Lung Ultrasound for COVID-19 Initial Triage and Monitoring https://ClinicalTrials.gov/show/NCT04474236
NCT04471649 Hydroxy Chloroquine and Covid in RA Patients https://ClinicalTrials.gov/show/NCT04471649
NCT04465981 Investigation of Antibody and Immune Responses to SARS-CoV-2 Proteins https://ClinicalTrials.gov/show/NCT04465981
NCT04468386 Specimen Collection Study Protocol https://ClinicalTrials.gov/show/NCT04468386
NCT04466462 Cross-sectional Study of COVID-19 Infection in Hospital Health Personnel https://ClinicalTrials.gov/show/NCT04466462
NCT04465058 Characteristics of Critically Ill COVID 19 Patients https://ClinicalTrials.gov/show/NCT04465058
NCT04463758 Covid-19 in Pregnancy: a French Population-based Cohort of Women and Newborns https://ClinicalTrials.gov/show/NCT04463758
NCT04476914 Stress Related Disorders in Family Members of COVID-19 Patients Admitted to the ICU https://ClinicalTrials.gov/show/NCT04476914
NCT04468802 Do Childhood Measles and DTaP Vaccination Decrease the Mortality Rate Caused by COVID-19 in OECD Countries? https://ClinicalTrials.gov/show/NCT04468802
NCT04468412 Influence of COVID-19 on Vascular Endothelial Function https://ClinicalTrials.gov/show/NCT04468412
NCT04468256 The Heart Hive COVID-19 Study https://ClinicalTrials.gov/show/NCT04468256
NCT04468217 Evaluation of an Alternative Method of Obtaining Viral RNA for the Detection of SARS-CoV-2 Virus Using PCR https://ClinicalTrials.gov/show/NCT04468217
NCT04466982 Assessment of Olfactory Dysfunction in SARS CoV-2 (COVID-19) Infection https://ClinicalTrials.gov/show/NCT04466982
NCT04466644 COVID-19: A Prevalence Study of Two ART Centres After the Pandemic Lockdown in the USA (COVID-19 Free Clinics) https://ClinicalTrials.gov/show/NCT04466644
NCT04465552 Arrhythmic Manifestations and Management in Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04465552
NCT04467008 Covid-19 Rapid Diagnostic Tests on Blood Drop https://ClinicalTrials.gov/show/NCT04467008
NCT04472052 Frequency of Perforated Appendicitis in Times of COVID-19 https://ClinicalTrials.gov/show/NCT04472052
NCT04468035 Early Cognitive Assessment and Evolutionary Monitoring of Patients With Severe ARDS on COVID-19 Pneumonia Requiring Mechanical Ventilation https://ClinicalTrials.gov/show/NCT04468035
NCT04474496 Impact of COVID-19 on Marshallese Communities in the U.S. https://ClinicalTrials.gov/show/NCT04474496
NCT04475211 LILLE COVID RESEARCH NETWORK (Covid-19) https://ClinicalTrials.gov/show/NCT04475211
NCT04473365 Rapid Diagnostic Profiling of SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04473365
NCT04474444 Ambulance Calls for Substance Use and Alcohol in a Pandemic (ASAP) https://ClinicalTrials.gov/show/NCT04474444
NCT04470323 Functional Exhaustion of T Cells in COVID19 Patients https://ClinicalTrials.gov/show/NCT04470323
NCT04496128 COVID19 Neurological Manifestation https://ClinicalTrials.gov/show/NCT04496128
NCT04496076 COVID-19 Brain Injury https://ClinicalTrials.gov/show/NCT04496076
NCT04471051 An Observational Cohort Trial of Outcomes and Antibody Responses Following Treatment With COVID19 Convalescent Plasma in Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04471051
NCT04470583 Evaluating Clinical Parameters of COVID-19 in Pregnancy https://ClinicalTrials.gov/show/NCT04470583
NCT04469660 Impact of COVID-19 Pandemic on the Psychological Wellbeing of Healthcare Professionals in India https://ClinicalTrials.gov/show/NCT04469660
NCT04469647 COVID 19 Seroprevalence Amongst Healthcare Workers in JHAH https://ClinicalTrials.gov/show/NCT04469647
NCT04510025 Capturing MultiORgan Effects of COVID-19 https://ClinicalTrials.gov/show/NCT04510025
NCT04484597 Predictors of COVID-19 Infection and Disease Progression https://ClinicalTrials.gov/show/NCT04484597
NCT04475068 Postural Recruitment Maneuver in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 Infection https://ClinicalTrials.gov/show/NCT04475068
NCT04474301 Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04474301
NCT04473547 COVID 19 Preventive Measures Among Mansoura Nursing Students https://ClinicalTrials.gov/show/NCT04473547
NCT04473300 Assessment of Lung Recruitablity of Acute Respiratory Distress Syndrome With SARS-CoV-2 Pneumonia by Electrical Impedance Tomography https://ClinicalTrials.gov/show/NCT04473300
NCT04473183 Epidemiologic Assessment of SARS-CoV-2 (COVID-19) Prevalence in Minnesota https://ClinicalTrials.gov/show/NCT04473183
NCT04471701 Italian Web-based Cross-sectional Survey on COVID-19 https://ClinicalTrials.gov/show/NCT04471701
NCT04472013 Systematic Assessment of SARS-CoV-2 Neurotropic Capacity in Modestly and Critically Ill Patients, and Patients Who Died From COVID-19 https://ClinicalTrials.gov/show/NCT04472013
NCT04474457 Efficacy and Safety of Favipiravir in the Treatment of COVID-19 Patients Over 15 Years of Age https://ClinicalTrials.gov/show/NCT04474457
NCT04474288 The COVID-19 PUI Reality Check (CPRC) Study https://ClinicalTrials.gov/show/NCT04474288
NCT04474067 COVID-19 - Cytokine Storm https://ClinicalTrials.gov/show/NCT04474067
NCT04473157 COVID-19 in Patients With Anosmia in Egypt https://ClinicalTrials.gov/show/NCT04473157
NCT04473131 Immune Profiling of COVID19-patients Admitted to ICU https://ClinicalTrials.gov/show/NCT04473131
NCT04473118 Assessment of Mental Health in Healthcare Workers Exposed to COVID-19 Patients https://ClinicalTrials.gov/show/NCT04473118
NCT04480034 Obesity Surgery During 2020 Italian Pandemic https://ClinicalTrials.gov/show/NCT04480034
NCT04494776 SARS-COV-2 Infection in Kidney Transplant Recipients: a Brazilian Multicenter Study https://ClinicalTrials.gov/show/NCT04494776
NCT04477902 Long-Term Experience and Health Effects of COVID-19 https://ClinicalTrials.gov/show/NCT04477902
NCT04476823 European Pathology Laboratories and COVID-19 https://ClinicalTrials.gov/show/NCT04476823
NCT04476602 Ambulatory Management of Moderate to High Risk COVID-19 (SARS-CoV-2) Patients - The Coronavirus Related Outpatient Work Navigators (CROWN) Protocol https://ClinicalTrials.gov/show/NCT04476602
NCT04476589 Prognostication of Recovery in Early Disorders of Consciousness After COVID-19 https://ClinicalTrials.gov/show/NCT04476589
NCT04522310 ProAdrenomedullin Assessment of Multi-Organ Failure in COvid-19 Sepsis https://ClinicalTrials.gov/show/NCT04522310
NCT04480515 Does COVID-19 Pandemic Reduce In-hospital Mortality? https://ClinicalTrials.gov/show/NCT04480515
NCT04479982 Microbial Infection and AMR in Hospitalized Patients With Covid 19 https://ClinicalTrials.gov/show/NCT04479982
NCT04477889 Methodist Health System COVID-19 Patient Registry https://ClinicalTrials.gov/show/NCT04477889
NCT04477473 Perceived Impact of the COVID-19 Pandemic on Medical Management and Symptoms in a High Risk Group https://ClinicalTrials.gov/show/NCT04477473
NCT04480398 Efficacy and Safety of Guduchi Ghan Vati for Covid-19 Asymptomatic Patients https://ClinicalTrials.gov/show/NCT04480398
NCT04480060 Experience of an Emergency Intensive Care Unit During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04480060
NCT04479137 Possible Predictors of Mortality Based on COVID-19 for Patients Under 50 Years Old: A Multi-Center Experience of Istanbul https://ClinicalTrials.gov/show/NCT04479137
NCT04479293 Post COVID-19 Functional Status in Egypt https://ClinicalTrials.gov/show/NCT04479293
NCT04479280 Evaluation of Coagulopathy in Critically Ill COVID-19 Patients. https://ClinicalTrials.gov/show/NCT04479280
NCT04479124 The Impact of COVID-19 Pandemic to Trauma Patients in Emergency Department: A Multicenter Experience of Istanbul https://ClinicalTrials.gov/show/NCT04479124
NCT04491214 Post ICU Follow up in Patients With Severe SARS-CoV-2 Infection (Covid-19) https://ClinicalTrials.gov/show/NCT04491214
NCT04481620 Development and Validation of a Prediction Model for the Transition From Mild to Moderate Form of COVID-19, Using Data From Chest CT https://ClinicalTrials.gov/show/NCT04481620
NCT04480580 Seroprevalence of SARS-Cov-2 in the Setting of a Non-dedicated COVID-19 Hospital in a Low CoV-2 Incidence Area: Implications for Surgery https://ClinicalTrials.gov/show/NCT04480580
NCT04506632 Burden for STaff Working in the NHS https://ClinicalTrials.gov/show/NCT04506632
NCT04486729 Respiratory Mechanics and Gas Exchange Characteristics in Patient With SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04486729
NCT04483622 Immunoglobulin G Antibody Immune Response Profile Following Infection With SARS-CoV-2 in COVID-19 Egyptian Patients https://ClinicalTrials.gov/show/NCT04483622
NCT04482205 Covid -19 Pandemic: Economic Burden on Patients Operated for Traumatic Close Fractures https://ClinicalTrials.gov/show/NCT04482205
NCT04495764 Registry of Sustained Immunity to COVID-19 Among ESKD Patients https://ClinicalTrials.gov/show/NCT04495764
NCT04486521 Clinical Outcome of Anti-IL6 vs Anti-IL6 Corticosteroid Combination in Patients With SARS-CoV-2 Cytokine Release Syndrome https://ClinicalTrials.gov/show/NCT04486521
NCT04486417 Feasibility of a Telematics Pre-operative Assessment in a Bariatric Surgery During Covid-19 https://ClinicalTrials.gov/show/NCT04486417
NCT04484545 Prognostic Factors in Patients Admitted to an Urban Teaching Hospital With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04484545
NCT04483908 COVID-19 in Baselland: Investigation and Validation of Serological Diagnostic Assays and Epidemiological Study of Sars-CoV-2 Specific Antibody Responses https://ClinicalTrials.gov/show/NCT04483908
NCT04492267 Inflammatory Bowel Disease (IBD) and Covid-19 Infection https://ClinicalTrials.gov/show/NCT04492267
NCT04488549 Delayed Colorectal Cancer Care During Coronavirus Disease (COVID-19) Pandemic (DECOR-19) https://ClinicalTrials.gov/show/NCT04488549
NCT04488510 Pathogens Involved in Secondary Infections During Severe Forms of Covid-19 Pneumonia: https://ClinicalTrials.gov/show/NCT04488510
NCT04487977 Survey on COVID-19 Airway Management https://ClinicalTrials.gov/show/NCT04487977
NCT04485364 Place of Circulating Biomarkers and Respiratory Eicosanoids in the Prognosis of Severe Forms of Covid-19 Pneumonia https://ClinicalTrials.gov/show/NCT04485364
NCT04486404 Needs, Perceptions and Acute Stress of Healtcare Workers Caring for COVID-19 Patients in South America https://ClinicalTrials.gov/show/NCT04486404
NCT04570982 Clinical Protocol for Convalescent Plasma and Remdesivir Therapy in Nepal https://ClinicalTrials.gov/show/NCT04570982
NCT04500652 Mental Health Status and Related Factors Among Physical Medicine & Rehabilitation Physicians in the Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04500652
NCT04500600 Well-Being and Health-Related Quality of Life in Cancer Patients and Survivors During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04500600
NCT04491227 Global Assessment of Acute and Chronic Kidney Disease Incidence and Outcomes in Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04491227
NCT04488588 Survival and 30-days Hospital Outcome in COVID-19 Patients in Upper Egypt https://ClinicalTrials.gov/show/NCT04488588
NCT04488471 Impact of Isolation in Patients With IBD During the COVID-19 Crisis https://ClinicalTrials.gov/show/NCT04488471
NCT04487951 N-terminal Pro B-type Natriuretic Peptide and Vitamin D Levels as Prognostic Markers in COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04487951
NCT04487769 Lung Ultrasound in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04487769
NCT04487197 SARS-CoV2 (COVID-19) Seroepidemiological Transplanted Subjects (Kidney, Kidney-pancreas, Pancreas, Langerhans Islets) https://ClinicalTrials.gov/show/NCT04487197
NCT04487119 Hematology and Clinical Picture in Pediatric COVID-19 Infection https://ClinicalTrials.gov/show/NCT04487119
NCT04492904 Singapore COVID-19 Chemosensory Tracking (SCCT) Study https://ClinicalTrials.gov/show/NCT04492904
NCT04492384 Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients https://ClinicalTrials.gov/show/NCT04492384
NCT04491318 COVID-19 Quarantine on Musculoskeletal Status in Hemophilia https://ClinicalTrials.gov/show/NCT04491318
NCT04491201 National Survey of the Impact of COVID-19 Pandemics https://ClinicalTrials.gov/show/NCT04491201
NCT04551690 Prevalence of COVID-19 (Coronavirus Disease 19) in Pregnant Women on Labor in a Public Hospital in Chile (COroNavirus diSease Covid-19 pandEmic iN ChilE) https://ClinicalTrials.gov/show/NCT04551690
NCT04501822 One-year Cardiac Follow-up of Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04501822
NCT04493268 HYPONATREMIA IN COVID-19 PATIENTS https://ClinicalTrials.gov/show/NCT04493268
NCT04492371 COVID-19 Infection and Multiple Myeloma https://ClinicalTrials.gov/show/NCT04492371
NCT04491292 Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce https://ClinicalTrials.gov/show/NCT04491292
NCT04490174 Serological Surveillance for COVID-19 in Central North Carolina https://ClinicalTrials.gov/show/NCT04490174
NCT04501432 Cardiac Rehabilitation and Ongoing Physical Activity During COVID-19 https://ClinicalTrials.gov/show/NCT04501432
NCT04494893 ImmuneRACE - Immune Response Action to COVID-19 Events https://ClinicalTrials.gov/show/NCT04494893
NCT04596098 Immune Responses to COVID-19; Isolation of Neutralizing Antibodies for Therapeutics and Vaccine. https://ClinicalTrials.gov/show/NCT04596098
NCT04496141 Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19 https://ClinicalTrials.gov/show/NCT04496141
NCT04495907 COVID-19 Progression in End-Stage Kidney Disease https://ClinicalTrials.gov/show/NCT04495907
NCT04505605 Study of a Possible Respiratory Degradation Prognosis Caused by Biomarkers in Severe Forms of COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04505605
NCT04498416 CoCo-20: a Longitudinal Follow-up Study of the French Paediatric Population During and After the Coronavirus Pandemic COVID-19 https://ClinicalTrials.gov/show/NCT04498416
NCT04498299 Stress Echocardiography in Patients Recovery From Mild COVID-19 Illness https://ClinicalTrials.gov/show/NCT04498299
NCT04497311 Tomographic Findings in COVID-19 and Influenza https://ClinicalTrials.gov/show/NCT04497311
NCT04497818 Correlation Fear of COVID-19 & Dental Treatment Anxiety https://ClinicalTrials.gov/show/NCT04497818
NCT04497636 Mental Health Impact of the COVID-19 Pandemic Among Migrants in Chile https://ClinicalTrials.gov/show/NCT04497636
NCT04497441 Netizens’ Perception of COVID-19 Information & Information Sources. https://ClinicalTrials.gov/show/NCT04497441
NCT04498507 Psychosocial Outcomes in Families of COVID-19 ICU Patients https://ClinicalTrials.gov/show/NCT04498507
NCT04497467 Changes in Out-patient Visits in Taiwan During the Time of Global COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04497467
NCT04506515 Psychological Impact of COVID-19 Pandemic in Healthcare Workers https://ClinicalTrials.gov/show/NCT04506515
NCT04505631 Follow-up of Respiratory Sequelae of Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04505631
NCT04499300 Elderly Patients and COVID-19 Infection: a Cohort of Fifty Patients Over Ninety Years of Age https://ClinicalTrials.gov/show/NCT04499300
NCT04498065 MYocardial DOmmages Related to COVID-19 https://ClinicalTrials.gov/show/NCT04498065
NCT04498286 COVID-19 and SARS-CoV-2 Antibodies in Multiple Sclerosis Patients https://ClinicalTrials.gov/show/NCT04498286
NCT04498091 EPIdemiological Approaches to the Cardiovascular Consequences of COVID-19 https://ClinicalTrials.gov/show/NCT04498091
NCT04497246 Psychological Impact, Mental Health and Sleep Disorder Among Patients Hospitalized and Health Care Workers During the 2019 Coronavirus Outbreak (COVID-19) https://ClinicalTrials.gov/show/NCT04497246
NCT04503525 Nutritional Assessment of Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04503525
NCT04503447 COVID-19 Seroprevalence Study in ITM Staff https://ClinicalTrials.gov/show/NCT04503447
NCT04500639 Over-the-counter Medications & COVID-19 https://ClinicalTrials.gov/show/NCT04500639
NCT04502108 Behavior During and After COVID-19 Crisis https://ClinicalTrials.gov/show/NCT04502108
NCT04501991 Short-term Impact of COVID-19 Lockdown on Metabolic Control of Type 2 Diabetes https://ClinicalTrials.gov/show/NCT04501991
NCT04507893 Comparison Between Positive and Negative COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04507893
NCT04509713 Canine COVID-19 Detection https://ClinicalTrials.gov/show/NCT04509713
NCT04526405 Frequency of COVID-19 Antibodies in Patients With Hereditary Hematological Diseases https://ClinicalTrials.gov/show/NCT04526405
NCT04510441 Artificial Intelligence-assisted Diagnosis and Prognostication in COVID-19 Using Electrocardiograms https://ClinicalTrials.gov/show/NCT04510441
NCT04507282 Eosinophil and Anticoagulation in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04507282
NCT04507230 COVID-19 Associated Coagulopathy in Egypt https://ClinicalTrials.gov/show/NCT04507230
NCT04506229 Genetic Mechanisms Underlying SARS-CoV-2 Infection and the Impact of COVID-19 on Cognitive Function https://ClinicalTrials.gov/show/NCT04506229
NCT04510012 Characterizing the Immune Response and Neuronal Damage in COVID-19 https://ClinicalTrials.gov/show/NCT04510012
NCT04508972 The VOICE-COVID-19 https://ClinicalTrials.gov/show/NCT04508972
NCT04508777 COVID SAFE: COVID-19 Screening Assessment for Exposure https://ClinicalTrials.gov/show/NCT04508777
NCT04513210 Reliability of Standardized Protocol of Ultrasound of the Lungs in Prediction of Severity of Covid-19 Infection https://ClinicalTrials.gov/show/NCT04513210
NCT04510623 Host Response Mediators in Coronavirus (COVID-19) Infection https://ClinicalTrials.gov/show/NCT04510623
NCT04513847 PsoVac: Educational Needs re Vaccines for Biologic Patients With Psoriasis https://ClinicalTrials.gov/show/NCT04513847
NCT04512300 Parental Attitude Toward Children Dental Treatment During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04512300
NCT04512118 CT Abnormalities Evocative of Lung Infection Are Associated With Lower 18F-FDG Uptake in Confirmed COVID-19 Patients https://ClinicalTrials.gov/show/NCT04512118
NCT04521010 Staff Absenteeism and Delivery of Healthcare Services During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04521010
NCT04514016 Cross Sectional CFAR HIV/COVID Study https://ClinicalTrials.gov/show/NCT04514016
NCT04514003 The Corona and COVID-19 Study in Telemark and Agder https://ClinicalTrials.gov/show/NCT04514003
NCT04517695 Blood Volume Assessment in COVID-19 ICU Patients - BVAC19 https://ClinicalTrials.gov/show/NCT04517695
NCT04517097 Study of the Specific Seroprevalence of SARS-CoV-2 in a Sample of Patients and Salaried Staff From a French Anti-cancer Center at the End of the Containment Period of the SARS-CoV-2 Pandemic https://ClinicalTrials.gov/show/NCT04517097
NCT04516928 Study of SARS-CoV2 Virus (COVID-19) Seroprevalence Among Lyon-Bron Military Health Schools Personnel https://ClinicalTrials.gov/show/NCT04516928
NCT04515108 Perinatal Outcomes and Hematologic Parameters in COVID-19 Pregnancies https://ClinicalTrials.gov/show/NCT04515108
NCT04514874 Assessment of the Prevalence and the Impact of the COVID-19 Epidemic in the French Flight Crew in 2020 https://ClinicalTrials.gov/show/NCT04514874
NCT04544072 Analysis of the Quality and Quantity of Antibiotic Prescriptions for Bacterial Respiratory Tract Superinfection in Patients Hospitalized in COVID-19 Wards https://ClinicalTrials.gov/show/NCT04544072
NCT04517136 Impact of Perceived Control on Operational Strain: a Study of COVID-19 Pandemic Caregivers and Military Personnel on Operational Missions https://ClinicalTrials.gov/show/NCT04517136
NCT04516824 Experience of Orthopaedic and Spine Center Pakistan During COVID-19 https://ClinicalTrials.gov/show/NCT04516824
NCT04519372 SARS-CoV-2 /COVID-19 Admission Screening in a University Hospital Setting https://ClinicalTrials.gov/show/NCT04519372
NCT04525404 MOIST Study: Multi-Organ Imaging With Serial Testing in COVID-19 Infected Patients https://ClinicalTrials.gov/show/NCT04525404
NCT04522076 Prospective Hospital Registry of Patients With Suspected or Confirmed Coronavirus Infection (COVID-19) and Community-acquired Pneumonia https://ClinicalTrials.gov/show/NCT04522076
NCT04519502 Maternal Morbidity and Mortality During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04519502
NCT04519398 Investigating the Involvement of ACE and Angiotensinogen Genes’ Polymorphism Along With Other Thrombophilic Genotypes in Severe Forms of COVID-19 With/Without Thrombotic Events https://ClinicalTrials.gov/show/NCT04519398
NCT04519307 Evaluation of Newborns Presenting With Suspected COVID 19 https://ClinicalTrials.gov/show/NCT04519307
NCT04519255 Study for Quantitative Analysis of the Recovered COVID-19 Patients by 18F-FDG-PET/CT https://ClinicalTrials.gov/show/NCT04519255
NCT04518735 Evolution of COVID-19 in Anticoagulated or Antiaggregated Patients (CORONA Study) https://ClinicalTrials.gov/show/NCT04518735
NCT04531735 Respiratory Syncytial Virus Infection May be More Dangerous in Neonate https://ClinicalTrials.gov/show/NCT04531735
NCT04525911 Assessment of Long-term Impact Post COVID-19 for Patients and Health Care Professionals of the European Hospital https://ClinicalTrials.gov/show/NCT04525911
NCT04524520 COVID19-OR (SARS-CoV-2): Observation,Risk & Recovery https://ClinicalTrials.gov/show/NCT04524520
NCT04527497 Clinical Course and Treatment of COVID-19 Inpatients in Hospital https://ClinicalTrials.gov/show/NCT04527497
NCT04525287 Prediction Models for Diagnosis and Prognosis of Severe COVID-19 https://ClinicalTrials.gov/show/NCT04525287
NCT04523051 Rehabilitation After Admission in Intensive Care Unit for COVID-19 https://ClinicalTrials.gov/show/NCT04523051
NCT04523012 COVID-19 and HIV Patients https://ClinicalTrials.gov/show/NCT04523012
NCT04525716 The Effect of Covid-19 on Patient Outcomes Among Operated Patients https://ClinicalTrials.gov/show/NCT04525716
NCT04525443 Endothelial Function and COVID-19 https://ClinicalTrials.gov/show/NCT04525443
NCT04524754 Prevalence and Outcomes of Olfactory and Gustatory Dysfunctions in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04524754
NCT04524234 Cardiac Dysfunction in Critically Ill Patients Infected With COVID-19 https://ClinicalTrials.gov/show/NCT04524234
NCT04531254 Back to School COVID-19 Simulation Study https://ClinicalTrials.gov/show/NCT04531254
NCT04527458 Case Fatalities in Hospitalised COVID-19 Patients in the UK https://ClinicalTrials.gov/show/NCT04527458
NCT04559542 Body Weight Regulation, Disordered Eating Behaviour, and Experiences of Sexual Harassment in Female Martial Art Athletes https://ClinicalTrials.gov/show/NCT04559542
NCT04532411 COVID-19 Testing Sample Acquisition Throughput and Efficiency https://ClinicalTrials.gov/show/NCT04532411
NCT04531111 Glycemic Control Among Children and Adolescents With Type 1 Diabetes During COVID-19 Pandemic in Egypt https://ClinicalTrials.gov/show/NCT04531111
NCT04528901 Study of seroPREvalence Vis-à-vis SARS-CoV2 and Correlation With Clinical Forms of COVID-19 in Patients Followed in Pneumology in the Cluster Area of the Grand-Est Region (Strasbourg University Hospital) https://ClinicalTrials.gov/show/NCT04528901
NCT04527601 Extremely Premature Births During the Peak of the COVID-19 Pandemic: an International Study of the Active SafeBoosC III Departments https://ClinicalTrials.gov/show/NCT04527601
NCT04534400 Automated Quantification of Radiologic Pulmonary Alteration During Acute Respiratory Failure https://ClinicalTrials.gov/show/NCT04534400
NCT04531501 COVID-19 Saliva Test Research Study https://ClinicalTrials.gov/show/NCT04531501
NCT04530500 COVID-19 In-vitro Diagnostic Test and Androgen Receptor Gene Expression https://ClinicalTrials.gov/show/NCT04530500
NCT04530461 Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases https://ClinicalTrials.gov/show/NCT04530461
NCT04529447 Response of Korean Medicine Hospital to COVID-19 https://ClinicalTrials.gov/show/NCT04529447
NCT04529408 EARSATS-19: In-ear Measurement of Blood Oxygen Saturation in COVID-19 Follow up https://ClinicalTrials.gov/show/NCT04529408
NCT04590352 Mucosal Immunity Against SARS-CoV-2 Infection in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04590352
NCT04537559 Impact of COVID-19 Outbreak on Non-COVID-19 Patients https://ClinicalTrials.gov/show/NCT04537559
NCT04536285 Hospitalized Children and Adolescent Patients With Type 1 Diabetes During the COVID-19 Pandemic in Egypt https://ClinicalTrials.gov/show/NCT04536285
NCT04531319 Immune Cell Subgroups in Covid 19 Patients https://ClinicalTrials.gov/show/NCT04531319
NCT04549636 COVID-19 Related Lung Ventilation and Perfusion Injury https://ClinicalTrials.gov/show/NCT04549636
NCT04535154 Patient-reported Outcomes and Lung Function After Hospitalization for COVID-19 https://ClinicalTrials.gov/show/NCT04535154
NCT04534569 Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF) https://ClinicalTrials.gov/show/NCT04534569
NCT04535297 Consequences of the COVID-19 Lockdown on Health and Well-being of Patients With Parkinson Disease and Post-stroke https://ClinicalTrials.gov/show/NCT04535297
NCT04534608 COVID-19 Child Health Investigation of Latent Disease in Hamburg https://ClinicalTrials.gov/show/NCT04534608
NCT04534595 Data Collection on the Model Schools Pediatric Health Initiative at 5 SBHC Sites: COVID-19 Questionnaire https://ClinicalTrials.gov/show/NCT04534595
NCT04539834 Electrolyte State in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04539834
NCT04578197 NeuroCovid - a Study of Intensive Care-requiring Covid-19 Patients https://ClinicalTrials.gov/show/NCT04578197
NCT04542044 Evaluation of the Safety and Outcomes of Outpatient Management With Mild to Moderate COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04542044
NCT04540029 Measuring Outcomes of Maternal COVID-19-related Prenatal Exposure https://ClinicalTrials.gov/show/NCT04540029
NCT04537117 Knowledge, Attitudes and Clinical Practices of Pediatric Dentists Regarding Covid-19 https://ClinicalTrials.gov/show/NCT04537117
NCT04602260 Functional Recovery of Hospitalised Patients With COVID-19: The COREG Extension Study https://ClinicalTrials.gov/show/NCT04602260
NCT04544605 Special Chinese Medicine Out-patient Programme for Discharged COVID-19 Patients https://ClinicalTrials.gov/show/NCT04544605
NCT04540484 COVID-19 IgG Formation in Physicians at ALGH and Their Household Members https://ClinicalTrials.gov/show/NCT04540484
NCT04538586 Influence of the COVId-19 Pandemic on STRESS, and Screening Procedures (COVISTRESS Screening) https://ClinicalTrials.gov/show/NCT04538586
NCT04544033 IL- 6 Gene (174G/C) Single Nucleotide Polymorphism as an Indicator of COVID-19 Severity in Egyptian Patients https://ClinicalTrials.gov/show/NCT04544033
NCT04554251 Global Impact of COVID-19 on Pulmonology Special Units https://ClinicalTrials.gov/show/NCT04554251
NCT04622748 Neurocognitive Functions of Recovered COVID-19 Patients https://ClinicalTrials.gov/show/NCT04622748
NCT04548908 Prevalence Of COVID-19 Among Health-workers in a French General Hospital https://ClinicalTrials.gov/show/NCT04548908
NCT04541472 Influence of the COVId-19 Pandemic on the STRESS of Dental Surgeons (COVISTRESS - Dental Surgery) https://ClinicalTrials.gov/show/NCT04541472
NCT04552340 Epidemiologic, Clinical and Molecular Characteristics of Patients With Acute Respiratory Failure Affected by 2019-NCOV. https://ClinicalTrials.gov/show/NCT04552340
NCT04549350 Sleep Quality Among HCWs https://ClinicalTrials.gov/show/NCT04549350
NCT04544150 Gastrointestinal Manifestations Among Patients With COVID19 https://ClinicalTrials.gov/show/NCT04544150
NCT04542226 Observational Open Study of Polyoxidonium in Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04542226
NCT04542200 Workforce Serosurveillance to Track Long-term Modifications to COVID-19 Exposure Due to Factors in the Built Environment https://ClinicalTrials.gov/show/NCT04542200
NCT04546776 COVID-19 Persistence in Stool https://ClinicalTrials.gov/show/NCT04546776
NCT04545047 Observational Study of Convalescent Plasma for Treatment of Veterans With COVID-19 https://ClinicalTrials.gov/show/NCT04545047
NCT04544176 COVID-19 Risk From Attending Outpatient Appointments https://ClinicalTrials.gov/show/NCT04544176
NCT04576351 The Norwegian Study of Nervous System Manifestations and Sequelae After COVID-19 https://ClinicalTrials.gov/show/NCT04576351
NCT04556565 MIND/COVID-19: Mental Health Impact and NeeDs Associated With COVID-19: a Comprehensive National Evaluation in Spain https://ClinicalTrials.gov/show/NCT04556565
NCT04550403 Clinical Phenotype and Outcomes of Inpatients With COVID-19 and Diabetes https://ClinicalTrials.gov/show/NCT04550403
NCT04549831 Genetic Bases of COVID-19 Clinical Variability https://ClinicalTrials.gov/show/NCT04549831
NCT04547218 Study on Incidence of Elective Surgery Postponed During COVID-19 Pandemic in Geriatric Population https://ClinicalTrials.gov/show/NCT04547218
NCT04547114 Breath Analysis for SARS-CoV-2 in Infected and Healthy Subjects https://ClinicalTrials.gov/show/NCT04547114
NCT04554979 COVID-19 Disease Duration and GIT Manifestations. A New Disease Severity Classification. An Egyptian Experience https://ClinicalTrials.gov/show/NCT04554979
NCT04550312 The Impact of Lifestyle Changes on Non-COVID Deaths https://ClinicalTrials.gov/show/NCT04550312
NCT04595110 Hemostatic Profile in Patients Affected by COVID-19 https://ClinicalTrials.gov/show/NCT04595110
NCT04555954 Determining the Physical Activity Level of Healthy Adults During Pandemic https://ClinicalTrials.gov/show/NCT04555954
NCT04550390 Study of the Analytical Performance of Different Salivary Self-collection Methods for the Detection of COVID-19. https://ClinicalTrials.gov/show/NCT04550390
NCT04551378 The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors https://ClinicalTrials.gov/show/NCT04551378
NCT04569292 COVID-19 Infection in Cancer Pantients https://ClinicalTrials.gov/show/NCT04569292
NCT04557358 Impact in the Medical Care Among the Rheumatic Diseases Patients in a Tertiary Hospital in México During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04557358
NCT04555187 Cardiovascular Risk Stratification in Covid-19 https://ClinicalTrials.gov/show/NCT04555187
NCT04556513 Functional Recovery From Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19: Influence of Socio-Economic Status https://ClinicalTrials.gov/show/NCT04556513
NCT04560855 Secure Self-monitoring Through a Combination of Connected Objects: Implementation in COVID-19 Patients Monitored at Home https://ClinicalTrials.gov/show/NCT04560855
NCT04555109 Convalescent Plasma for COVID-19 Research Donor Study https://ClinicalTrials.gov/show/NCT04555109
NCT04568018 Surfactant-BL in Adult Acute Respiratory Distress Syndrome Due to COVID-19 https://ClinicalTrials.gov/show/NCT04568018
NCT04567927 Prevalence and Risk Factors for Venous Thromboembolic Events in Critically Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04567927
NCT04558645 Evaluation of Physical Activity and Quality of Life of Patients With Type 1 Diabetes Mellitus During the Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04558645
NCT04558307 Feasibility of Rapid COVID-19 Testing in Disadvantaged Populations https://ClinicalTrials.gov/show/NCT04558307
NCT04556604 Surgical Consent During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04556604
NCT04556318 Identification of Differences in Breath Components Detected With IMS in Patients Tested on SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04556318
NCT04558320 COVID-19 and Lactating Mothers https://ClinicalTrials.gov/show/NCT04558320
NCT04563247 Seroprevalence of SARS-CoV-2 in Asymptomatic Frontline COVID-19 HCWs https://ClinicalTrials.gov/show/NCT04563247
NCT04560413 Depression, Anxiety and SARS-CoV-2 (Covid-19) Phobia in Post-stroke Patients https://ClinicalTrials.gov/show/NCT04560413
NCT04558385 Seroconversion in COVID-19 Recovered Population https://ClinicalTrials.gov/show/NCT04558385
NCT04568850 Waxing and Waning of Serum SARS CoV-2-IgG Level in COVID-19 Exposed Population https://ClinicalTrials.gov/show/NCT04568850
NCT04561102 Evaluation of the COVIDSeq Test in Nasal Swab and Saliva From an Asymptomatic Population https://ClinicalTrials.gov/show/NCT04561102
NCT04561089 Evaluation of the COVIDSeq Test in Saliva Specimens From Illumina Personnel https://ClinicalTrials.gov/show/NCT04561089
NCT04578509 Evaluation of a Screening Program for SARS-CoV-2 Infection in the General Population Based on the Use of New Detection Approaches or for Diagnostic Orientation on Saliva https://ClinicalTrials.gov/show/NCT04578509
NCT04587323 VEGF and sFlt-1 Levels in the Pathogenesis and Severity of COVID-19 Disease https://ClinicalTrials.gov/show/NCT04587323
NCT04565782 Corona Virus Infection Among Liver Transplant Recipients https://ClinicalTrials.gov/show/NCT04565782
NCT04562285 Sustained Immunity to SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04562285
NCT04562246 SARS-CoV-2 IgG and IgM Serologic Assays https://ClinicalTrials.gov/show/NCT04562246
NCT04561193 Investigation of Subsequent and Co-infections Associated With SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04561193
NCT04561024 Evaluation of a COVID-19 Pneumonia CXR AI Detection Algorithm https://ClinicalTrials.gov/show/NCT04561024
NCT04560530 The Role of CT Chest Scan in the Pre-anesthetic Assessment of Suspected or Confirmed COVID -19 Patients https://ClinicalTrials.gov/show/NCT04560530
NCT04567836 Screening of Health-care Workers in an University Hospital for SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04567836
NCT04568044 Evaluation of Humoral Immunity Following COVID-19 in Pregnancy https://ClinicalTrials.gov/show/NCT04568044
NCT04563156 Follow-up and Rehabilitation of Survivors of Severe Coronavirus Disease 2019 (COVID-19) Infection https://ClinicalTrials.gov/show/NCT04563156
NCT04575571 MAVIPAN: My Life and the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04575571
NCT04568551 COVID-19-associated Anxiety of Pregnant Women for Anomalies, Stillbirth and Preterm Labor https://ClinicalTrials.gov/show/NCT04568551
NCT04566965 Serology to Covid for Recording Exposures and Evaluating Needs https://ClinicalTrials.gov/show/NCT04566965
NCT04565106 Automatic Oxygen Titration With O2matic® to Patients Admitted With COVID-19 and Hypoxemic Respiratory Failure https://ClinicalTrials.gov/show/NCT04565106
NCT04565080 Clinical Correlates of COVID-19 Pandemic in Patients With Functional Movement Disorder (FMD) and Parkinson’s Disease (PD) https://ClinicalTrials.gov/show/NCT04565080
NCT04565067 Identification and Characterization of SARS-CoV-2 Specific CD8 T Cells in Humans https://ClinicalTrials.gov/show/NCT04565067
NCT04564274 COV2Base-A Rare Disease by COVID Study https://ClinicalTrials.gov/show/NCT04564274
NCT04564287 An Observational Study of Neurologic Function After COVID-19 Infection https://ClinicalTrials.gov/show/NCT04564287
NCT04569344 COVID-19 and Venous Thromboembolism Risk https://ClinicalTrials.gov/show/NCT04569344
NCT04567979 Prospective Determination of COVID-19 Infection Rate in a Chemotherapy Unit in Mexico. https://ClinicalTrials.gov/show/NCT04567979
NCT04611841 Medical-biological Research of the Pathogenesis of COVID-19 Disease Caused by SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04611841
NCT04594291 MRI Changes of Acute Kidney Injury in COVID-19 https://ClinicalTrials.gov/show/NCT04594291
NCT04576299 Health Care Workers’ Perception of Patient Safety During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04576299
NCT04568655 The Noninvasive Ventilation to COVID-19 Patients https://ClinicalTrials.gov/show/NCT04568655
NCT04581577 Perceptions of the Clinical and Psychosocial Impact of Covid-19 in Patients With Neuromuscular and Neurological Disorders https://ClinicalTrials.gov/show/NCT04581577
NCT04573335 Diabetes Outcomes in COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04573335
NCT04572438 A Cohort Study of Mechanically Ventilated COVID-19 Patients Undergoing Tracheostomy https://ClinicalTrials.gov/show/NCT04572438
NCT04583319 Validation of a Rapid, Non-invasive Point-of-care IVD Test for Diagnosis of SARS-COV-2 (COVID-19) Infection https://ClinicalTrials.gov/show/NCT04583319
NCT04573634 A Registry Study of COVID-19 Serologic and Virologic Testing to Accelerate Recovery and Transition https://ClinicalTrials.gov/show/NCT04573634
NCT04579289 Managerial and Environmental Risk for COVID 19 in French Long Term Care Institutions https://ClinicalTrials.gov/show/NCT04579289
NCT04575532 Detection of COVID-19 Decompensation https://ClinicalTrials.gov/show/NCT04575532
NCT04573062 Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health https://ClinicalTrials.gov/show/NCT04573062
NCT04575168 Clinical Study Spartan COVID-19 V2 System https://ClinicalTrials.gov/show/NCT04575168
NCT04577105 Risk Factors and Computed Tomography Findings in COVID-19. https://ClinicalTrials.gov/show/NCT04577105
NCT04595123 Impact of COVID-19 Pandemic in Perinatal Mental Health (RISEUP-PPD-COVID-19) https://ClinicalTrials.gov/show/NCT04595123
NCT04584606 Ain Shams University Experience: Clinical Determinants of Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04584606
NCT04579627 Facial Hair, PPE and COVID-19 https://ClinicalTrials.gov/show/NCT04579627
NCT04579471 Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study https://ClinicalTrials.gov/show/NCT04579471
NCT04578132 Description of the Population With Genitourinary Tumors and COVID-19 https://ClinicalTrials.gov/show/NCT04578132
NCT04579588 Understanding Immunity to the Flu Vaccine in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04579588
NCT04579458 Assessment of COVID-19 in Tearfilm https://ClinicalTrials.gov/show/NCT04579458
NCT04581928 Patients Reactions Towards Their Diagnosis as Having COVID-19 https://ClinicalTrials.gov/show/NCT04581928
NCT04581044 Impact of COVID-19 on Psoriasis Practice https://ClinicalTrials.gov/show/NCT04581044
NCT04583865 Feasibility and Quality of TeleConsultation in Pediatric Anesthesia https://ClinicalTrials.gov/show/NCT04583865
NCT04582331 Improving Real-time COVID-19 Monitoring Through Smartphone Voice Analysis https://ClinicalTrials.gov/show/NCT04582331
NCT04581889 Prevalence of Antibodies Against SARS-CoV-2 Virus That Causes COVID-19 in Tübingen Children https://ClinicalTrials.gov/show/NCT04581889
NCT04581083 Validation of Laboratory Techniques, Strategies, and Types of Samples for Epidemiological Control in the Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04581083
NCT04586413 Post Acute COVID-19 Quality of Life (PAC-19QoL) Tool Development and Patient Registry (PAC-19QoLReg) https://ClinicalTrials.gov/show/NCT04586413
NCT04587258 Improving Cancer Screening and Prevention During the COVID-19 Pandemic in Underserved Populations of Rhode Island https://ClinicalTrials.gov/show/NCT04587258
NCT04586114 Effect of Corticosteroid Treatment on Prognosis in ARDS Secondary to Covid-19 https://ClinicalTrials.gov/show/NCT04586114
NCT04584450 Investigation of Validity and Reliability of Post-COVID-19 Functional Status Scale https://ClinicalTrials.gov/show/NCT04584450
NCT04583345 Physical Activity Levels of Hypertensive and Healthy Individuals Under Social Isolation During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04583345
NCT04582903 Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence https://ClinicalTrials.gov/show/NCT04582903
NCT04584658 Dysphagia and Dysphonia Outcomes in SARS CoV-2 (COVID-19) Infection (DYADS Study) https://ClinicalTrials.gov/show/NCT04584658
NCT04605757 Long-term Evolution of Pulmonary Involvement of Novel SARS-COV-2 Infection (COVID-19): Follow the Covid Study https://ClinicalTrials.gov/show/NCT04605757
NCT04588363 COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C (PRISM) https://ClinicalTrials.gov/show/NCT04588363
NCT04595240 Semen Analysis Changes in Covid-19 Positivepatients https://ClinicalTrials.gov/show/NCT04595240
NCT04590794 SuPAR in Adult Patients With Covid-19 https://ClinicalTrials.gov/show/NCT04590794
NCT04590378 Pulmonary Embolism and COVID-19 https://ClinicalTrials.gov/show/NCT04590378
NCT04588909 Outcomes of Elective Colorectal Cancer Surgery During COVID 19 Pandemic: Implications for Cancer Care Policy https://ClinicalTrials.gov/show/NCT04588909
NCT04596579 SARS-CoV-2 (COVID-19) Immune Surveillance Among a Population Based Sample of Adults in Florida https://ClinicalTrials.gov/show/NCT04596579
NCT04593654 Dosing of Thromboprophylaxis and Mortality in Critically Ill COVID-19 Patients https://ClinicalTrials.gov/show/NCT04593654
NCT04592055 The Effect of COVID-19 on Diabetes Mellitus https://ClinicalTrials.gov/show/NCT04592055
NCT04591704 The Effect of Diabetes Mellitus on the Prognosis of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04591704
NCT04603664 Role of NGAL and Cystatin C in Prediction of Acute Kidney Injury Covid-19 Infection https://ClinicalTrials.gov/show/NCT04603664
NCT04624503 Prognostic and Clinical Impact of Cardiovascular Involvement in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04624503
NCT04599998 Long-term Follow-up Findings of Inpatients for COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04599998
NCT04596943 RGD PET/CT Imaging in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04596943
NCT04607941 Study of Socio-demographic Factors, Behaviors and Practices Associated With Infection With SARS-CoV-2 Responsible for COVID-19 https://ClinicalTrials.gov/show/NCT04607941
NCT04598620 Non-invasive Prognostication of COVID-19 Patients by Use of Biomarkers in Exhaled Breath Condensate https://ClinicalTrials.gov/show/NCT04598620
NCT04602637 Training Load Management in Three Professional Tennis Players During COVID-19 Lockdown: a Case Series Study https://ClinicalTrials.gov/show/NCT04602637
NCT04601012 OCTA Study: Retinal Vascular Changes in SARS-CoV-2 Patients https://ClinicalTrials.gov/show/NCT04601012
NCT04602481 COVID-19 in People With Primary Ciliary Dyskinesia https://ClinicalTrials.gov/show/NCT04602481
NCT04605952 Study to Find the Percentage of Cases Retaining COVID-19 IgG Antibodies 45-65 After They Have Tested Positive https://ClinicalTrials.gov/show/NCT04605952
NCT04603755 Electrical Impedance Tomography: Collapse in Dependent Areas as a Predictor of Response to Prone Position Ventilation in COVID-19 Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04603755
NCT04604249 Prevalence of COVID-19 in High Altitude : Insights From the Highest City of the World https://ClinicalTrials.gov/show/NCT04604249
NCT04603677 Northern Colorado COVID-19 Biobank https://ClinicalTrials.gov/show/NCT04603677
NCT04604080 Post-COVID-19 Epidemic Depression Assessment in Adults in South Punjab Pakistan https://ClinicalTrials.gov/show/NCT04604080
NCT04605692 Evaluation of Occupational Burnout and Stress Among Dentists in Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04605692
NCT04609839 FOLLOW-UP OF PATIENTS WITH COVID-19. https://ClinicalTrials.gov/show/NCT04609839
NCT04609774 Aerosol Transmission of Severe Acute Respiratory Syndrome Coronavirus of Coronavirus Disease 2019 https://ClinicalTrials.gov/show/NCT04609774
NCT04618341 A Clinical Study of Online Active Play Program With Adolescents https://ClinicalTrials.gov/show/NCT04618341
NCT04609085 SARS-COV2 Pandemic Serosurvey in a Rare Disease Population https://ClinicalTrials.gov/show/NCT04609085
NCT04610554 Lung Diffusing Capacity for Nitric Oxide and Carbon Monoxide Early After Mild-to-severe COVID-19 https://ClinicalTrials.gov/show/NCT04610554
NCT04615390 Recovery Profiles in Patients With SARS-CoV-2 Outcomes Undergoing Rehabilitation https://ClinicalTrials.gov/show/NCT04615390
NCT04618835 Physical Activity a Vital Sign? 40 Steps to Safety Test for Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04618835
NCT04616976 COVID-19 With Convalescent Plasma https://ClinicalTrials.gov/show/NCT04616976
NCT04619693 Biomarkers for Dexamethasone Response in Sars-Cov-2 / COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04619693
NCT04615728 MANAGEMENT OF APPENDICITIS DURING THE COVID-19 PANDEMIC https://ClinicalTrials.gov/show/NCT04615728
NCT04623177 Thromboprophylaxis for Patients in ICU With COVID-19 https://ClinicalTrials.gov/show/NCT04623177
NCT04615195 Effect of COVID19-related COntainment in ChildreN https://ClinicalTrials.gov/show/NCT04615195
NCT04618861 Surfactant Protein D Levels in Covid-19 Infection: Case-Control Study https://ClinicalTrials.gov/show/NCT04618861
NCT04619407 Screening for COVID-19 in Teachers, Childcare Educators, Pupils and Preschoolers https://ClinicalTrials.gov/show/NCT04619407
NCT04621214 Innovation of Audio-Visual Triage System in Combating the Spread of COVID-19 Infection and Its Efficacy: A Novel Strategy https://ClinicalTrials.gov/show/NCT04621214
NCT04619576 Influence of the COVId-19 Pandemic on STRESS of Occupational Health Workers https://ClinicalTrials.gov/show/NCT04619576
NCT04621084 Influence of the COVId-19 Pandemic on STRESS and Eating Habits https://ClinicalTrials.gov/show/NCT04621084
NCT04627194 Characteristics of COVID-19 Patients in Kazakhstan in Early 2020 https://ClinicalTrials.gov/show/NCT04627194
NCT04645433 Effect of Favipiravir on Mortality in Patients With COVID-19 at a Tertiary Center Intensive Care Unit https://ClinicalTrials.gov/show/NCT04645433
NCT04623346 Orthopaedic Conservative Treatment in the Time of Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04623346
NCT04623047 Using Smart Watches to Detect and Monitor COVID-19 https://ClinicalTrials.gov/show/NCT04623047
NCT04625075 Manganese-Enhanced Magnetic Resonance Imaging of MyOcardial injuRY in COVID 19 (COVID-19) https://ClinicalTrials.gov/show/NCT04625075
NCT04631497 Assessment of Stress, Depression and Anxiety in Healthcare Caring for Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04631497
NCT04628195 Cardiac Performance in Mechanically Ventilated COVID-19 Patients https://ClinicalTrials.gov/show/NCT04628195
NCT04625257 COVID-19 in Baselland: Validation of Simple and Accurate Tests for COVID-19 Detection, Monitoring and Tracing (ACCURATE-BL-COVID-19) https://ClinicalTrials.gov/show/NCT04625257
NCT04625296 Behaviour and Experience of Communities Healthcare Professionals Facing the SARS CoV-2 (COVID-19) Epidemic https://ClinicalTrials.gov/show/NCT04625296
NCT04628637 High GRP78 Levels in Covid-19 Infection: A Case-Control Study https://ClinicalTrials.gov/show/NCT04628637
NCT04628000 Baseline Vitamin D Deficiency and COVID-19 Disease Severity https://ClinicalTrials.gov/show/NCT04628000
NCT04632615 Sleep Behaviour in Athletes During Home Confinement Due to the Covid-19 Outbreak https://ClinicalTrials.gov/show/NCT04632615
NCT04627623 Prevalence and Risk Factors of COVID-19 in the Upper Silesian Agglomeration https://ClinicalTrials.gov/show/NCT04627623
NCT04629638 Maternal Attachment and Depression Anxiety Score Evaluation in COVID-19 Positive Pregnant Women https://ClinicalTrials.gov/show/NCT04629638
NCT04633941 Impact of Social Distancing on Bariatric Versus Non-Surgical Obese Patients During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04633941
NCT04630015 Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and Telehealth https://ClinicalTrials.gov/show/NCT04630015
NCT04629222 Tracheobronchitis in Respiratory Involvement on the Lung SPECT/CT Images of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04629222
NCT04629183 Risk Stratification of COVID-19 Patients Discharged From the Emergency Department https://ClinicalTrials.gov/show/NCT04629183
NCT04635787 Vital Sensor Monitors for CV19 Detection https://ClinicalTrials.gov/show/NCT04635787
NCT04631861 Physical Activity and the Risk of COVID-19 Infection and Mortality https://ClinicalTrials.gov/show/NCT04631861
NCT04643548 WHO - Neurological Abnormalities in SARS-CoV-2 ICU Patients https://ClinicalTrials.gov/show/NCT04643548
NCT04635813 The Impact of COVID-19 Pandemic on Thyroid Surgery in Italy: Results From a Nation-wide Multicentric Study https://ClinicalTrials.gov/show/NCT04635813
NCT04644159 Longitudinal Follow-up of a Population Cohort in a French City With High SARS-CoV-2 Circulation, in Early 2020 [COVID-19] https://ClinicalTrials.gov/show/NCT04644159
NCT04642703 Mortality in Patients With Severe COVID-19 Pneumonia Who Underwent Tracheostomy https://ClinicalTrials.gov/show/NCT04642703
NCT04636294 Borderline COVID-19 PCR Test Result https://ClinicalTrials.gov/show/NCT04636294
NCT04644146 Genetic Predisposition to Severe Forms of COVID-19 (SARS-CoV2 Infection) https://ClinicalTrials.gov/show/NCT04644146
NCT04645563 Using Whatsapp for the Consultation https://ClinicalTrials.gov/show/NCT04645563
NCT04645368 Study of Longidaze in the Prevention & Treatment of Pulmonary Fibrosis, Interstitial Lung Diseases Caused by COVID-19 https://ClinicalTrials.gov/show/NCT04645368
NCT04642196 COVID-19 in Home Healthcare https://ClinicalTrials.gov/show/NCT04642196
NCT04641988 Cardiac Biomarkers and Mortality in Critically Ill Patients With SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04641988
NCT04644302 Circulatory Coherence in COVID and Non-COVID Patients With Sepsis https://ClinicalTrials.gov/show/NCT04644302
NCT04643522 Semen Parameters and COVID-19 in Infertile Men https://ClinicalTrials.gov/show/NCT04643522

Registrires

nct_id brief_title link
NCT04314271 The Observational Study of Cardiac and Pulmonary Ultrasound and Evaluation of Treatment of Severe Patients With Novel Coronavirus Pneumonia https://ClinicalTrials.gov/show/NCT04314271
NCT04318314 COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04318314
NCT04315870 Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy: The Italian Registry on Coronavirus in Pregnancy. https://ClinicalTrials.gov/show/NCT04315870
NCT04323592 Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome https://ClinicalTrials.gov/show/NCT04323592
NCT04319016 Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy https://ClinicalTrials.gov/show/NCT04319016
NCT04320472 Acute Encephalopathy in Critically Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04320472
NCT04321811 Behavior, Environment And Treatments for Covid-19 https://ClinicalTrials.gov/show/NCT04321811
NCT04323839 COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY) https://ClinicalTrials.gov/show/NCT04323839
NCT04325412 Cardiac complicAtions in Patients With SARS Corona vIrus 2 (COVID-19) regisTrY https://ClinicalTrials.gov/show/NCT04325412
NCT04327570 In-depth Immunological Investigation of COVID-19. https://ClinicalTrials.gov/show/NCT04327570
NCT04327479 Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection https://ClinicalTrials.gov/show/NCT04327479
NCT04327674 The Use of Focused Lung Ultrasound in Patients Suspected of COVID-19 https://ClinicalTrials.gov/show/NCT04327674
NCT04329559 COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study https://ClinicalTrials.gov/show/NCT04329559
NCT04336956 Covid-19 Pediatric Observatory https://ClinicalTrials.gov/show/NCT04336956
NCT04331574 Renin-Angiotensin System Inhibitors and COVID-19 https://ClinicalTrials.gov/show/NCT04331574
NCT04331171 Epidemiological Observation From a Smartphone Self-monitoring Application for Suspected COVID-19 Patients’ Triage https://ClinicalTrials.gov/show/NCT04331171
NCT04333953 COVID-19 in Patients With HIV https://ClinicalTrials.gov/show/NCT04333953
NCT04341766 Evolution of Pulmonary Ultrasound in Patients Hospitalized for Covid (Coronavirus Disease) 19 https://ClinicalTrials.gov/show/NCT04341766
NCT04334291 International COVID19 Clinical Evaluation Registry, https://ClinicalTrials.gov/show/NCT04334291
NCT04333875 Morbidity and Mortality Due to Deferral of Aortic Valve Replacement in Patients With Severe Aortic Stenosis https://ClinicalTrials.gov/show/NCT04333875
NCT04336345 Outcomes of Patients With COVID-19 in the Intensive Care Unit https://ClinicalTrials.gov/show/NCT04336345
NCT04347278 Observational Study of Follow-up of Hospitalized Patients Diagnosed With COVID-19 to Evaluate the Effectiveness of the Drug Treatment Used to Treat This Disease. COVID-19 Registry https://ClinicalTrials.gov/show/NCT04347278
NCT04335773 COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology https://ClinicalTrials.gov/show/NCT04335773
NCT04345536 Prospective Quality Register of Patients With Confirmed Covid-19 at Oslo University Hospital https://ClinicalTrials.gov/show/NCT04345536
NCT04337346 Evaluation of Covid 19 Anxiety in Endometriosis Patients https://ClinicalTrials.gov/show/NCT04337346
NCT04339881 NOsocomial Dissemination Risk of SARS-Cov2 https://ClinicalTrials.gov/show/NCT04339881
NCT04354519 The United Kingdom Multiple Sclerosis Register Covid-19 Substudy https://ClinicalTrials.gov/show/NCT04354519
NCT04353583 Renal Outcome in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04353583
NCT04340479 The Use of Ultrasound in Establishing COVID-19 Infection as Part of a Trauma Evaluation https://ClinicalTrials.gov/show/NCT04340479
NCT04340466 French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management Study https://ClinicalTrials.gov/show/NCT04340466
NCT04358042 PSYCHIATRIC Disorders and Covid-19 https://ClinicalTrials.gov/show/NCT04358042
NCT04344249 Cohort of Patients With Inflammatory Bowel Disease During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04344249
NCT04342806 Healthcare Worker Exposure Response and Outcomes (HERO) Registry Study, COVID-19 https://ClinicalTrials.gov/show/NCT04342806
NCT04344002 LunG and Melanoma canceR pAtients coVId19 Disease (GRAVID) https://ClinicalTrials.gov/show/NCT04344002
NCT04349982 ICU Trial in Critical Ill COVID-19 Patients https://ClinicalTrials.gov/show/NCT04349982
NCT04348227 How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country’s ICU? https://ClinicalTrials.gov/show/NCT04348227
NCT04344912 Impact of COVID19 Outbreak in Cardiac Acute Care https://ClinicalTrials.gov/show/NCT04344912
NCT04348942 A COVID-19 Symptom, Exposure and Immune Response Registry https://ClinicalTrials.gov/show/NCT04348942
NCT04347993 A Prospective “Universal” Observational Database for COVID-19 https://ClinicalTrials.gov/show/NCT04347993
NCT04347798 IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT https://ClinicalTrials.gov/show/NCT04347798
NCT04357275 The RIsk Stratification in COVID-19 Patients in the ICU Registry https://ClinicalTrials.gov/show/NCT04357275
NCT04378452 Assessment of the Psycho-social Impact of COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04378452
NCT04351529 Austrian COVID-19 Registry https://ClinicalTrials.gov/show/NCT04351529
NCT04354818 Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA) https://ClinicalTrials.gov/show/NCT04354818
NCT04352764 ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings https://ClinicalTrials.gov/show/NCT04352764
NCT04354701 COVID-19 and Cancer Consortium Registry https://ClinicalTrials.gov/show/NCT04354701
NCT04356586 Immune Response to Covid-19 in 300 Health Care Workers With Mild Symptoms https://ClinicalTrials.gov/show/NCT04356586
NCT04366206 Factors Associated With Clinical Outcomes in Patients Hospitalized for Covid-19 in GHT-93 Est https://ClinicalTrials.gov/show/NCT04366206
NCT04357639 Impact of Long-term Protease Inhibitors in Patients Living With HIV on the Incidence of COVID-19 ( COVIP ) https://ClinicalTrials.gov/show/NCT04357639
NCT04380766 Covid-19 Pandemic and Pancreatic Surgery in Italy https://ClinicalTrials.gov/show/NCT04380766
NCT04359927 Long-term Effects of Coronavirus Disease 2019 on the Cardiovascular System: CV COVID-19 Registry https://ClinicalTrials.gov/show/NCT04359927
NCT04359602 COVID-19 Recovered Volunteer Research Participant Pool Registry https://ClinicalTrials.gov/show/NCT04359602
NCT04374110 Drug Safety and the Occurrence of Complications During Hospitalization in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04374110
NCT04361591 COVID-19 in Liver Transplant Recipients https://ClinicalTrials.gov/show/NCT04361591
NCT04361500 Registry of COVID-19 Patients Treated With the Seraph 100 Microbind Affinity Blood Filter https://ClinicalTrials.gov/show/NCT04361500
NCT04366986 International Registry of Coronavirus (COVID-19) Exposure in Pregnancy https://ClinicalTrials.gov/show/NCT04366986
NCT04364984 ARB, ACEi, DRi in COVID-19 https://ClinicalTrials.gov/show/NCT04364984
NCT04363632 Prospective Analysis of Morbi-mortality of Patients With Cancers in Active Phase of Treatment Suspected or Diagnosed of a SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04363632
NCT04433871 COVID-19 in Pediatric Oncology and Hematology Centers in France https://ClinicalTrials.gov/show/NCT04433871
NCT04365322 Study of Specific Viral Immune Responses Induced by SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04365322
NCT04393142 Serologic Testing of Household Contacts of Confirmed Cases of COVID-19 https://ClinicalTrials.gov/show/NCT04393142
NCT04370821 COVID-19 CHAMPS Study of Healthcare, First Responder and Service Workers https://ClinicalTrials.gov/show/NCT04370821
NCT04368975 ARDS Caused by COVID-19 https://ClinicalTrials.gov/show/NCT04368975
NCT04368234 Duke COVID-19 Shared Data and Specimen Repository https://ClinicalTrials.gov/show/NCT04368234
NCT04368143 COVID-19 Immune Repertoire Sequencing https://ClinicalTrials.gov/show/NCT04368143
NCT04367714 Antibody Response Against SARS-CoV-2 in Dialysis Patients During COVID-19 https://ClinicalTrials.gov/show/NCT04367714
NCT04367207 African Covid-19 Critical Care Outcomes Study https://ClinicalTrials.gov/show/NCT04367207
NCT04380727 Almitrine and COVID-19 Related Hypoxemia https://ClinicalTrials.gov/show/NCT04380727
NCT04370067 HUNgarian COronaVirus Disease-19 Epidemiological Research https://ClinicalTrials.gov/show/NCT04370067
NCT04369300 Anxiety And Depression During COVID-19 IN INDIA https://ClinicalTrials.gov/show/NCT04369300
NCT04367857 ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers https://ClinicalTrials.gov/show/NCT04367857
NCT04367350 Prospective Registry of Corona Virus Disease 2019 (Covid-19) Patients With Neuromuscular Involvement https://ClinicalTrials.gov/show/NCT04367350
NCT04368065 COVID-19 Active Research Experience (CARE) https://ClinicalTrials.gov/show/NCT04368065
NCT04372199 SEVERITY SCORE FOR COVID-19 PNEUMONIA https://ClinicalTrials.gov/show/NCT04372199
NCT04371328 Emergency Management in a Dedicated Respiratory Unit of Patients With a Possible COVID-19 Infection https://ClinicalTrials.gov/show/NCT04371328
NCT04374045 Testing for Dysautonomia in Patients Hospitalized for SARS-CoV-2 Infection (COVID-19) : COVIDANS Study https://ClinicalTrials.gov/show/NCT04374045
NCT04371744 QT-Logs : Artificial Intelligence for QT Interval Analysis of ECG From Smartwatches in Patient Receiving Treatment for Covid-19 https://ClinicalTrials.gov/show/NCT04371744
NCT04373759 Cardiac Arrest Incidence and Outcome Among Patients With COVID-19 in French ICUs https://ClinicalTrials.gov/show/NCT04373759
NCT04379440 Geriatric Population COVID-19 Observational Study (GEROCOVIDobs) https://ClinicalTrials.gov/show/NCT04379440
NCT04383457 Covid-19 Triage Using Camera-based AI https://ClinicalTrials.gov/show/NCT04383457
NCT04379544 Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19 https://ClinicalTrials.gov/show/NCT04379544
NCT04376398 Survey: COVID-19 Patients Managed in the Operating Theatre of Belgian Hospitals https://ClinicalTrials.gov/show/NCT04376398
NCT04390555 The Global PCHF-COVICAV Registry https://ClinicalTrials.gov/show/NCT04390555
NCT04388605 Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic https://ClinicalTrials.gov/show/NCT04388605
NCT04385797 Cognitive Outcomes During COVID-19 confiNemeNt in Elderly and Their Caregivers Using Technologies for DEMentia https://ClinicalTrials.gov/show/NCT04385797
NCT04388436 Post Covid-19 Cardiopulmonary and Immunological Changes https://ClinicalTrials.gov/show/NCT04388436
NCT04386265 Compassionate Use of Hyperbaric Oxygen Therapy https://ClinicalTrials.gov/show/NCT04386265
NCT04391920 Registry of CytoSorb Therapy in COVID-19 ICU Patients https://ClinicalTrials.gov/show/NCT04391920
NCT04389996 COVID-19 Pandemic Impact on Patients With Cancer - a Danish Survey https://ClinicalTrials.gov/show/NCT04389996
NCT04388631 Detection Rate of SARS-CoV-2 in Male Genitourinary System and Its Impact on Male Reproductive Health. https://ClinicalTrials.gov/show/NCT04388631
NCT04391946 Observatory of Patients With Chronic Lymphocytic Leukemia / Lymphocytic Lymphoma or Waldenstrom Disease Infected With COVID-19 https://ClinicalTrials.gov/show/NCT04391946
NCT04387929 Detection of Anti-COVID-19 Antibody Levels in an Hospital Population https://ClinicalTrials.gov/show/NCT04387929
NCT04397575 The GCO-002 CACOVID-19 Cohort: a French Nationwide Multicenter Study of COVID-19 Infected Cancer Patients https://ClinicalTrials.gov/show/NCT04397575
NCT04389554 D-dimer Levels in Pregnant With COVID-19 https://ClinicalTrials.gov/show/NCT04389554
NCT04490837 Rapid Diagnostic Test for COVID-19 Based on Antibody Detection (YCOVID) https://ClinicalTrials.gov/show/NCT04490837
NCT04391686 Resting Energy Expenditure of the COronaVirus (COVID19) Patient in Reanimation Context https://ClinicalTrials.gov/show/NCT04391686
NCT04394000 Impact of an Intensified Thromboprofylaxis Protocol in COVID-19 https://ClinicalTrials.gov/show/NCT04394000
NCT04393324 The Critical Care Response to the COVID-19 Pandemic in Madrid https://ClinicalTrials.gov/show/NCT04393324
NCT04497194 Registry of COVID-19 Patients at AOUI Verona https://ClinicalTrials.gov/show/NCT04497194
NCT04395781 Pediatric Acute and Critical Care COVID-19 Registry of Asia https://ClinicalTrials.gov/show/NCT04395781
NCT04394390 Do Vitamin D Levels Really Correlated With Disease Severity in COVID-19 Patients? https://ClinicalTrials.gov/show/NCT04394390
NCT04413955 Registry of Seraph®-100 Microbind® Affinity Blood Filter for COVID-19 Under EUA https://ClinicalTrials.gov/show/NCT04413955
NCT04408339 COVID-19 in Cancer Patients: Evaluation of Clinical Course and Impact on Oncological Care Including Biobanking https://ClinicalTrials.gov/show/NCT04408339
NCT04395794 SARS-CoV-2 Disguise Study https://ClinicalTrials.gov/show/NCT04395794
NCT04398264 Characteristics of COVID-19 Infection Among PREGnant Women https://ClinicalTrials.gov/show/NCT04398264
NCT04453748 The Assessment of the Prevalence, Clinical Course and Treatment of COVID-19 Complications https://ClinicalTrials.gov/show/NCT04453748
NCT04401033 Increased Risk of SARS-CoronaVirus-2 (SARS-CoV-2) Infection Associated With Endoscopy (DECORE Study) https://ClinicalTrials.gov/show/NCT04401033
NCT04401540 Characteristics of Neonatal Covid-19 in Turkey https://ClinicalTrials.gov/show/NCT04401540
NCT04403672 Performance Evaluation of RealDetectâ„¢ COVID-19 RT-PCR Kit for the Detection of SARS-CoV-2 Virus https://ClinicalTrials.gov/show/NCT04403672
NCT04411563 Epigenetic Tools as Prognostic Predictors in Covid19 https://ClinicalTrials.gov/show/NCT04411563
NCT04412382 Covid-19: Possible Role of Neutrophil Extracellular Traps https://ClinicalTrials.gov/show/NCT04412382
NCT04410471 Humoral Immunity Against SARS-CoV-2 in Liver Transplanted Patients After COVID-19 in Comparison With Immunocompetent Patients https://ClinicalTrials.gov/show/NCT04410471
NCT04412317 Use of PCR-Sars-CoV-2 in Children https://ClinicalTrials.gov/show/NCT04412317
NCT04416009 Extracellular Water in Covid 19 Pneumonia https://ClinicalTrials.gov/show/NCT04416009
NCT04412551 Lung Ultrasound for Assessment of Patients With Moderate to Severe Covid-19 https://ClinicalTrials.gov/show/NCT04412551
NCT04488562 Home Monitoring and Evaluation After Admission for COVID-19 in the Netherlands https://ClinicalTrials.gov/show/NCT04488562
NCT04435457 Cardiovascular Implications of COVID-19 https://ClinicalTrials.gov/show/NCT04435457
NCT04418557 COVID-19 and Obstetric Transmission https://ClinicalTrials.gov/show/NCT04418557
NCT04422444 Post Intensive Care Syndrome in COVID19 Patients https://ClinicalTrials.gov/show/NCT04422444
NCT04422587 Evaluation of the COVID-19 Infection Response in Patients Admitted to the Emergency Department for Dyspnea https://ClinicalTrials.gov/show/NCT04422587
NCT04425759 Prevalence and Risk Factors of SARS-CoV-2 Antibody Responses (COVID-19) https://ClinicalTrials.gov/show/NCT04425759
NCT04423003 Endoscopic Interventions in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04423003
NCT04422470 Registry of Patients With Hematologic Disease and COVID-19 in Russia https://ClinicalTrials.gov/show/NCT04422470
NCT04434144 A Comparative Study on Ivermectin and Hydroxychloroquine on the COVID19 Patients in Bangladesh https://ClinicalTrials.gov/show/NCT04434144
NCT04429477 Cerebral Compliance Impairment in COVID-19 https://ClinicalTrials.gov/show/NCT04429477
NCT04426084 Cardiovascular Risk Factors and Severe COVID-19. A Nationwide Registry-based Case-Control Study https://ClinicalTrials.gov/show/NCT04426084
NCT04503434 Patients’ Experiences in a Medicalized Hotel for COVID-19 Acute Care Support https://ClinicalTrials.gov/show/NCT04503434
NCT04430374 Registry for a Cardiovascular Patient Who COVID-19 Infection in Qatar and Gulf https://ClinicalTrials.gov/show/NCT04430374
NCT04431869 In-Utero Vascular Accidents in Neonates From COVID-19 Infected Mothers https://ClinicalTrials.gov/show/NCT04431869
NCT04433364 COPE - COVID-19 in Pregnancy and Early Childhood https://ClinicalTrials.gov/show/NCT04433364
NCT04435041 Remote-by-Default Care in the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04435041
NCT04444310 Antibody Responses in Contacts of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04444310
NCT04443140 Preeclampsia-like Syndrome Induced by COVID-19: Is it a Real Public Health Issue in Pregnancy During the Pandemic? https://ClinicalTrials.gov/show/NCT04443140
NCT04449042 The PAWS-COVID-19 (Pediatric AirWay complicationS COVID-19) Registry https://ClinicalTrials.gov/show/NCT04449042
NCT04445402 Pediatrics HOT COVID-19 Database in NY Tristate https://ClinicalTrials.gov/show/NCT04445402
NCT04466306 Pediatric Acute Kidney Injury in COVID-19 https://ClinicalTrials.gov/show/NCT04466306
NCT04450277 Delivery of Protocolised Emergency Surgical Care During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04450277
NCT04460170 COVID-19 Follow up Intensive Care Studies https://ClinicalTrials.gov/show/NCT04460170
NCT04453579 Bariatric Surgery During Lockdown, Impact of COVID-19 on Physical and Mental Health https://ClinicalTrials.gov/show/NCT04453579
NCT04457505 One Year Follow-ups of Patients Admitted to Spanish Intensive Care Units Due to COVID-19 https://ClinicalTrials.gov/show/NCT04457505
NCT04455347 Cardiac and Thoracic Imaging in Pediatric Patients With Evidence of Systemic Inflammation COVID19 Linked https://ClinicalTrials.gov/show/NCT04455347
NCT04521088 Epidemiological Analysis of Ambulant Patients in a COVID-19 Outpatient Clinic https://ClinicalTrials.gov/show/NCT04521088
NCT04459689 COVID-19 in PID Survey https://ClinicalTrials.gov/show/NCT04459689
NCT04465474 Coronavirus Disease 2019 (COVID-19) During Pregnancy: Prevalence of Seroconversion, Effect on Maternal and Perinatal Outcomes and Risk of Vertical Transmission (COVID-MAP) https://ClinicalTrials.gov/show/NCT04465474
NCT04459364 The Prevalence of Pulmonary Hypertension in Patients With COVID-19. https://ClinicalTrials.gov/show/NCT04459364
NCT04460196 Healthcare Renunciation During the Confinement Period in Connection With the COVID-19 Epidemic in Adult Emergency Departments https://ClinicalTrials.gov/show/NCT04460196
NCT04463862 COVID - AirPollution https://ClinicalTrials.gov/show/NCT04463862
NCT04472078 Seroprevalence of Coronavirus Disease 2019 (COVID-19) Antibodies in a Vulnerable Neighbourhood, Buenos Aries Argentina https://ClinicalTrials.gov/show/NCT04472078
NCT04479488 Brazilian Registry for Clinical Presentation of Individuals With COVID-19 (SARS-Brazil) https://ClinicalTrials.gov/show/NCT04479488
NCT04479150 Complications and Mortality Following Emergency Digestive Surgery During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04479150
NCT04481646 Novel Face Mask Sampling for COVID-19: A Diagnostic and Public Health Tool https://ClinicalTrials.gov/show/NCT04481646
NCT04511429 COVID-19 in Immunosuppressed Children https://ClinicalTrials.gov/show/NCT04511429
NCT04498546 Mask Usage and Exercise During the COVİD-19 Pandemic https://ClinicalTrials.gov/show/NCT04498546
NCT04497402 Sex-Informed Data in the COVID-19 Pandemic. https://ClinicalTrials.gov/show/NCT04497402
NCT04503057 Exhaled Breath Particles as a Clinical Indicator for Lung Injury and Acute Respiratory Distress Syndrome (ARDS) https://ClinicalTrials.gov/show/NCT04503057
NCT04515199 Home Management of Adult Egyptian Mild COVID-19 Cases https://ClinicalTrials.gov/show/NCT04515199
NCT04508920 A Survey to Assess Effects of Covid-19 on Cardiovascular Patients https://ClinicalTrials.gov/show/NCT04508920
NCT04506528 The C3I COVID-19 Project https://ClinicalTrials.gov/show/NCT04506528
NCT04505709 Clinical, Immunological, Genomic, Virological and Bioethical Actors of COVID-19 https://ClinicalTrials.gov/show/NCT04505709
NCT04508712 Long-term Outcomes in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04508712
NCT04508959 The McMaster Multi-Regional COVID-19 Hospital Case Registry https://ClinicalTrials.gov/show/NCT04508959
NCT04605965 WEAICOR: Wearables to Investigate the Long Term Cardiovascular and Behavioral Impacts of COVID-19 https://ClinicalTrials.gov/show/NCT04605965
NCT04517630 Renal Biomarkers in AKI and COVID-19 https://ClinicalTrials.gov/show/NCT04517630
NCT04527315 COVID-19 Survivorship Registry https://ClinicalTrials.gov/show/NCT04527315
NCT04531202 CORE Study COVID-19 https://ClinicalTrials.gov/show/NCT04531202
NCT04533360 Prevalence of COVID-19 Antibodies Kingman AZ https://ClinicalTrials.gov/show/NCT04533360
NCT04532632 Taste and Smell Impairment in Critically Ill COVID-19 Patients https://ClinicalTrials.gov/show/NCT04532632
NCT04535128 COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic Complications https://ClinicalTrials.gov/show/NCT04535128
NCT04544878 Pediatric Intensive Care and COVID-19 https://ClinicalTrials.gov/show/NCT04544878
NCT04542512 Risk Factors for Necrotic Cholecystitis During COVID-19 Pandemic. https://ClinicalTrials.gov/show/NCT04542512
NCT04542954 Optimized Management of Covid-19 Positive Kidney Transplant Recipients: Single Center Experience From the Middle East https://ClinicalTrials.gov/show/NCT04542954
NCT04560608 Elucidating the Symptomatic, Explanatory and Prognostic Characteristics of GERIAtric Patients Hospitalized for COVID-19 https://ClinicalTrials.gov/show/NCT04560608
NCT04546191 Symptoms and Wellbeing of People Infected With Covid-19 Virus in Iceland https://ClinicalTrials.gov/show/NCT04546191
NCT04641182 Prone Position for Nonintubated Patients With COVID-19 and Hypoxemic Respiratory Failure https://ClinicalTrials.gov/show/NCT04641182
NCT04553575 CoViD-19 Patient in Reims University Hospital in March to April 2020 https://ClinicalTrials.gov/show/NCT04553575
NCT04553055 Antibiotic Misuse During COVID-19 Pandemic: A Cross-sectional Survey Addressed to Community Pharmacists https://ClinicalTrials.gov/show/NCT04553055
NCT04581135 Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19 https://ClinicalTrials.gov/show/NCT04581135
NCT04558996 Spanish Registry of Pregnant Women With COVID-19 https://ClinicalTrials.gov/show/NCT04558996
NCT04558203 The Relationship Between COVID-19 and Autoimmune Diseases, Lessons From Practice https://ClinicalTrials.gov/show/NCT04558203
NCT04559009 COVID-19 Amyotrophic Lateral Sclerosis (ALS) Registry https://ClinicalTrials.gov/show/NCT04559009
NCT04568421 Argentinian Registry of Patients With Rheumatic Diseases and COVID-19 Infection https://ClinicalTrials.gov/show/NCT04568421
NCT04568005 Evaluation of Lymphedema Patients Status During Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04568005
NCT04573868 National Study “AEC COVID-19” https://ClinicalTrials.gov/show/NCT04573868
NCT04583566 Differential Expression of Cytokines, Transcriptome and miRNA in Coronavirus Disease 2019 (COVID-19) Egyptian’s Patients https://ClinicalTrials.gov/show/NCT04583566
NCT04581096 Mapping COVID-19 Spread in a Tertiary Hospital https://ClinicalTrials.gov/show/NCT04581096
NCT04583306 The Salivary Raman COVID-19 Fingerprint https://ClinicalTrials.gov/show/NCT04583306
NCT04601090 Survival Rates and Longterm Outcomes After COVID-19 https://ClinicalTrials.gov/show/NCT04601090
NCT04598347 Evaluation of the Possible Vertical Transmission of SARS-CoV-2 Through Study of Amniotic Fluid and Chorionic Villi of Affected Pregnant Women for the COVID-19 https://ClinicalTrials.gov/show/NCT04598347
NCT04598256 Endoscopic Procedures of Children in the Normalization Process of Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04598256
NCT04609501 Delivery During Covid-19 Pandemic: Implications for Obstetrics, Maternal Psychopathology, and Mother-Infant Relationship https://ClinicalTrials.gov/show/NCT04609501
NCT04609332 Endothelial Damage and Angiogenesis Biomarkers During COVID-19 https://ClinicalTrials.gov/show/NCT04609332
NCT04604119 Anxiety and Burnout in Anesthetists and Intensive Care Unit Nurses During Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04604119
NCT04606732 CardioVascular Disease Progression and Prognosis in COVID-19 https://ClinicalTrials.gov/show/NCT04606732
NCT04613245 Health-Related Quality of Life of Patients With Asthma During the Pandemic of COVID-19 https://ClinicalTrials.gov/show/NCT04613245
NCT04611269 Clinical Characteristics and Outcomes of Patients With COVID-19 on Mechanical Ventilation in Argentina https://ClinicalTrials.gov/show/NCT04611269
NCT04625036 NO-mediated Vascular Function in Covid-19 Patient https://ClinicalTrials.gov/show/NCT04625036
NCT04615026 Prevalence of Thrombosis in COVID-Patients https://ClinicalTrials.gov/show/NCT04615026
NCT04615000 SeroCovid<19: A Prospective Covid-19 Seroconversion Study in a Tertiary Pediatric Patient Cohort https://ClinicalTrials.gov/show/NCT04615000
NCT04619368 Post-intensive Care Follow-up of Patients Hospitalized for an Acute Respiratory Distress Syndrome Caused by COVID-19 https://ClinicalTrials.gov/show/NCT04619368
NCT04615676 Prospective Evaluation of the Predictive Criteria of Severity for Respiratory Infection Due to COVID-19 Virus https://ClinicalTrials.gov/show/NCT04615676
NCT04632732 Apelin; ACE2 and Biomarkers of Alveolar-capillary Permeability in SARS-cov-2 (COVID-19). https://ClinicalTrials.gov/show/NCT04632732
NCT04623697 Covid-19 Infection and New Onset Type 1 Diabetes https://ClinicalTrials.gov/show/NCT04623697
NCT04626076 International Registry of Healthcare Workers Exposed to COVID-19 Patients https://ClinicalTrials.gov/show/NCT04626076
NCT04629001 Effect of Covid-19 on Outcomes of Pregnancy https://ClinicalTrials.gov/show/NCT04629001
NCT04636021 Restoring Non-Emergent Cardiovascular Care in the Peri- COVID-19 Era https://ClinicalTrials.gov/show/NCT04636021
NCT04631172 Covid-19 Anxiety and Phobia Levels of the Parents https://ClinicalTrials.gov/show/NCT04631172